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Thesis Summary
The aim of this work was to elucidate the mechanisms underlying the siderophore 
activity of myoinositol hexakisphosphate (myo-InsP6). myo-InsP6 is found in the 
natural environment of P. aeruginosa and in many, if not all, plant and animal cells.
Using a range of lower inositol phosphates, it was possible to identify key structural 
motifs responsible for inositol phosphate-mediated iron uptake. Using the hydroxyl 
radical assay, the 1,2,3 trisphosphate motif appears to provide the optimum 
conformation for interaction with ferric iron. However, this conformation is 
associated with a particularly low ability to mediate iron transport in P. aeruginosa. 
Conversely, myo-Ins(l,4,5)P3 appears to have a lower ability to interact with iron and 
is associated with a larger degree of iron transport. This inverse relationship was 
attributed to the differences in abilities to yield iron to a putative carrier system. 
Models are proposed to illustrate ferri-inositol phosphate interactions.
In attempting to identify mechanisms responsible for iron release from inositol 
phosphates, conformational mobility of the inositol ring was not regarded as 
essential. However, P. aeruginosa reductase activity was capable of removing iron 
from the range of inositol phosphates tested. With respect to the bacterial 
mechanisms involved in myo-InsP6-mediated iron transport, the integrity of the outer 
membrane and the dependence upon active transport systems were noted as key 
factors. Specific binding of [3H]-myo-InsP6 to the outer membrane was 
demonstrated although this did not appear to be via a specific outer membrane 
protein. Finally, it was not possible to isolate a mutant unable to use ferri-myo-InsPg 
as an iron source, although a model was proposed to explain this alternative 
mechanism of iron acquisition in P. aeruginosa.
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Chapter 1
Introduction
1.1. The Biological Importance of Iron
Iron is the fourth most abundant element on earth and impacts significantly on many 
biological systems. It is the second most abundant metal after aluminium (reviewed 
by Neilands, 1991). It is an essential component in cytochromes, hydroperoxidases, 
in iron-sulphur proteins and ribonucleotide reductase and most life-forms cannot 
exist in the absolute absence of iron (Neilands, 1991).
Iron has unusual chemistry in that it can exist as either the Fe(Hl) (ferric) or the Fe(II) 
(ferrous) oxidation state. However, the majority of iron is present as Fe(IH). Fe(II) 
is relatively soluble and it is possible to obtain a 100 mM solution at neutral pH. 
However, because of the formation of insoluble oxyhydroxide polymers of the 
general composition FeOOH e.g. goethite and hematite, the greatest concentration of 
Fe (HI) possible in the same conditions is approximately 10'18 M (Neilands, 1991). 
To sustain bacterial growth, Fe(III) must be present between 10'8 to 10'6 M, hence 
many bacteria have developed iron-uptake systems that overcome the insolubility of 
this important element. Such systems permit iron acquisition and its subsequent 
uptake into the bacterium.
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In vivo iron availability is also very low despite large amounts being present. The 
human body contains 4 to 5g of iron (Bagg and Neilands, 1987b), approximately 
75% of which is bound in haemoglobin. Much of the remainder is stored in the liver 
in ferritin resulting in only trace amounts being available for enzyme and transport 
functions. The human body is remarkably efficient in its use and internal cycling of 
iron. Iron from old erythrocytes is salvaged, stored temporarily in ferritin and then 
used in the synthesis of new haemoglobin. The cycle is so efficient that only 1 mg of 
iron is required each day to maintain homeostasis. This translates to a daily dietary 
requirement of approximately 10 mg (reviewed by Neilands, 1991).
Most extracellular iron is found in body fluids such as plasma and mucosal 
secretions bound to the high affinity iron-binding glycoproteins transferrin and 
lactoferrin (Griffiths, 1991). Transferrin is the major plasma iron-binding 
glycoprotein and lactoferrin is found primarily in mucosal secretions.
During infection, the host is able to reduce significantly the amount of free iron 
available by two processes. One process involves the release of lactoferrin from 
polymorphonucleocyte (PMN) leucocytes which, having a high affinity for iron, 
removes iron from serum transferrin (Webster et al., 1980). Iron-lactoferrin 
complexes are thought to be internalised by macrophages and eliminated by the 
reticuloendothelial system (van Snick et al., 1974; Klempner et al., 1978). An 
alternative method involves iron bound to transferrin being transferred to 
intracellular storage in ferritin molecules (Konijn and Hershko, 1989). This non­
2
specific mechanism forms a first line defence mechanism against invading 
pathogens.
The level of iron within the cell must be controlled precisely since an excess leads to 
the formation of damaging free radicals. It is the versatility of iron, with its two 
stable valencies, that confers considerable potential for a range of 
oxidation/reduction reactions and chemical reactivities. One particular problem is 
that iron is a central component in Haber-Weiss-Fenton chemistry.
Iron catalyses the formation of highly reactive hydroxyl free radicals that react with 
many biological molecules . In particular, hydroxyl free radicals damage DNA and 
perturb membranes by peroxidation of lipids (Halliwell and Gutteridge, 1984). 
Haber-Weiss-Fenton chemistry is summarised as follows:-
O2 + Fe3+ —» 0 2 + Fe2+
2 O2 + 2H+ —^ H2O2 + 0 2
H20 2 + Fe2+ -> Fe3+ + O H ' + OH*
Precise regulation is therefore essential to ensure that the intracellular iron 
concentration is maintained at a level suitable for cell homeostasis and yet not cause 
toxicity. In iron-replete conditions, iron is stored in the intracellular storage 
compound ferritin and cellular iron-uptake via the transferrin receptor is limited. 
Conversely, in iron-deplete conditons, ferritin synthesis is reduced and the cell 
directs synthesis of the transferrin receptor to acquire iron. Iron levels in mammalian
3
cells are maintained, in part, by the reciprocal control of the transferrin receptor and 
ferrritin mRNA via a cytosolic protein termed the iron-regulatory factor (IRF) 
(Mullner et al., 1989). All ferritin mRNAs have an iron-responsive element (IRE) 
located in their 5’ untranslated regions (Casey et a l, 1988) and a similar structure is 
found in the 3’ untranslated regions of TfR (transferrin receptor) mRNAs. 
Regulation occurs as a result of IRF binding the IREs of the relevant mRNAs. In 
iron-deplete conditions, IRF binds to the IRE of TfR mRNA, protecting it from 
nuclease digestion hence enhancing TfR expression. This leads to increased iron- 
uptake into the cell. In addition, IRF binds to the IRE of ferritin mRNA, but in this 
case blocks ferritin production. However, in iron-replete conditions, IRF dissociates 
from TfR mRNA resulting in its degradation leading to reduced TfR production. 
IRF binds less tightly to ferritin mRNA resulting in increased expression with a 
subsequent increase in ferritin production. Consequently, excess iron becomes bound 
to ferritin in a form that cannot take part in Haber-Weiss chemistry (Ward et al., 
1994).
Pseudomonas aeruginosa, in common with many other bacteria, produces a ferritin­
like compound, termed bacterioferritin, for intracellular iron storage (Moore et al., 
1986). The three-dimensional structures of the bacterioferritins are similar to animal 
ferritins and most contain 3 to 12 haem groups in 24 subunits of 17 to 19 kDa. In 
addition, bacterioferritins contain 8 to 10% by weight of non-haem iron (Moore et 
al., 1994).
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1.2. The Response of Gram-negative Bacteria to Iron Limitation
In response to iron-deplete conditions, many Gram-negative bacteria derepress high- 
affinity iron-uptake mechanisms based on the production of siderophores which 
scavenge environmental iron and transport it back to the bacterium. In addition, 
many Gram-negative bacteria produce exoproducts capable of inflicting considerable 
damage to host tissue. Exoproduct-mediated cellular damage results in the release of 
intracellular iron which also becomes available for the bacterium.
Siderophores have extremely high affinities towards ferric iron and enable 
solubilisation and transport of the metal into the bacterial cell via proteins located in 
the outer membrane. In vivo siderophore production has been confirmed for several 
pathogens. These include P. aeruginosa, whose siderophores have been observed in 
the sputa of cystic fibrosis patients (Haas et al., 1991a) and Vibrio cholerae which 
releases the siderophore vibriobactin (Griffiths et al., 1984) to collect iron released 
as a result of haemolysin-mediated cell damage (Honda and Finkelstein, 1979). In 
addition, schizokinen, a citrate based siderophore produced by Bacillus and 











Figure 1.1. Bacterial siderophore-mediated iron-uptake where sid =
siderophore (adapted from Griffiths, 1987).
Other human pathogens have developed methods for removing iron directly from 
transferrin and lactoferrin. Neisseria gonnorhoeae and Neisseria meningitidis have 
outer membrane protein receptors that remove iron directly from host glycoproteins. 
The receptors are specific for transferrin or lactoferrin, since neither glycoprotein is 
capable of blocking the binding of the other. By binding the relevant glycoprotein, 
the organism is able to scavenge sufficient iron for growth (reviewed by Wooldridge 
and Williams, 1993).
1.3. The Clinical Importance of Pseudomonas aeruginosa
P. aeruginosa is a Gram-negative opportunist pathogen of considerable clinical 
importance (Hancock, 1986) It is carried by many people and is ranked alongside 
Enterococcus faecalis and Escherichia coli as being one of the major causes of
6
nosocomial infections (Schaberg et al., 1991). However, P. aeruginosa rarely causes 
infections in healthy people and, in most cases, the disease process begins with some 
alteration or circumvention of the normal host defences (Pollack, 1990). P. 
aeruginosa is associated with several life-threatening infections in patients already 
suffering debilitating illness. These include the immunocompromised, following 
transplant surgery or as a result of leukaemia, and patients suffering from severe 
bums, cancer and diabetes mellitus. It is also the leading cause of mortality in cystic 
fibrosis (CF) patients (Koch and Hoiby, 1993).
1.3.1. Pseudomonas aeruginosa in Cystic Fibrosis
CF is the most common autosomal recessive genetic disease amongst Caucasians 
affecting approximately 1 in 2500 live births (Collins, 1992). Mutations causing CF 
occur in the gene encoding a cAMP-regulated transmembrane chloride channel 
called the cystic fibrosis transmembrane regulator (CFTR) protein. In the lung, 
deficiencies in CFTR impair chloride and water secretion by the respiratory 
epithelium, resulting in the formation of thick dehydrated mucus that is difficult to 
clear. This seems to provide some micro-organisms with a favourable growth 
environment. The most common infective agents are P. aeruginosa, Burkolderia 
(Pseudomonas) cepacia, and Staphylococcus aureus, although Haemophilus 
influenzae, non-tuberculous mycobacteria and Aspergillus fumigatus have also been 
isolated (Deretic et al., 1995). Of these, P. aeruginosa is the most prevalent with 
over 80% of patients eventually becoming infected (Koch and Hoiby, 1993). Once 
established, P. aeruginosa is difficult to control particularly since it is inherently 
resistant to many antibiotics. Moreover, this is exacerbated by conversion to a
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mucoid phenotype where the exopolysaccharide alginate is overproduced. Death 
resulting from chronic infection is usually a result of airway damage that impairs gas 
exchange that ultimately causes a fatal deterioration in respiratory function.
1.4. Siderophore Systems of Pseudomonas aeruginosa
P. aeruginosa responds to iron-limiting conditions by derepressing high-affinity 
iron-uptake systems based on two unrelated siderophores, pyochelin and pyoverdine. 
The combination of pyoverdine and pyochelin increases the ability of P. aeruginosa 
to grow in the presence of human serum and transferrin (Cox, 1982; Ankenbauer et 
a l, 1985).
A recent study by Meyer et al., (1996) indicates that pyoverdine is essential for the 
virulence of P. aeruginosa. Using a mouse model, pyoverdine-deficient mutants 
were less virulent than the pyoverdine-producing equivalent which caused eventual 
death. Virulence of the pyoverdine-deficient strain was restored when purified 
pyoverdine originating from the wild-type strain was added to the site of infection. 
Competition experiments, demonstrating the ability of pyoverdine to remove iron 
from ferritransferrin in vitro, supported these findings.
Mucoid strains of P. aeruginosa isolated from the lungs of infected CF patients 
produce pyoverdine and pyochelin in a manner similar to their non-mucoid 
counterparts (Haas et al., 1991b). Pyoverdine has a much higher affinity for Fe(]H) 
than pyochelin (K = 1032 M '1 and 2.5xl05 M '1, respectively), and is regarded as the
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more important siderophore (Cox and Graham, 1979; Ankenbauer et al., 1985; 
Wendenbaum etal., 1983).
1.4.1. Pyochelin
Pyochelin was first isolated by Cox and Graham (1979) from ethyl acetate extracts of 
P. aeruginosa culture supernatants. It is synthesised during active growth in culture 
media containing limited amounts of FeCl3. When added to iron-deficient cultures, 
pyochelin promotes bacterial growth and can reverse growth inhibition by the iron- 
chelator ethylenediamine di-(o-hydoxyphenylacetic acid) (EDDHA). Pyochelin 
production is not unique to P. aeruginosa and is also produced by Burkholderia 
{Pseudomonas) cepacia and Pseudomonas fluorescens (Cuppels et al., 1987; Sokol, 
1986).
Pyochelin is structurally unique and has neither hydroxamate nor catecholic- 
chelating groups (Ankenbauer and Quan, 1994). The pyochelin molecule consists of 
a salicyl ring bonded to a thiazoline ring which is itself bonded to a N- 
methylthiazolidine ring (Cox et al., 1981) and has been assigned the nomenclature 2- 
[2-(o-hydroxyphenyl)-2-thiazoline-4-yl]-3-methyl-4-thiazolidine carboxylic acid. 
The unusual combination of thiazoline and thiazolidine heterocyclic rings in 
pyochelin has not been observed in other siderophores. Only anguibactin, from 
Vibrio anguillarium possesses a thiazoline ring (Jalal et al., 1989). However, unlike 




Figure 1.2. The structure of pyochelin (Cox et al., 1981).
1.4.2. Pyochelin-associated O uter M em brane Proteins
The receptor for ferripyochelin was initially suggested to be a weakly iron repressible 
14 kDa outer membrane protein (Sokol and Woods, 1986). Antibodies raised against 
the 14 kDa receptor were able to reduce, ferripyochelin uptake (Sokol and Woods, 
1986) and a mutant deficient in surface expression of this protein was devoid of 
ferripyochelin uptake (Sokol, 1987).
Heinrichs et al. (1991) described a 75 kDa OMP, strongly derepressed under iron- 
deficient conditions, that was involved with pyochelin-mediated iron uptake, 
suggesting that P. aeruginosa may have two ferripyochelin uptake systems. A mutant 
deficient in expression of the 75 kDa protein still showed ferripyochelin uptake and 
expressed the 14 kDa OMP. Further studies illustrated that the uptake system 
utilising the high molecular weight OMP operated at iron concentrations 5-10 fold 
lower than those required for uptake via the 14 kDa system. These apparent 
differences in affinity suggest that the proposed low affinity system functions during 
marginal iron-limitation with the high affinity uptake system coming into effect as 
iron limitation becomes more severe. In addition, the 75 kDa OMP is expressed only 
in late log or early stationary phase cells, which in batch culture at least, are expected
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to be more iron-limited than early log phase cells. Early log phase cells appear to 
transport ferripyochelin via the less iron-repressible 14 kDa protein.
Ankenbauer and Quan (1994) isolated and cloned the 75 kDa ferripyochelin receptor, 
FptA. It has strong homology with hydroxamate siderophore receptor proteins, 
including FpvA (P. aeruginosa pyoverdine receptor), PupA (Pseudomonas putida 
WCS358 pseudobactin 358 receptor) and FhuE (E. coli coprogen, rhodotorulic acid 
and ferrioxamine E receptor).
1.4.3. The Role of Iron in Pyochelin Biosynthesis
Production of both pyochelin and the ferripyochelin receptor is strongly regulated by 
PchR (Heinrichs and Poole, 1993). PchR has strong homology to the AraC family 
of transcriptional activators found in bacteria including E. coli, Salmonella 
typhimurium, Citrobacter freundii and Erwinia chrysanthemi. There is a DNA 
sequence upstream of pchR that has homology with the E. coli Fur (ferric uptake 
regulator - section 1.5.5.) recognition sequence suggesting that PchR production is 
iron-regulated i.e. iron is responsible for mediating the level of expression of an 
activator protein (PchR) rather than directly affecting the structural genes for 
siderophore and receptor. PchR is also required for pyochelin induction of the 
ferripyochelin receptor. This suggests that PchR may undergo posttranscriptional 
regulation by pyochelin in activating receptor synthesis and may also upregulate 
pyochelin synthesis in response to the siderophore. The combination of PchR and Fur 
imply that pyochelin and FptA synthesis are subjected to both positive and negative 
siderophore specific regulation (Heinrichs and Poole, 1993).
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Other work regarding siderophore induction of OMP expression was performed by 
Gensberg et al. (1992). It was noted that addition of purified siderophore to the 
growth medium of siderophore-deficient strains of P. aeruginosa induced expression 
of specific IROMPs with a subsequent increase in the rate of iron transport 
(Gensberg et a l,  1992). For example, addition of pyochelin increased ferripyochelin 
transport but not ferripyoverdine transport with a corresponding increase in 
expression of the 75 kDa IROMP. Addition of pyoverdine induced expression of an 
85 kDa IROMP with an increase in ferripyoverdine transport. Evidently, in addition 
to iron-limitation, P. aeruginosa can also respond to the presence of siderophores. 
This may explain why P. aeruginosa retains two siderophore systems even though 
the iron binding ability of pyoverdine is much greater than pyochelin. It was 
postulated that both siderophores are produced initially in low quantities, followed 
by further de-repression of the system most suited to that particular environment 
(Gensberg et al., 1992). The ability to use two systems may also protect against the 
possibility of mutation removing one of the iron uptake systems. A similar induction 
system was observed by Poole et al, (1990) when growth of P. aeruginosa in the 
presence of the E. coli siderophore enterobactin resulted in the expression of an iron- 
uptake system responsible for ferrienterobactin transport (section 1.7.). In P. putida 
WCS358, the PupB receptor which is associated with ferripseudobactin BN8 and 
ferripseudobactin BN7 transport appears to be involved with initiation of a signal 
transduction pathway leading to its own synthesis (Koster et al., 1994) via a positive 
regulator element PfrA. This is similar to some periplasmic-binding-protein- 
dependent transport systems like the phosphate specific Pst system, which in addition
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to their transport function, have a role in signal transduction (Cox et al., 1988). 
PupB is the first example of an IROMP playing this role.
1.4.4. Pyoverdine
P. aeruginosa also produces one of several pyoverdine siderophores related to the 
pseudobactins produced by other fluorescent pseudomonads. Pyoverdines are highly 
water soluble fluorescent compounds giving rise to the characteristic green-yellow 
culture supernatants observed when P. aeruginosa is grown under iron-limiting 
conditions.
All pyoverdines share a dihydroxyquinolone chromophore and two N- 
hydroxyomithines attached to a varying amino acid backbone (Albrecht-Gary et al.,
1994). Pyoverdine PaA of P. aeruginosa is a 6,7-dihydoxyquinoline-containing 
fluorescent chromophore bound to the N-terminus of an octapeptide (D-Ser-L-Arg- 
D-Ser-L-N5-OH-Orn-L-Thr-L-Thr-L-Lys-L-N5-OH-Om) (Jego et a l,  1993). 
Transport of the different ferripyoverdine and ferripseudobactin complexes is via 
corresponding IROMPs. The varying specificities of IROMPs towards the various 
pyoverdines has been attributed to subtle differences in the amino acid backbone of 
the siderophores (Poole et al., 1991).
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Figure 1.3. The structure of the fully protonated form of pyoverdine PaA 
(Albrecht-Gary et al ., 1994).
Poole et al., (1991) reported a 90 kDa IROMP associated with ferripyoverdine 
uptake. Loss of this IROMP was concomitant with a loss of both ferripyoverdine 
transport and pyoverdine production. However, a mutant deficient in the production 
of this 90 kDa OMP always transported very low levels of ferripyoverdine. 
Similarly, the 90 kDa deficient strain also demonstrated pyoverdine-dependent 
growth on EDDHA-supplemented media suggesting a second uptake system may 
exist. In addition, similar phenomena were noted in an 85 kDa OMP mutant deficient 
in the transport of ferripyoverdine which showed a 5% residual ferripyoverdine 
uptake (Smith et al., 1992). The mutant deficient in the 85 kDa protein appeared to 
compensate by over-production of the 75 kDa protein associated with ferripyochelin
The ferripyoverdine receptor gene, fpvA, was cloned by Poole et al., (1993b). The 
deduced 90 kDa polypeptide has homology to regions shown to be conserved in 
TonB-dependent receptor proteins (section 1.6.1.). There is particularly strong 
homology with the PupA protein of P. putida WCS358 which is the receptor for 
ferripseudobactin WCS358. FpvA also shares a large degree of homology with 
FhuE, the E. coli receptor for ferric coprogen, ferric rhodotorulic acid and 
ferrioxamine B which is a little more surprising considering the pyoverdines and 
pseudobactins are structurally different to these molecules. However, they do all 
share hydroxyomithine residues (Winkelmann, 1986).
1.4.5. The Role of Iron in Pyoverdine Biosynthesis.
A large number of genes are involved in pyoverdine biosynthesis and it is proposed 
that they have evolved from a common ancestral origin (Rombel and Lamont, 1992). 
The most studied species are pi ant-growth-enhancing P. putida, plant pathogen 
Pseudomonas syringae, Pseudomonas sp M l 14 and P. aeruginosa.
All genes associated with pyoverdine production in P. aeruginosa have been isolated 
in the 47' position on the chromosomal map, termed the pvd  region (Tsuda et al., 
1995). Pyoverdine synthesis appears to be directed from this region and expression 
of some of the pvd  genes is regulated at the level of transcription (Miyazaki et al.,
1995).
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PvdS has been identified as a positive regulator of several genes in the pvd  region 
and was isolated by Cunliffe et al., (1995) and Miyazaki et al., (1995) independently. 
PvdS is required for expression of at least two promoters of pyoverdine synthesis and 
is suspected of acting at many other promoters of pyoverdine production that have 
yet to be characterised. PvdS mutants are unable to synthesise pyoverdine due to the 
lack of transcription from the pvd  promoters (Cunliffe et al., 1995). PvdS shares 
significant homology to RNA polymerase sigma factors produced by E. coli which 
direct the synthesis of extracellular products. There is strong homology towards E. 
coli fe c i  which is a positive regulator of the fee  (ferric citrate transport) operon and 
P. putida Pupl, a positive regulator of the pupB gene (van Hove et al., 1990; Koster 
et al.,1994). Feci and Pupl are modulated by FecR and PupR, respectively, although 
it is not known whether there is a similar modulator for P. aeruginosa. However, the 
promoter region of pvdS is similar to those of the pupl and fe c i  operons and has an 
area with strong homology to the Fur box in E. coli. Consequently, transcription of 
the pvdS promoter is repressed by the presence of iron so that in the absence of iron, 
Fur is unable to bind pvdS leading to pyoverdine biosynthesis (Cunliffe et al., 1995).
Similarities to other species include homology between pvdS and pbrA from P. 
fluorescens M l 14 (Sexton et a l, 1995). With P. putida, at least 15 genes in five gene 
clusters are required for pseudobactin synthesis (Marugg et al., 1985) and similar 
numbers have been identified in Pseudomonas sp. BIO (Moores et al., 1984) and P. 
syringae (Loper et al., 1984). It is thought that P. aeruginosa will have a similarly 
complex genetic composition.
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PvdA is another gene involved in pyoverdine biosynthesis and encodes the enzyme 
L-omithine N5 oxygenase. This enzyme catalyses the hydroxylation of L-omithine to 
N5-hydroxylomithine, a component of the peptide moiety (Visca et a l ,  1994). 
Finally, PvdD is proposed to be involved in the formation of the octapeptide by a 
non-ribosomal method (Merriman et al., 1995).
1.4.6. Pyoverdine Secretion
Less is known regarding the secretion of pyoverdine, although Poole et a l, (1993a) 
proposed the involvement of an operon encoding three proteins OprK, MexA and 
MexB. OprK is a 50 kDa OMP which has homology with several export proteins, 
MexB is a 108 kDa cytoplasmic membrane protein which acts as an efflux pump and 
MexA is a 40 kDa periplasmic protein thought to link OprK and MexB. A similar 
system comprising the 50 kDa OprM, the 46 kDa MexC and the 100 kDa MexD (Li 
et a l ,  1994) has been suggested to play a role in the secretion of pyochelin 
(Hamzehpour et a l,  1995). Both systems were first identified in association with 
multidrug efflux which enable bacteria to avoid the harmful effects of antimicrobial 
agents. Antimicrobials thought to be excreted by these systems include the 
quinolones, tetracycline and chloramphenicol (Poole et a l, 1993a; Hamzehpour et 
al., 1995).
1.5. Em erging Themes in Gene Regulation in Pseudomonas aeruginosa 
In addition to the siderophores produced in response to iron deprivation, P. 
aeruginosa can also produce several virulence factors responsible for damage to the
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host. This section identifies some of the emerging trends in the genetic regulation of 
this organism, with particular respect to the role of iron.
1.5.1. The Role of Iron in Exotoxin A Biosynthesis
Exotoxin A (ETA) is one of the major virulence factors of P. aeruginosa. This 
enzyme, which is toxic to animals at the microgram or submicrogram level (reviewed 
by Vasil et al., 1990), is an ADP-ribosyltransferase toxin that inhibits protein 
synthesis in eukaryotic cells in a similar manner to diphtheria toxin. It is a classical 
A-B toxin, with a domain designated B which is required for binding on the 
eukaryotic cell surface and a domain designated A which is responsible for the toxic 
activity. The production of ETA is highly regulated (Storey et al., 1991) with 
maximal expression occurring under iron-limiting conditions such as those in the 
human host. Regulation of the structural gene, toxA, is influenced by the regA gene 
and its products. A second gene, termed regB is required for optimal ETA production 
(Wick et al., 1990). There is also evidence that toxA activity is enhanced by LasR, 
the transcriptional regulator originally associated with elastase production (Gambello 
and Iglewski, 1991). The ability of RegA to bind RNA polymerase suggests that it 
may be an alternative sigma factor (Walker et al., 1994) (section 1.5.4.).
1.5.2. Exoenzyme S
Exoenzyme S (ExoS), like ETA, is an ADP-ribosyltransferase enzyme although their 
synthesis and excretion are independent. ExoS has been isolated in approximately 
90% of clinical isolates suggesting a clear role in pathogenesis (Goranson and Frank,
1996). ExoS production is dependent upon growth conditions, suggesting that it is
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produced in response to environmental stimuli such as stress and temperature (Frank 
and Iglewski, 1991). However, the availability of iron has little effect. Interestingly, 
yields are reduced by ciprofloxacin, tobramycin and ceftazidime at sub-MIC 
concentrations (Grimwood e ta l ,  1989).
1.5.3. Quorum Sensing and the Role of Elastase in Iron Acquisition
Elastase is an important virulence factor that contributes to the pathogenicity of P. 
aeruginosa. It is a metalloprotease with a broad substrate-specificity attacking host 
molecules including elastin, collagen, immunoglobulins and some components of the 
complement cascade. Elastase, therefore, releases iron to the bacterium and 
inactivates the host immune response (Iglewski et al., 1990).
In addition, elastase also cleaves transferrin and lactoferrin which are normally found 
in the lung and contribute to the host defence mechanisms. Iron released as a result 
of transferrin and lactoferrin cleavage is scavenged by the siderophore pyoverdine. 
This also generates new iron chelates which, in contrast to transferrin-bound iron, are 
able to catalyse formation of highly cytotoxic radicals from neutrophil-derived 
superoxide and hydrogen peroxide via the Haber-Weiss reaction (Britigan et al.,
1993). This cleavage can work in tandem with neutrophil-derived proteases 
contributing to P. aeruginosa-associated lung injury by digesting the extracellular 
matrix (Fick and Hata, 1989). In addition, pyocyanin, a blue-coloured secretory 
product of P. aeruginosa, previously associated with reducing ciliary activity 
(Jakowski et a l ,  1991) has the ability to undergo redox cycling under aerobic 
conditions resulting in the formation of superoxide and hydrogen peroxide. Iron
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bound to the siderophore pyochelin can generate free radicals as a result of Haber- 
Weiss chemistry and the combination of pyocyanin and ferripyochelin work 
synergistically in mediating epithelial cell damage (Britigan et al., 1992).
Optimum elastase production occurs at late-log and stationary growth phases. 
Although the exact environmental signals are unclear, iron-deplete conditions appear 
to have a weak positive effect on elastase production. However, elastase and several 
other exoproducts of P. aeruginosa are not produced until the cell density is 
relatively high and is understood to operate via an autoinducer-responsive 
transcriptional regulatory system termed “Quorum Sensing” (Latifi et al., 1995). The 
bacteria produce a diffusible compound, the autoinducer, which accumulates in the 
growth medium. The bacterium is freely permeable to the autoinducer so that at low 
levels the compound diffuses out of the cell and therefore has no effect. However, at 
high cell densities, the autoinducer accumulates above critical levels required for 
expression of the respective genes (reviewed by Fuqua et al., 1994). This type of 
system was first isolated in the marine bacterium Vibrio fischeri, which utilises the 
LuxI-LuxR autoinduction system for expression of luminescence genes. The Vibrio 
automducer is termed VAI (Nealson et al., 1970). This self-stimulating regulatory 
mechanism has the potential to generate a strong response to appropriate stimuli by 
co-ordinating the response from an entire population of cells via autoinducer 
production.
P. aeruginosa elastase production is subject to quorum sensing regulation and 
several systems have now been described. One system relies upon the interaction of
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LasR, a cell density-dependent transcriptional activator of several genes required for 
virulence, and the Pseudomonas autoinducer (PAI), an N-acyl-L-homoserine lactone, 
which is synthesised under the direction of LasI, the cell density-dependent signal 
generator. LasR and LasI show distinct homology with LuxR and LuxI of V. fischeri 
(Gambello and Iglewski, 1991; Passador et al., 1993). LasR is a global regulator that 
activates transcription of several genes including lasB which codes for elastase 
production, las A which codes for Las A protease production and aprA which codes 
for alkaline protease. LasR also enhances transcription of the exotoxin A gene, toxA 
(Gambello etal., 1993).
Briefly, PAI interacts with LasR to form a complex which interacts positively with 
promoters of Iasi. This positive regulation of Iasi by the PAI-LasR complex results 
in enhanced PAI production until a saturating concentration is reached i.e. a positive 
feedback loop (Seed et al., 1995). LasI requires significantly lower concentrations of 
PAI for expression than are required by lasB, therefore with low levels of PAI, the 
PAI-LasR complex interacts with the higher affinity Iasi, generating further amounts 
of LasI. Larger amounts of LasI result in additional amounts of PAI which would 
accumulate to such a level where enough activated LasR would be present to 
associate with the lower affinity elements such as the lasB elements. This system, 
whereby las I  and lasB are activated by different levels of PAI suggest a two tier 
autoinduction hierachy (Seed et al., 1995).
The first N-acyl-L-homoserine lactone to be identified in culture supernatants of P. 
aeruginosa was N-(3-oxohexanoyl)-L-homoserine lactone (OHHL) (Bainton et al.,
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1992). Jones et al. (1993) demonstrated that OHHL was able to restore partial 
elastase synthesis in pleiotropic mutants unable to synthesise a number of virulence 
factors. It was later discovered that LasI also directed the synthesis of a second N- 
acyl-L-homoserine lactone, N-(3-oxododecanoyl)-L-homoserine lactone (OdDHL) 
(Pearson et al., 1994) although this compound was unable to restore elastase 
synthesis in pleiotropic mutants (Latifi et al., 1995). However, a genetic locus was 
identified that could complement the pleiotropic mutant and restore elastase 
production. The locus encodes LuxR and LuxI homologues termed VsmR (virulence 
determinants and secondary metabolites) and VsmI, which were distinct from LasR 
and LasI (Winson et al., 1995). These genes have also been termed RhlR and Rhll 
(Latifi et al, 1995). VsmI directs the synthesis of two N-acyl-L-homoserine lactone 
molecules which have have been identified as N-butanoyl-L-homoserine lactone 
(BHL) and N-hexanoyl-L-homoserine lactone (HHL) which are found in the ratios of 
15:1 in P. aeruginosa culture supernatants (Winson et al., 1995). In addition, BHL is 
more potent at restoring elastase production suggesting that this is the natural ligand, 
although it is possible that HHL regulates other systems that are as yet unexamined.
Multiple autoinducer systems have been reported in Vibrio harveyi (Bassler et al.,
1994) and Erwinia carotovora (Swift et al., 1993). However, P. aeruginosa is the 
first organism in which two LuxR homologues (LasR and VsmR/RhlR) and two 
LuxI homologues (LasI and Vsml/Rhll) have been described along with their 
respective autoinducers. Consequently, the roles played by each homologue and the 
proposed interactions between them suggests that quorum sensing in P. aeruginosa
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is emerging to form a complex system regulating virulence factor and metabolite 
production in response to cell population density (Latifi et al., 1995).
The success of P. aeruginosa as a pathogen appears to result in part from its ability 
to regulate virulence factor production in response to environmental signals. Quorum 
sensing systems would appear to allow it to launch an aggressive attack on the host 
in areas of high cell density such as alveolar abscesses (Brint and Ohman, 1995).
1.5.4. The Role of Alternative Sigma Factors
The involvement of alternative sigma factors in the genetic regulation of P. 
aeruginosa is becoming increasingly evident. One particularly interesting factor 
thought to function as an alternative sigma factor is PvdS which is iron regulated and 
directs several elements of pyoverdine biosynthesis (section 1.4.6; Cunliffe et al.,
1995). In addition, conversion of P. aeruginosa to the exopolysaccharide alginate- 
overproducing mucoid form is also thought to depend upon the alternative sigma 
AlgU (Deretic et al., 1994).
Alginate overproducing forms are rarely found in environmental strains whereas 
strains isolated from the CF lung are frequently mucoid. It is an O-acetylated linear 
polymer of D-mannuronate and L-guluronate residues (Evans and Linker, 1973), 
which is thought to suppress leukocyte function and nonopsonic phagocytosis, 
promote adhesion and scavenge reactive oxygen intermediates (Deretic et al., 1994).
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Alginate is produced from a complex pathway involving several biosynthetic 
enzymes. AlgD encoding phosphomannose dehydrogenase, undergoes strong 
transcriptional up-regulation in mucoid cells. All genes in the alginate biosynthesis 
cluster are transcribed in the same direction as algD and and all appear to be 
regulated by the algD promoter (Chitnis and Ohman, 1993). Factors affecting algD 
regulation include dehydration, osmolarity, nutrient deprivation, oxygen availability 
and slow growth rate and are mediated via the activities of AlgR and AlgU. 
Ultimately, control of algD expression is via the algU, mucA, mucB gene cluster. 
AlgU  (also termed algT-Martin et al., 1993a) is most likely an alternative sigma 
factor required for initiation of algD transcription as the gene product has 77% 
homology to the sigma factor a E of E. coli (DeVries and Ohman, 1994).
MucA and MucB normally repress algU expression although in a significant number 
of CF isolates, mucA is inactivated by frameshift and nonsense mutations (Martin et 
al., 1993b). Mutations in mucA or mucB, result in derepression of alginate sysnthesis 
leading to a conversion to mucoidy. MucA and MucB have been proposed to act in a 
manner similar to anti-o factors which prevent the a  factors interacting with the core 
RNA polymerase (Deretic et al., 1995).
1.5.5. The Role of Fur in Iron Regulation
As noted in section 1.4., P. aeruginosa responds to conditions of iron deprivation by 
the derepression of high affinity iron uptake systems based on the siderophores 
pyoverdine and pyochelin. Production of pyochelin and the respective ferripyochelin 
receptor are tightly iron regulated and appear to be under the control of the
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transcriptional activator PchR (section 1.4.3.). Similarly, PvdS is involved in the 
transcription of at least two pyoverdine biosynthesis genes and its production 
depends on iron deprivation (section 1.4.6.). Finally, virulence factors such as 
exotoxin A have also been demonstrated to be tightly iron regulated via the regAB 
operon (section 1.5.1.) Global regulation of these systems has been attributed to the 
15.2 kDa Fur (ferric uptake regulator) protein (Prince et al., 1993). It is proposed 
that Fur does not interact directly with the biosynthetic genes but instead regulates 
the expression of the positive regulatory factors associated with siderophore and 
exotoxin biosynthesis i.e. PchR, PvdS and RegAB. The P. aeruginosa fu r  gene was 
cloned and sequenced by Prince et al. (1993) and its effects on iron-regulated 
promotors characterised by Ochsner et al. (1995).
The role of iron in genetic regulation is best understood in E. coli where the Fur 
protein is one of the major regulatory components. The presence of the fu r  gene was 
first described in mutants of Salmonella typhimurium (Ernst et al., 1978) and later in 
E. coli by Hantke (1981). E. coli fu r  was sequenced by Schaffer et al., (1985) and 
the gene product, Fur, identified as the component responsible for the repressor 
effect (Wee et al., 1988).
E. coli Fur is a 17 kDa protein (Schaffer et al., 1985) responsible for the global 
regulation of many siderophore-dependent iron-uptake systems and virulence factor 
production (Venturi et al., 1995). In vitro experiments demonstrated that the 
absolute exclusion of oxygen was required for the operation of Fur suggesting that 
the biologically active metal was Fe(It) and not Fe(III). Fur is, therefore, a metal-
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regulated protein rather than a metalloprotein i.e. Fur is normally isolated in the 
metal-free state and will accept cations as activators. In contrast, metalloproteins are 
normally isolated containing a stoichiometric amount of a specific metal ion. An 
important factor in the operation of Fur and its co-repressor Fe (II), is that the interior 
of the cell must be highly reducing in order to reduce Fe (IE) to Fe (II) (Bagg and 
Neilands 1987a).
Fe (II) acts as a co-repressor. The Fur-Fe(II) complex binds to a consensus sequence, 
GATAATGATAATCATTATC, termed the “Fur Box” located in the promoter 
regions of iron-regulated genes. In iron replete conditions, the Fur-Fe(II) complex 
inhibits transcription from these promoters, hence preventing expression of iron- 
regulated genes. In iron depleted conditions, Fur and Fe (II) dissociate leading to 
derepression of Fur-dependent promoters and an increase in expression of iron- 
regulated genes (Bagg and Neilands 1987a). Strains with fu r  mutations display 
constant derepression of iron-regulated systems at concentrations of iron that 
normally repress their production (Calderwood and Mikalanos, 1987). Interestingly, 
it has never been possible to isolate/wr-null mutants in P. aeruginosa suggesting that 








Figure 1.4. A diagrammatic representation of the Fur repressor system 
(Litwin and Calderwood, 1993).
Fur homologues have now been isolated in several other species, including 
Salmonella typhimurium  (Foster and Hall, 1992), Yersinia pestis (Staggs and Perry, 
1991), Vibrio cholerae (Litwin et al., 1992), Vibrio vulnificas (Litwin and 
Calderwood, 1993) and P. putida (Venturi et al., 1995). There is considerable 
homology between the Fur homologues of different species with the exception of P. 
aeruginosa. P. aeruginosa Fur is only 53% identical to E. coli Fur and 49% identical
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to V. cholerae and Yersinia pestis Fur. Most of the differences occur in the carboxy 
terminus of the protein which, in E. coli, is the metal binding domain (Prince et al.,
1993).
1.6. Models of Iron Transport Across the Gram-Negative Cell Wall
Following the release of iron-scavenging siderophores into the environment, the iron- 
siderophore complexes have to be internalised and the iron liberated to the interior of 
the bacterium. In Gram-negative bacteria, this requires transport across the 




















Figure 1.5. Schematic representation of the Gram-negative cell wall. LPS = 
lipopolysaccharide; PL = phospholipid; P = protein; LP = lipoprotein (Adapted
from Alberts et al., 1994).
1.6.1. Iron Transport Across the Outer M embrane
The outer membrane of Gram-negative bacteria is a non-classical lipid bilayer that 
allows passage of small hydrophilic molecules into the periplasm via trimeric porin 
proteins spanning this bilayer, (Nikaido, 1982). The outer leaflet comprises LPS and 
the inner leaflet is largely phospholipid (Postle, 1990a). The periplasm is an aqueous
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environment containing several detoxifying enzymes, scavenging enzymes and 
binding proteins responsible for facilitating active transport. Peptidoglycan gives the 
cell rigidity and protects the bacterium from osmotic stress (Hancock and Bell,
1988). The cytoplasmic membrane is the site of several proteins responsible for the 
generation and maintenance of electrochemical potential as well as those proteins 
which use the electrochemical potential for active transport of nutrients into the cell 
(Postle, 1990a).
The Gram-negative envelope confers a large degree of protection from a wide range 
of antibiotic compounds, digestive enzymes and various components of the host 
immune response. However, the success of OM impermeability provides an obstacle 
for transport of nutrients into the cell. Ferri-siderophore complexes and vitamin B 12 
cannot be transported via porin pathways and rely on active transport processes 
involving the TonB protein.
I .6 .I .I . The Role of TonB
TonB couples energy from the cytoplasmic membrane and facilitates active transport 
of iron-siderophore complexes and vitamin B J2 across the outer membrane. This 
enables Gram-negative bacteria to benefit from the impermeability of the OM yet 
still allowing the passage of certain essential nutrients into the celf (Postle, 1990a).
The majority of work on TonB has been performed in E. coli. E coli TonB is a 26 
kDa protein (Postle and Good, 1983) rich in proline residues at the amino terminus. 
TonB mutants are effectively iron-limited and therefore hyper-express their high
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affinity iron-uptake systems. TonB expression is regulated by iron and Fur (Postle, 
1990b) and fails to be expressed under anaerobic conditions. This is probably a 
result of the free solubility of ferrous iron in anaerobic conditions which is 
transported in a TonB-independent manner (Hantke, 1987). Fur binds in vivo to the 
“Fur Box” located between the -35 and -10 regions of the TonB promoter to reduce 
TonB transcription in iron-replete media (Postle, 1993).
Predicted structure analysis suggests that TonB has two hydrophobic regions, one at 
each terminus, whilst the central region is hydrophilic (Poste and Good, 1983). The 
hydrophobic amino terminus is anchored in the cytoplasmic membrane and the 
majority of the hydrophilic region extends into the periplasm (Postle and Skare
1988).
Briefly, a TonB-dependent transport system comprises an outer membrane receptor, 
a periplasmically located binding protein and a complex of cytoplasmic membrane 
proteins for active transport of ligands across the cytoplasmic membrane. The outer 
membrane receptors are essentially gated porins, closed at the cell surface by their 
ligand binding peptides (Klebba et al., 1993) and that opening and closing of TonB- 
dependent channels is an energy-dependent phenomenon (Woolridge et al., 1992). 
All TonB-dependent outer membrane receptors show distinct regions of homology 
where the TonB protein is proposed to make contact termed the “TonB boxes” 
(Kadner, 1990). However, TonB itself does not participate in transport across the 
cytoplasmic membrane (Postle, 1993).
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One popular hypothesis of TonB function is that in the energised state, TonB spans 
the periplasm, touching the underside of outer membrane receptors at the periplasmic 
face of the OM. Energised TonB induces a change in conformation of the receptors 
causing them to release their substrate to periplasmic binding proteins (Rutz et al.,
1992). Induction of receptor-release consumes energy so that the TonB protein 
switches back to the unenergised conformation and has to be re-energised by 
cytoplasmic membrane potential. This strengthens the suggestion that there is a 
physical interaction between the TonB protein and the relevant receptors (Braun et 
al., 1991). In addition, competition exists between the different TonB-dependent 
receptors for the limited amounts of functional TonB. Kadner and Heller (1995) 
noted that mutual inhibition of vitamin Bi2 and ferrisiderophore uptake is overcome 
by increasing the availability of functional TonB.
I.6.I.2. TonB-Associated Proteins
Other proteins associated with TonB activity are ExbB and ExbD encoded by the exb 
operon. ExbB is a 26 kDa cytoplasmic membrane protein with its amino terminus 
protruding into the periplasm (Eick-Helmerich and Braun, 1989). The majority of 
ExbB is found in the cytoplasm and appears to stabilise the TonB protein. Postle and 
Skare (1988) demonstrated that plasmid-encoded TonB had a functional half-life of 
10 min which was reduced to 2 min in a strain with an exbB mutation. 
Overexpression of TonB can compensate for an exbB mutation whereas 
overexpression of ExbB cannot compensate for a TonB mutation (Fischer et al.,
1989). It appears that ExbB offers proteolytic protection, probably by its ability to 
convert TonB to a protease-resistant conformation (Skare et al., 1993). However,
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with exbB mutations, there still remains approximately 10% residual TonB- 
dependent activity which is most likely a result of crosstalk with the Tol system 
which is involved with the uptake of biopolymers (Braun et al., 1991). The exb 
locus has two reading frames whilst the tol locus has four, designated tolQRAB. 
ExbB has 26% identity and 79% similarity with the TolQ sequence and ExbB has 
25% identity and 70% similarity to TolR. The similarities of ExBD to TolQR 
proteins suggest a common ancestry. Whilst mutations in exbBD did not completely 
abolish TonB activity, activity was lost upon a double mutation of both exbBD and 
tolQ (Braun and Herrmann, 1993). It is thought that there is a mechanical interaction 
between TonB and ExbB/TolQ proteins (Eick-Helmerich and Braun, 1989).
Less is known about ExbD. It is found in both the cytoplasmic membrane and 
periplasm, with the majority, like TonB, being in the periplasm (Postle, 1993). In 
addition, ExbB binds ExbD and prevents degradation by proteases (Fischer et al.,
1989). Ahmer et al. (1995) noted that exbB and exdD were so close that they appear 
to be co-ordinately expressed as a single operon and it is most like that they are co­
transcribed from the exbB promoter. The phenotypes of strains lacking either intact 
ExbB or ExbD proteins are indistinguishable, suggesting that the roles they play in 
TonB stabilisation are interchangeable.
Ligand release is thought to be precipitated by detachment of TonB from the outer 
membrane receptor due to a conformational change. ExbB and ExbD are thought to 
recycle TonB back to an active conformation. The ligand is then free to interact with 
the periplasmic binding proteins followed by transport across the cytoplasmic
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membrane. The TonB system includes all of the ferric-siderophore receptor proteins 
known for E. coli including FepA (enterobactin), IutA (aerobactin), FecA (ferric 
citrate), FhuA (ferrichrome) and FhuE (rhodoturulic acid) (reviewed by Guerinot,
1994).
I.6.I.3. TonB Homologous Systems in Other Gram-Negative Bacteria
A TonB homologue has recently been identified in P. aeruginosa (Poole et al.,
1996). P. aeruginosa TonB appeared novel compared to previously described TonB 
proteins since it lacked an N-terminal membrane anchor sequence. However, it does 
appear to have an N-terminal extension located in the cytoplasm although the 
function of this is unknown. It was noted that P. aeruginosa TonB shared 31% and 
21% identity with the TonB proteins of E. coli and P. putida, respectively, and was 
able to complement tonB mutaions in both of these organisms (Poole et al., 1996).
TonB homologues have been identified in several other Gram-negative organisms 
including Salmonella typhimurium (Hannavey et al., 1990), Klebsiella pnuemoniae 
(Bruske et al., 1993), Enterobacter aerogenes (Bruske and Heller, 1993), Serratia 
marsescens (Gaisser and Braun, 1991), Yersinia enterocolitica (Koebnik et al.,
1993), and as noted previously, Pseudomonas putida (Bitter et al., 1993). In 
Haemophilus influenzae, a 28 kDa TonB homologue was found to be required for 
utilisation of haem (Jarosik et al., 1994). All have similar sequences, with 
substantial runs of identical residues. Heterologous tonB genes from many of the 
enteric bacteria function to some extent in E. coli (Postle, 1993) although P. putida 
and E. coli TonB proteins are not functionally interchangeable (Bitter et al., 1993).
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Vibrio cholerae does not appear to have a TonB homologue although the outer 
membrane haem transport protein, HutA, was found to have a region displaying 
strong homology with the TonB box from TonB-dependent receptors. It is thought 
however, that a TonB-like protein may exist, although this has yet to be isolated 
(Henderson and Payne, 1994).
1.6.2. Transport Across the Cytoplasmic Membrane
The final barrier for the ferri-siderophore complex is passage across the cytoplasmic 
membrane. Most high-affinity iron-uptake systems in Gram-negative bacteria are 
thought to use periplasmic-binding-protein-dependent transport and one of the most 
widely studied systems is enterobactin-mediated iron transport in E. coli. The 
ferrienterobactin complex interacts with FepA which is located in the outer 
membrane and as result of TonB activity is transfered to the periplasm. The 
ferrienterobactin complex then becomes bound to the periplasmic binding protein 
FepB which in turn presents the complex to the FepC, D and G proteins. These 
proteins use energy derived from the hydrolysis of ATP to promote the passage of 
the iron-siderophore complex into the cytoplasm (Stephens et al., 1995). With the 
exceptions of siderophore complexes and vitamin B 12, which have specific outer 
membrane receptors, these periplasmic systems serve as the initial receptor for active 
transport of substrates into the bacteria. The overall system is similar to that used in 
the transport of peptides, amino acids and sugars (Nikaido and Saier, 1992). The 
usual arrangement of proteins comprises a periplasmic binding protein, one or two 
very hydrophobic proteins located in the cytoplasmic membrane and a hydrophilic 
membrane associated protein with recognition sequences for nucleotide binding such
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as ATP (Angerer et al., 1990). Transport across the cytoplasmic membrane is 
therefore considered to occur independently of outer membrane transport (Schoffler 
and Braun, 1989) (for further details see chapter 7).
1.6.3. Iron Release from Siderophores
The final stage of iron transport is the release of iron from the siderophore. Again 
the most studied system is enterobactin-mediated iron transport in E. coli, with 
release thought to take place either at the inner face of the cytoplasmic membrane or 
within the cytoplasm itself. However, the actual mechanism of iron release from 
siderophores is relatively poorly understood.
1.6.3.1. Cytoplasmic Esterase-Mediated Iron Release
It was thought that E. coli was able to mediate iron release through the activity of a 
cytoplasmic esterase. Enterobactin which is a trimer of dihydroxybenzoylserine 
(O'Brien and Gibson, 1970), is hydrolysed by this enzyme with a subsequent release 
of iron (O'Brien et a l, 1970). However, the observation that a hydrolysis-resistant, 
synthetic analogue of enterobactin, N,N',N"-tri(l,3,5-tris)-2,3- 
dihydroxybenzoylaminomethylbenzene could still release iron to E. coli, suggested 
that other processes could be in operation (Heidinger et al., 1983).
1.6.3.2. Reductase-Mediated Iron Release
It is now well documented that reduction of siderophore-bound iron from Fe(III) to 
Fe(II) results in release of the iron from siderophores due to the low affinity of 
siderophores towards Fe(II). Ferrisiderophore-reductase activity has been reported in
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a variety of organisms including E. coli (Fischer et al., 1990), Bacillus subtilis 
(Gaines et al., 1981) and P. aeruginosa (Halle and Meyer, 1992a*, Cox, 1980). In 
describing the reductase associated with ferripyoverdine activity, Halle and Meyer 
(1992a) noted that the reductase is a soluble enzyme located in the cytoplasm. 
Immunological screening also identified this enzyme in 18 Pseudomonas strains 
including P. stutzeri, a non-fluorescent species, suggesting that it is ubiquitous 
amongst Pseudomonads. Later work by Halle and Meyer (1992b) found that the 
proposed ferripyoverdine reductase reduced numerous ferri-complexes suggesting 
that the P. aeruginosa reductase is a non-specific enzyme which may be involved in 
several reductase pathways (see chapter 6).
1.7. Exogenous Siderophore-mediated Iron Transport by Pseudomonas 
aeruginosa
In additon to the endogenous siderophores pyochelin and pyoverdine, several 
exogenous compounds have siderophore activity in P. aeruginosa. These include 
siderophores produced by other species of bacteria and fungi such as ferrioxamine B, 
the siderophore of Streptomyces spp. (Cornelis et al., 1987). Other exogenous 
compounds proposed to have roles in mediating iron uptake include citrate and 
salicylate. A 43 kDa OMP has been postulated to be the ferric-citrate receptor 
(Harding and Royt, 1990) although a receptor has yet to be assigned to the 
ferrisalicylate complex. However, since salicylate is both a precursor to, and part of 
the structure of pyochelin, interaction may be via the 14 and 75 kDa EROMPS 
(Meyer, 1992). In addition to the proposed interaction of exogenous siderophores 
with IROMPS which have yet to be assigned function, it has been proposed that
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some siderophore-like molecules may rely on the porin protein OprF (Meyer, 1992). 
OprF is a major uptake route for many hydrophilic molecules across the outer 
membrane of P. aeruginosa (Nikaido and Hancock, 1986). Mutants deficient in 
OprF expression were observed to be very poor users of several exogenous 
siderophores (Meyer, 1992).
One particularly well documented example of P. aeruginosa utilising exogenous 
siderophores is that of the E. coli siderophore, enterobactin. Poole et al. (1990) 
demonstrated that EDDHA-induced growth inhibition could be reversed by addition 
of enterobactin. The presence of enterobactin induced expression of a novel 80 kDa 
IROMP termed PfeA. PfeA was found to have 60% homology with the E. coli 
enterobactin receptor FepA and shared similar immunological reactivities (Dean and 
Poole, 1993). However, mutants lacking PfeA still underwent enterobactin dependent 
growth, albeit at much higher concentrations of iron, suggesting two systems may be 
operating. One system appears to be of high affinity and is specifically inducible in 
the presence of enterobactin in iron-limiting growth conditions with the other being 
of much lower affinity and is independent of enterobactin for induction. Like 
pyoverdine, it was not possible to isolate a mutant that was completely devoid of 
ferrienterobactin transport reinforcing the notion that two systems exist to reduce the 
chance of a deleterious mutation occurring.
Iron transport has also been observed using 2,3-dihydroxybenzoic acid, a 
biosynthetic precursor of enterobactin, and N-(2,3-hydroxybenzoyl)-L-serine, an 
enterobactin breakdown product (Screen et al., 1995). Iron transport using N-(2,3-
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hydroxybenzoyl)-L-serine was energy-dependent and iron-repressible and growth of 
the bacteria in the presence of either pyoverdine or pyochelin had little effect. 
However, growth in the presence of enterobactin did result in an increased rate of 
iron transport via the inducible enterobactin uptake system. However, with 2,3- 
dihydroxybenzoic acid, iron transport was neither iron repressible nor strongly 
energy-dependent, hence a second system may be in use that is as yet 
uncharacterised.
1.8. Inositol Phosphate-M ediated Iron T ransport in Pseudomonas aeruginosa 
One compound recently discovered to have siderophore activity in P. aeruginosa is 
rayo-inositol hexakisphosphate (myo-InsP6 or phytic acid). Smith et al. (1994) 
demonstrated that myo-InsPg had siderophore activity and was able to reverse the 
iron-restricted growth inhibition of P. aeruginosa by EDDHA. 55Fe-InsPg uptake was 
strongly iron-regulated and repressed after growth in iron-sufficient conditions. 
Using electron transport chain inhibitors, uptake of myo-InsPg was shown to be an 
active process. This appears to be the first report of myo-InsPg activity in prokaryotic 
cells.
1.8.1. Nom enclature and Stereochemistry of Inositol Derivatives
Inositol was first described as an optically inactive isomer of cyclohexane hexol 
which was designated “Inosit”. Following the discovery and synthesis of other 
isomers, this was extended to “inositol” and there are now nine possible isomeric 
inositols, including one enantiomeric pair with the prefixes scyllo-, myo-, neo-, epi-,
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c/s-, muco-, alio-, D-chiro-(+) and L-chiro-{-) (reviewed by Potter and Lampe, 
1995).
1.8.2. myo-Inositol
myo-Inositol is a mcso-cylcohexane hexol, has a plane of symmetry and when in 
dilute solution at neutral pH, has five equatorial hydroxyl groups and one axial 
hydroxyl group. The carbon bearing the axial hydroxyl group is designated C-2 and 
the other carbons may be numbered from C-l to C-6 starting on either side of C-2 
and proceeding around the ring in either a clockwise or anticlockwise manner. By 
convention, numbering anti-clockwise in an assymetrically substituted inositol leads 
to a configerational D-prefix and clockwise numbering gives a substituted inositol 
with an L-pefix (Potter and Lampe, 1995).
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Figure 1.6. Diagrammatic representation of the numbering and stereo­
chemistry of the inositol ring
Humans obtain the majority of myoinositol in the diet from plants with only a small 
amount being biosynthesised. In both plants and animals, de-novo synthesis occurs 
by isomerisation of D-glucose 6-phosphate catalysed by L-myo-inositol-1-phosphate 
synthase. L-myoinositol-l-phosphate synthase has been purified from yeast 
(Donahue and Henry, 1981), mammalian testes (Maeda and Eisenberg, 1980; Mauck 
et a l ., 1980), and brain (Einsberg and Maeda, 1985). m yoinositol is subsequently 
generated by the activity of inositol monophosphatase on L-myoinositol-1- 
phosphate. This enzyme has also been purified from brain (Takimoto et a l ., 1985; 
Attwood et a l ,  1988; Meek et al., 1988). The observation that the brain does not 
have access to dietary myoinositol because of its inability to traverse the blood-brain
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barrier, provides evidence that de novo D-glucose-6-phosphate-mediated myo­
inositol biosynthesis must be in operation.
1.8.3. Inositol Polyphosphates in Eukaryotic Systems
Inositol polyphosphates are perhaps best known for their role as second messengers 
in eukaryotic cells. Interest in these important biological molecules dates back nearly 
150 years when the parent compound, inositol was first isolated (reviewed by Potter 
and Lampe 1995). There was some interest in these compounds during the late 
1950s although it was in 1975, when Michell (1975) proposed a link between 
agonist-stimulated phospholipid turnover and increased levels of intracellular 
calcium. The missing link was identified by Berridge and his co-workers as a myo­
inositol polyphosphate second messenger (Streb etal., 1983).
Cells communicate via hormones and neurotransmitters. Lipophilic hormones such 
as steroids can pass through the lipid bilayer of cell membranes and interact with 
specific intra-cellular targets. However, many hydrophilic chemical messengers are 
unable to traverse cell membranes and cannot interact with intra-cellular targets. 
Such compounds deliver their message by binding to specific receptors on the cell 
surface which in turn activate mechanisms that transmit the signal into the cell 
(Berridge and Irvine, 1989). This forms the basis of second messenger signalling 
whereby second messengers are employed to transmit the chemical message to the 
interior of the cell.
4 2
Briefly, the second messenger system comprises a ligand, such as a hormone, binding 
to an appropriate receptor, stimulating a GTP-binding protein (G-protein) to bind 
GTP. Activation of the G-protein results either in the stimulation or inhibition of 
other membrane-bound enzymes which act as amplifiers. Such amplifiers include K+ 
channels, Ca2+ channels, adenylate cyclase (AC), guanylate cyclase (GC) and 
phosphatidylinositol-4,5-bisphosphate-specific phospholipase C (Ptdlns-PLC), which 
in turn generate second messengers on the cytosolic side of the cellular membrane. 
Second messengers include adenosine 3’5’-cylic adenosine monophosphate (cAMP), 
1,2-di-O-acylglycerol (DAG), Ins(l,4,5)P3 and Ca2+ ions.
1.8.4. The Phosphatidylinositol Cycle
Phosphatides containing inositol comprise less than 10% of the total phospholipid in 
animal cells. Phosphatidylinositol (Ptdlns) is the most common, forming over 90% 
of the total amount and is located primarily in the endoplasmic reticulum. The 
phosphoinositides PtdIns(4)P and PtdIns(4,5)P2 are located primarily in the inner 
leaflet of the plasma membrane. Following activation, the receptor-associated G- 
protein activates the membrane bound phosophodiesterase (phosphoinositidase), 
phospholipase-C (Cockroft and Thomas, 1992). Phospholipase-C cleaves 
PtdIns(4,5)P2 into two second messengers, D-myo-inositol 1,4,5 trisphosphate (myo- 
Ins(l,4,5)P3) and 1,2-di-O-acylglycerol (DAG), which together form a bifurcating 
signalling pathway. myo-Ins( 1,4,5)P3 is hydrophilic and diffuses into the cytosol and 
activates the receptor of the Ca2+ channel on the endoplasmic reticulum resulting in 
release of calcium from internal stores. Raised cytosolic Ca2+ levels trigger 
processes including smooth muscle contraction, glycogen breakdown and exocytosis.
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DAG activates protein kinase C (PKC) which phosphorylates serine and threonine 
residues in target proteins and acts synergistically with myo-Ins(l,4,5)P3.
After eliciting the required response, myo-Ins(l,4,5)P3 must be deactivated to 
terminate its action. Metabolism of wyo-Ins(l,4,5)P3 to free inositol is complex and 
many inositol phosphate intermediates are formed. The sequence of events is 
summarised below.
The action of a 5-phosphatase (Downes et al., 1982) results in the production of myo- 
Ins(l,4)P2 which, having no known second messenger role, causes termination of the 
calcium mobilising signal. Alternatively, a 3-kinase phosphorylates myo-Ins(l,4,5)P3 
to produce myo-Ins(l,3,4,5)P4. Both myo-Ins(l,3,4,5)P4 and myo-Ins(l,3,4)P3, which 
is produced after the sequential action of the 5-phosphatase, may have moderate 
second messenger activity (Irvine, 1992). myo-Ins(l,3,4)P3 is metabolised to myo- 
Ins(l,3)P2 and/or myo-Ins(3,4)P2 and then subsebsequently to Ins(l)P and Ins(3)P, 
respectively, which are finally dephosphorylated to inositol by the action of inositol 
monophosphatase.
Other metabolic pathways for these compounds are also becoming apparent. The 
action of a 5/6-kinase (Shears et al., 1987; Balia et al., 1987) phosphorylates myo- 
Ins(l,3,4)P3 to myo-Ins(l,3,4,6)P4 which has a moderate calcium mobilising ability 
(Gawler et al., 1991; Ivorra et al., 1991), and to myo-Ins(l,3,4,5)P4. In animals, 
further action of the 5/6-kinase produces myo-Ins(l,3,4,5,6)P5 which is in later 
metabolised to myo-lnsP^, rayo-Ins(3,4,5,6)P4 or myo-Ins(l,4,5,6)P4.
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1.8.5. Inositol Hexa- and Pentakisphosphates
myo-InsP6 is the most abundant organic source of phosphate and is found in soil and 
all eukaryotic cells (Cosgrove, 1980). It has been found at levels up to an estimated 
600 pM (Martin et al., 1987) and whilst the exact biological role is unclear, myo- 
InsP6 may serve as either a phosphate or inositol store as it is metabolised to other 
inositol phosphates. In addition, it has been reported to function as a 
neurotransmitter (Vallejo et al., 1987), an antioxidant (Graf and Eaton, 1990) and 
may even have a role in the prevention and treatment of a range of cancers 
(Shamsuddin, 1995). Recently, myo-InsPg has been characterised with respect to its 
ability to prime human neutrophils hence having a pro-inflammatory role (Kitchen et 
al., 1996). Many plant materials are rich in myo-InsPg where it accumulates 
particularly in seeds. Consequently, diets rich in plant-based products contain large 
amounts of myo-InsP6 which has been the source of concern as the metal chelating 
ability of myo-InsPg may result in reduced absorption of many of the trace metals. 
The antioxidant effect is thought to result from the metal complexation properties of 
myo-InsP6 . The ability of myo-InsP6 to complex Fe(III) is extremely high with an 
affinity constant estimated to be between 1025-103° M '1 (Poyner et al., 1993). Graf et 
al. (1984) proposed that the ability of myo-InsP6 to complex Fe(III) prevents HO* 
formation from the superoxide anion via the iron-catalysed Haber-Weiss redox cycle. 
In addition, Graf et a l , (1984) suggested that myo-InsP6 increased oxygen-mediated 
oxidation of Fe(II) whilst blocking the hydrogen peroxide-mediated oxidation and 
concomittant hydroxyl radical production.
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The discovery of intracellular inositol pentakisphosphates brought further 
understanding of the iron binding properties of myo-InsP6. All bind Fe(III) although 
only those containing 1,2,3 (equatorial-axial-equatorial) trisphosphate grouping have 
antioxidant properties (Hawkins et al., 1993). The major InsP5 is Ins(l,3,4,5,6)P5 
which is also found in the majority of mammalian cells. Consequently, myo-InsPg 
and Ins(l,3,4,5,6)P5 are present in larger amounts than all other inositol 
polyphosphates (Berridge and Irvine, 1989; Shears, 1992). Ins(l,3,4,5,6)P5 is known 
to regulate the affinity of avian haemoglobin for oxygen and in common with myo- 
InsP6 is thought to have some function as a neurotransmitter (Vallejo et al., 1987).
The intracellular levels of myo-InsPg and myo-Ins(l,3,4,5,6)P5 fluctuate slowly in 
contrast to inositol which is incorporated rapidly into inositol lipids and myo- 
Ins(l,4,5)P3 (French et al., 1991; Menniti et al., 1990; Oliver et al., 1992). De novo 
synthesis of myo-InsP6 and myo-Ins(l,3,4,5,6)P5 proceed very slowly with myo- 
Ins(l,3,4,5,6)P5 formed by slow phosphorylation of myo-Ins(l,3,4)P3 (Hughes et al., 
1989; Balia et a l,  1989) by the actions of the 5/6-kinase. Even slower is the 
phosphorylation of myo-Ins(l,3,4,5,6)P5 to myo-InsP6 (Stephens et al., 1991). In 
contrast, the levels of myo-Ins(l,4,5)P3 fluctuate several fold within seconds, hence 
myo-InsPg and myo-Ins(l,3,4,5,6)P5 are not regarded as participating in general short­
term regulatory processes. Consequently, their roles in phosphate and inositol 
storage and as antioxidants appear more likely.
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1.9. Aims and Objectives
P. aeruginosa is a particularly resistant and robust pathogen reponsible for life 
threatening infections in certain groups of patients. Due to the failure of many 
currently available antimicrobial agents, improving our understanding of the methods 
of iron acquisition in P. aeruginosa may be useful in developing new modes of 
treatment directed against this organism.
myo-Inositol hexakisphosphate was first reported to have siderophore activity in P. 
aeruginosa PAOl by Smith et al., (1994) where it was able to reverse growth 
inhibition by EDDHA. The aim of this study was to characterise further this 
phenomenon and identify the mechanism by which myo-InsP6 transport is mediated.
To achieve this, attempts were made to identify key structural motifs responsible for 
raye>-InsP6-mediated iron uptake. This was achieved by examining structure-iron 
transport relationships of a wide range of inositol penta-, tetra-, and trisphosphates. 
The next aim was to determine whether a correlation existed between the ability of 
these compounds to mediate iron uptake into P. aeruginosa PA O 1 and their ability to 
interact with ferric iron. It was then aimed to identify the mechanisms associated 
with release of iron from the inositol phosphates to the bacterium. In addition, it was 
attempted to identify the mechanisms associated with P. aeruginosa PAOl that 
afforded inositol phosphates the ability to mediate iron transport into the bacterium. 
These were achieved by examing the possible roles of enzyme systems, the Gram- 
negative outer membrane with its associated proteins and the dependence upon
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active transport systems. Finally, attempts were made to isolate a mutant of P. 






P. aeruginosa PA O l Wild Type Hancock and Carey, 1979
P. aeruginosa IA1 Pvd-, Pch- mutant of 
P. aeruginosa PAO1
Ankenbauer et al., 1985
P. aeruginosa K372 Pch-, derivative of 
P. aeruginosa PAO6609 
(Pvd-), met-.
Poole etal., 1991
P. aeruginosa K239 P. aeruginosa PAOl 
(pMT 1000: :Tn501)
Poole and Hancock, 1986
P. aeruginosa PH2 P. aeruginosa IA1, StrR This study
P. aeruginosa PH3 P. aeruginosa PH2 
(pMT 1000: :Tn507)
This study
P. aeruginosa PH4 P. aeruginosa K372 
(pMT6121::Tn7737KH)
This study
P. aeruginosa H729 OprD::Q, KmR, met-. Trias e ta i ,  1989
P. aeruginosa H636 OprF::Q, StrR, met-. Woodruff and Hancock, 
1988
P. aeruginosa H576 0prP::O, HgR, met-. Poole and Hancock, 1986
E. coli CT725 E. coli DH1
(pMT6121::Tn/737KH)
Tsuda et. al., 1995
Table 2.1. Bacterial Strains.
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2.2. Chemicals
All chemicals were supplied by Fisons (Loughborough, U.K.) and Sigma Chemical 
Co. (Poole, U.K.) unless stated differently. Chemicals were of Analytical Reagent 
Grade or equivalent.
2.3. Inositol Phosphates
rayo-InsP6 and myo-Ins(l,4,5)P3 were obtained from Sigma Chemical Co. (Poole, 
U.K). myo-Ins(l,3,4,6)P4 was obtained from Calbiochem (San Diego, Ca, USA) and 
myo-Ins(l,2,3)P3 was obtained from Dr. I. Spiers (Department of Pharmaceutical and 
Biological Sciences, Aston University) All other inositol phosphates were from Prof. 
B.V.L. Potter, Dr. S.J. Mills, Dr. D. Lampe and Dr. A. Riley (School of Pharmacy 
and Pharmacology, University of Bath).
2 .4 .5aFe Transport Assay Glassware
Glassware for iron transport assays was soaked overnight in 0.01% EDTA solution 
and rinsed thoroughly in Milli-Q water prior to sterilisation to reduce levels of 
contaminating iron.
2.5. Radiochemicals
Iron-55 ferric chloride in aqueous solution, 740 MBq/ml, 1167 MBq/mg. E.I. DuPont 
de Nemours & Co. Ltd. (Wilmington, De, USA).
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[3H]-myo-Inositol hexakisphosphate, 0.37 MBq/ml, 119 Mbq/mg. E.I. DuPont de 
Nemours & Co. Ltd. (Wilmington, De, USA).
[3H]-D-myo-Inositol (1,4,5) Trisphosphate, 0.37 Mbq/ml, 1.35 Mbq/mg. Amersham 
Life Science Inc. (Cleveland, Oh, USA).
2.6. Complex Media









Luria Agar Luria Broth + 1.5% Agar (Difco).
Nutrient Agar Nutrient agar (Oxoid) 28 g
ddH20 to 1,000 ml.
2.7. Chemically Defined M edium (Meyer and Abdallah, 1978)
Succinate Medium K2H P04
k h 2p o 4
(NH4)2S 0 4
6 g
3 g  
1 g
M gS04.7H20  0.2 g
Sodium succinate 4 g
ddH20
pH
to 1,000 ml 
to 7.0.
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For growth of P. aeruginosa K372 and P. aeruginosa PH4, methionine was added to 
a final concentration 1 mM.
2.8. Equipm ent
A utom atic pipettes: Gilson pipetman, P-2, P-20, P-200 and P-1000 (Anachem Ltd., 
Luton, U.K.). Finnpipette Digital 10 ml (Labsystems, Helsinki, Finland).
Balances: Mettler AE 50 (Mettler Instrumente AG, Zurich, Switzerland). Oertling 
TP 31 (Oertling, U.K.).
Centrifuges: MSE Micro Centaur microfuge (Measuring and Scientific Equipment 
Ltd., London, U.K.). Beckman J2-MC High Speed Centrifuge using JA-20.1 and 
JA-14 rotors. Beckman L8-M Ultracentrifuge using a Ti-70 rotor (Beckman 
Instruments Inc., Palo Alto, Ca, USA). Sorvall OTD Ultracentrifuge using a TH-641 
Swinging Bucket Ultraspeed Rotor (DuPont Company, Medical Products, Sorvall 
Instruments, Wilmington, De, U.S.A.).
F iltration Equipm ent: 25 mm Swinnex units (Millipore, Molsheim, France). 
Whatman 25 mm Cellulose Nitrate 0.2 pm Membrane Filters (Whatman, Maidstone, 
U.K.).
Gel Electrophoresis A pparatus: Bio-Rad Mini Protean II Electrophoresis System 
(Bio-Rad Laboratories Ltd., Richmond, Ca, U.S.A.).
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Heated W ater Bath: Grant JB2 (Grant Instruments (Cambridge) Ltd., Cambridge, 
U.K.).
Heating Block: Techne Dri-Block DB-2A (Techne (Cambridge) Ltd., Duxford, 
U.K.).
Incubators: New Brunswick Scientific Controlled Environment Incubator Shaker 
(New Brunswick Scientific, Edison, NY, USA) and Heraeus B6060 (Heraeus 
Equipment Ltd., Brentwood, U.K.).
M agnetic S tirrer: Stuart Magnetic Stirrer (Stuart, U.K.)
pH  M eter: Corning pH Meter 240 (Ciba Coming Diagnostics Ltd., Watford, U.K.).
Power Supply: Bio-Rad 200/2.0 Power Supply (Bio-Rad Laboratories Ltd., 
Watford, U.K.)
R otary  Evaporator: Rotavapor-R (Buchi, Flawil, Switzerland).
Scintillation Counter: LKB Wallac 1215 RackBeta Liquid Scintillation Counter 
(Wallac, Finland).
Sonicator: MSE 150 Watt Ultrasonic Disintegrator Mark 2. (Measuring and 
Scientific Equipment Ltd., London, U.K.).
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Sonicating W ater B ath: Sonicleaner Type 6442AE (Ultrasonics Ltd., U.K.)
Spectrophotom eter: Milton Roy Spectronic 601 (Milton Roy, Stone, U.K.).
Spectrophotom eter Cuvettes: Elkay Micro Square Ultra-Vu Disposable Cuvettes 
(Elkay Products Inc., Ma, USA).
W ater Supply: Milli-Q Plus P.F. (Millipore, Molsheim, France)




3.1. Measurement of Bacterial Cell Concentration in Liquid Media
Bacterial cell concentrations in liquid media were quantified using spectrophotometric 
techniques. At low cell concentrations, the light scattered by a bacterial suspension is 
directly proportional to the cell concentration in accordance with the Beer-Lambert 
Law:-
OD = Log (Io/I)
Where OD = optical density
Io = intensity of incident light.
I = intensity of emergent light.
This relationship is obeyed between OD 0.03 and 0.3. Measurements of bacterial cell 
suspensions were made at 470 nm (OD470) to maximise scattering of light by the cells 
whilst minimising absorption by other media components and cell products. An OD470 
of 1.0 indicates an approximate cell concentration of lxlO9 cells/ml.
3.2. Freezing Bacterial Samples
Cells were grown overnight on nutrient agar supplemented with appropriate antibiotics. 
1.5 ml LB+50% glycerol was placed on the NA surface and the cells suspended using a 
sterile glass spreader. Samples were stored at -70°C.
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3.3. Preparation  of Pseudomonas aeruginosa M em brane Fraction
One litre of overnight P. aeruginosa culture grown at 37°C in a shaking orbital 
incubator was harvested by centrifugation at 6,000 g for 10 minutes at 4°C. The cells 
were washed with 50 ml 0.9% saline solution, centrifuged as before, then suspended in 
20 ml 0.9% saline. Cells were lysed by sonication in an ice bath by 10 x 30 s pulses with 
30 s intervals to allow cooling.
The sonicated suspension was centrifuged at 5,000 g for 5 minutes at 4°C to remove 
unbroken cells. The supernatant was centrifuged at 20,000 g for 1 hour and the 
membrane pellet washed and suspended in sterile Milli-Q water. The protein content 
was determined by the Lowry assay (Lowry et al., 1951), and the suspension stored at 
-20°C (section 3.6).
3.4. Preparation  of Pseudomonas aeruginosa O uter M em branes Using the Sarkosyl 
M ethod
The method used was based on that by Filip et a l ,  (1973). Cells grown overnight at 
37°C in an orbital shaker were harvested by centrifugation at 6,000 g for 10 min at 4°C. 
The supernatant was discarded, the cells washed with 50 ml 0.9% saline solution and 
resuspended in 20 ml 0.9% saline. Cells were lysed by sonication in an ice bath by 10 x 
30 second pulses with 30 second intervals to allow cooling.
The sonicated suspension was centrifuged at 6,000 g for 5 min at 4°C to remove 
unbroken cells. The supernatant was transferred to centrifuge tubes and Sarkosyl (N- 
lauroyl-sarcosinate) solution (20%w/v) added to a final concentration of 2%. After 1 h,
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the mixture was centrifuged for 60 min at 20,000 g and 4°C. The resulting pellet was 
resuspended in sterile Milli-Q water and stored at -20°C The protein content was 
determined using the Lowry assay (section 3.6; Lowry et a l,  1951).
3.5. Sucrose G radient Preparation of Cytoplasmic and O uter M em branes of 
Pseudomonas aeruginosa
Cells harvested from a 3 1 P. aeruginosa overnight culture were washed with 0.9% 
saline, suspended in 20 ml 0.9% saline and broken by sonication as described in section 
3.4. Following centrifugation at 5,000 g to remove unbroken cells, membranes were 
pelleted by centrifugation at 35,000 g for 1 h at 4°C and suspended in 1 ml 10% w/v 
sucrose solution. Sucrose gradients were prepared in centrifuge tubes by gently layering 
sucrose solutions of varying strength, with the strongest sucrose concentration at the 
bottom of the centrifuge tube. Solutions used were 1.2 ml each of 65%, 60%, 55%, 
50%, 45%, 40% and 35% w/v sucrose and the gradients stored at 4°C for one hour 
before use. The membrane sample was added to the top of the gradient and the 
gradients centrifuged for 18 h at 35,000 rpm and 4°C using a Sorvall TH-641 swing-out 
rotor. The lighter cytoplasmic membranes form a band near the top of the gradient 
whilst the heavier outer membranes partition towards the bottom of the gradient.
Following centrifugation, gradients were removed by transferring 200 p.1 samples from 
the top of the gradients to 96 well microtitre plates. Aliquots containing membrane 
fractions were identified using a plate reader measuring at 340 nm and the outer 
membrane fractions pooled. Membranes were pelleted from the sucrose solution by 
addition of sterile distilled water and centrifuging at 50,000 g for 40 minutes at 4°C. The
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membrane pellets were washed and suspended in 1 ml sterile distilled water and stored 
at -20°C.
3.6. Protein Quantification Using the Lowry Assay
The Lowry protein assay was used to determine the protein content of outer membrane 
preparations (Lowry et al., 1951). A standard curve was obtained using dilutions of a 
1 mg/ml stock solution of bovine serum albumin (BSA).
OMPs were analysed by adding 100 |il outer membrane suspension to 400 pi sterile 
Milli-Q water in a small boiling tube. A blank was prepared using 500 pi sterile Milli-Q 
water.
An equal volume (500 pi) of 0.5 M NaOH was added to each sample and the mixture 
heated to 100°C for 10 minutes. The mixtures were allowed to cool to room temperature 
followed by addition of 2.5 ml Lowry C reagent (1 ml Lowry B = 0.5% w/v 
CuS0 4.5H20  / 1% w/v NaK tartrate solution + 24 ml Lowry A = 5% w/v Na2C 0 3) with 
shaking. Folin and Ciocalteu’s Phenol Reagent (500 pi) was added after 10 min and 
mixed by vortexing. Optical density at 750 nm (OD750) of all samples was recorded after 
30 minutes against the similarly treated water blank
3.7. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE).
Separation of membrane proteins was performed by gel electrophoresis using a Mini- 
Protean system, according to the methods described by Lutenberg et. al., (1975). The 
running and stacking gel were prepared as described (table 3.1), and polymerisation
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initiated by addition of N ,N ,N \N ’-tetramethylethylenediamine (TEMED). The running 
gel was poured between glass plates separated by 1.5 mm plastic spacers and allowed to 
set for 10 min. A spray of electrode buffer on top of the gel ensured complete 
polymerisation and formation of a straight edge. This buffer solution was removed and 
the stacking gel cast in a similar method. A Teflon comb was inserted between the 
plates to create wells for sample application.
Samples were denatured at 100°C for 10 min with an equal volume of sample buffer 
before loading into the gel. The electrode buffer contained 25 mM Tris, 190 mM 
glycine and 0.1% SDS. In the Mini-Protean system, a constant voltage of 80 V was 
applied whilst the sample ran through the stacking gel and was increased to 180 V for 
electrophoresis through the running gel. Electrophoresis continued until the tracking 
dye had migrated to within 5 mm of the bottom of the gel. Gels were stained for protein 
with 0.1% w/v Coomassie brilliant blue R-250 in 50% methanol /10% glacial acetic 
acid. Gels were subsequently destained in 10% methanol/20% acetic acid.
Pre-stained low range molecular weight markers (Bio-Rad) consisted of the following:-
Protein
Phosphorylase B 
Bovine Serum Albumin 
Ovalbumin 
Carbonic Anhydrase 










Constituent Running Gel (10%) Stacking Gel (5% ) Sample buffer
Acrylamide Soln. 3.92 ml 2.0 ml
SDS 10% w/v 0.3 ml 0.12 ml 5 ml
1.5M Tris pH  8.8 3.7 ml
0.5M Tris pH  6.8 3.0 ml 2.5 ml
Milli-Q W ater 3.78 ml 6.4 ml 5 ml
10% TEM ED Soln. 30 pi 32 pi
AMPS 10% w/v 40 pi 40 pi
Glycerol 2.5 ml
2-m ercaptoethanol 0.25 ml
5 % Bromophenol Blue 0.2 ml
Acrylamide solution: 30% Acrylamide/Bis Solution, 37.5:1 (Bio-Rad Laboratories Ltd., 
Watford, U.K.).
AMPS: Ammonium persulphate (freshly prepared).
Bis: N,N'-methylene-bis-acrylamide 
TEMED: N,N,N,'N'-tetramethylethylene diamine
Table 3.1. Compositions of Running Gel, Stacking Gel and Sample Buffer for
SDS-PAGE
3.8. P reparation of Pseudomonas aeruginosa Spheroplasts
The method used was based on that described by Booth and Curtis, (1977). Log-phase 
P. aeruginosa grown in 3 1 succinate minimal medium was harvested by centrifugation 
at 8,000 g for 10 min and 4°C. Cells were suspended in 100 ml Tris/Sucrose solution 
(33 mM Tris pH 8.0, 0.25 M sucrose) and lysozyme and EDTA added to final 
concentrations of 30 pg/ml and 250 pg/ml, respectively. Following incubation at room 
temperature for 10 minutes, the cell suspension was centrifuged at 5,000 g for 5 min to
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remove whole cells and the resulting supernatant centrifuged at 10,000 g for 30 min to 
pellet the spheroplasts gently. Spheroplasts were carefully resuspended in 10 ml 
tris/sucrose and used immediately for iron transport assays.
The spheroplast:whole cell ratio was determined by dilution of cells in either sterile 
Milli-Q water or sterile tris/sucrose, followed by viable counting. Cells surviving 
dilution in water were judged to be whole cells, whereas dilution in Tris/sucrose 
represented the combination of spheroplasts and whole cells.
3.9. 55Fe Transport Assays Using Whole Cells or Spheroplasts
Glassware for iron transport assays was treated as described in section 2.4. Starter
cultures were incubated for 8 h and sub-cultured (1:10) for a further 17 h.
Whole cells grown in succinate medium in an orbital incubator at 37°C and 300 rpm 
were harvested by centrifugation at 5,000 g and 4°C for 20 min. The cells were washed 
twice in 100 mM MOPS buffer (pH 7.0) and suspended to an OD470 of 2.0 in MOPS 
buffer (pH 7.0) and 60 pM glucose to a final volume of 500 pi. The cell suspension was
equilibrated at 37°C for 15 min prior to transport studies.
The 55Fe-inositol phosphate complexes were formed at 37°C 15 min prior to uptake as 
200 pM  inositol phosphate and 400 nM [55Fe]-FeCl3 in MOPS buffer (pH 7.0) to a final 
volume of 500 pi. Addition of the 55Fe-inositol phosphate mixture to the cell suspension 
resulted in final concentrations of 100 pM inositol phosphate and 200 nM 55FeCl3 
(500:1 ratio). The resulting mixture was incubated at 37°C and iron transport assays
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performed by withdrawing 50 |il samples and filtering through 0.2 pm  nitrocellulose 
filters. The filters were washed with 20 ml 0.9% saline solution and air dried. When dry, 
filters were transferred to 4 ml scintillation fluid (Optiphase Hisafe, LKB) and the cell- 
associated activity retained on the filter determined by scintillation counting using the 
3H channel.
When performing 55Fe transport assays using spheroplasts, MOPS buffer and 0.9% 
saline were replaced by Tris/sucrose solution (section 3.8) to offer osmotic protection. 
All other aspects of the assay were performed as above.
3.10. Hydroxyl Radical Assay
The method used was based on that described by Graf et. al., (1984) and adapted by 
Hawkins et al., (1993). The assay mixture was prepared as follows to a final volume of 
1 m l:-
50 pi 1 M DMSO
100 pi 0.02% hypoxanthine in 20 mM tris pH 7.4 
50 pi xanthine oxidase (0.8 units/ml)
10 pi 10 mM inositol phosphate 
10 pi 500 pM FeCl3 (freshly prepared)
780 pi 20 mM tris pH 7.4.
The reaction mixture was incubated at 37°C for 30 min. Two hundred and fifty pi 
reagent B was added (15 g NH40 2CCH3, 0.3 ml glacial acetic acid, 0.2 ml acetyl 
acetone to 100 ml with distilled water) and the mixture heated at 60°C for 15 min. The
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generation of yellow colouration was measured by reading the absorbance at 410 nm 
using distilled water as a blank.
3.11. Pseudomonas aeruginosa PAOl Reductase Assay
The method used was that described by Halle and Meyer (1992a) and is based on the 
spectrophotometric measurement at 562 nm of the Fe(II)-Ferrozine complex formed 
during the assay.
Four 1 of overnight P. aeruginosa culture grown in succinate minimal medium were 
harvested by centrifugation at 6,000 g and 4°C. Cells were washed twice with distilled 
water, resuspended in 25 ml buffer A (50 mM Tris, 0.1 M KC1 at pH 7.4) and broken by 
sonication (10 x 30 s pulses with 1 min intervals for cooling). The protein content of 
the bacterial lysate was assayed using the Lowry Protein Assay (Lowry et. al., 1951) 
using BSA as a standard (Section 3.6.) and adjusted to 0.8 mg/ml by addition of buffer 
A.
Reductase assays were performed in a glass spectophotometer cuvette as follows. Two 
millilitres bacterial lysate (0.8 mg/ml) were added to the cuvette followed by addition of 
inositol phosphate and FeCl3, each to a final concentration of 0.2 mM. Anaerobiosis 
was achieved by flushing the mixture with argon for 10 min. The reaction was started 
by addition of FMN, Ferrozine and NADH to final concentrations of 0.05 mM, 0.8 mM 
and 0.15 mM, respectively. The cuvette was transferred to the spectrophotometer and 
the reaction followed by measuring the absorbance at 562 nm. A continous stream of 
argon was maintained through the reaction mixture for the duration of the reaction.
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The assay was performed at room temperature, all stock solutions were prepared in 
buffer B (25 mM Tris, pH 7.4) and both the bacterial lysate and stock solutions were 
stored at -20°C without loss of activity over a one month period. The amount of Fe(II)- 
Ferrozine produced was calculated from the known extiction coefficient for Fe(II)- 
Ferrozine (28,000 M ^cnr1).
3.12. Competitive Binding Assays of [ H]-InsP6 to Pseudomonas aeruginosa 
Membranes
Membranes were homogenised immediately before use in 100 mM HEPES buffer at 
4°C to a final concentration of 1.0 mg/ml. Binding was performed at 4°C for one hour in 
a 1.5 ml microcentrifuge tube using 1 mg homogenised membrane suspension and [3H]- 
InsP6 at a final concentration of 1.0 nM.
Free ligand was separated from bound ligand by centrifugation at 13,000 g for 5 min. 
Membrane pellets were washed twice with water at 30°C, air dried and solubilised 
overnight by addition of 100 fil Soluene (Packard, Meriden, Ct, U.S.A). One ml 
scintillation cocktail was added and the remaining activity determined by scintillation 
counting using the H channel.
3.13. Isolation and Purification of Pyoverdine
The method used was based on that described by Poole et al. (1991). An overnight 
culture of P. aeruginosa grown in 500 ml succinate minimal medium was harvested by 
centrifugation at 8,000 g for 10 minutes at 4°C. The supernatants were collected and the
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liquid phase removed using a rotary evaporator. The residual material was resuspended 
in 12 ml sterile Milli-Q water, centrifuged at 16,000 g to remove insolubles, and 
extracted once with an equal volume of ethyl acetate. The organic phase was discarded 
and solid NaCl added to the aqueous phase to saturation. The aqueous phase was 
extracted twice with 0.5 volume phenolichloroform and the organic phases pooled. 
Following addition of 2 volumes diethyl ether to the organic phase, the precipitated 
pyoverdine was pelleted by centrifugation at 10,000 g for 10 min at 4°C, and the 
resulting pellet washed three times with 3 ml diethyl ether. The pellet was air-dried, 
suspended in double distilled water to 20 mg/ml, and stored at -20°C.
3.14. Transposon Insertion Mutagenesis in Pseudomonas aeruginosa
Two strains were subjected to transposon mutagenesis, P. aeruginosa IA1 using
pMT 1000(Tn501) and P. aeruginosa K372 using pMT6121 (Tn/737KH).
3.14.1. Tn502 Insertion Mutagenesis of Pseudomonas aeruginosa IA1
Tn507 was obtained in pMTlOOO, an R68 plasmid derivative (Poole and Hancock,
1986), which is temperature-sensitive for replication and maintenance. pMTlOOO was
supplied in P. aeruginosa K239 (P. aeruginosa PAOl containing pMTlOOO) and was
transferred to P. aeruginosa IA1 by conjugation. Selection against K239 was achieved
using a spontaneous streptomycin resistant variant of P. aeruginosa IA 1 (P. aeruginosa
PH2).
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3.14.1.1. Spontaneous Pseudomonas aeruginosa IA1 Streptomycin-resistant Mutant
A spontaneous streptomycin resistant variant of P. aeruginosa IA1 was isolated using a 
method based on that described by Tsuda and lino (1983). One hundred pi IA1 
suspension at lxlO4 cells/ml was plated onto LA+Str750. Plates were incubated at 37°C 
for 48 hours and a spontaneous mutant isolated termed P. aeruginosa PH2.
3.14.1.2 Conjugation of Pseudomonas aeruginosa K239(pMTlOOO::Tn502) with 
Pseudomonas aeruginosa PH2
P. aeruginosa K239(pMTlOOO::Tn507), the donor strain, was incubated overnight with 
shaking at 30°C in LB in the absence of antibiotics to prevent carry-over into the 
conjugation mix. P. aeruginosa PH2, the recipient strain, was incubated overnight with 
shaking at 37°C. Fifty microlitres of donor and recipient cultures were spotted onto LA 
plates, incubated overnight at 30°C and the resulting cells harvested using 3 ml LB. 
Cells were plated at various dilutions on LA+Hg15+Str750 and incubated overnight at 
30°C. Transconjugants were isolated and grown in succinate minimal medium 
containing Hg15+Str750 using K239 and PH2 as controls. Growth in the absence of 
siderophore production confirmed the transconjugants to be PH2(pMT1000::Tn507). 
An example of this strain was isolated and termed PH3.
3.14.1.3. Frequency of Transposition.
The frequency of transposition i.e. the extent of transposon movement between plasmid 
and chromosome, was calculated by viable counting. An overnight culture of P. 
aeruginosa PH3 was serially diluted and plated in duplicate onto LA plates which were 
incubated at 30°C and 42°C, respectively The viable counts at each temperature were
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calculated. In addition, pMTlOOO carries tetracycline resistance which, like mercury 
resistance, is temperature-dependent. Because tetracycline resistance is conferred by 
the vector and not Tn507, transformed colonies were tested for tetracycline sensitivity to 
confirm loss of the vector.
3.14.1.4. Tn507 insertion mutagenesis of Pseudomonas aeruginosa PH3 
Pseudomonas aeruginosa PH3 was grown overnight at 30°C, plated at various dilutions 
onto LA+Hg15 and incubated at 42°C for 24 h. The overnight culture was stored at 4°C. 
The remaining culture was plated onto LA+Hg15 to give approximately 400 cfu per plate 
when grown at 42°C. The resulting colonies were screened by picking onto selective 
media in the order:-
i) Succinate minimal agar
ii) Succinate minimal agar+ 500 jiM myo-InsPg
iii) Luria agar + 500 |iM myo-InsP6
iv) Luria agar + Hg15
The selective plates were incubated for 48 hours at 37°C and examined for growth.
3.14.2. Tn7737KH Insertion Mutagenesis of Pseudomonas aeruginosa K372 
This transposon mutagenesis system is based on the transposon Tn7737KH located in 
the plasmid pMT6121 and like Tn507 carries mercury resistance for use as a selective 
marker. pMT6121 is also temperature sensitive capable of replication at 30°C but 
inhibited at 42°C.
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3.14.2.1. Conjugation of Escherichia coli CT725 with Pseudomonas aeruginosa 
K372
pMT6121 containing Tni737KH was transferred from E. coli CT725 to P. aeruginosa 
K372 by conjugation as described in section 3.13.1.2. K372(pMT6121::Tn/737KH) 
trans-conjugants were- selected using Hg15+Km250. One such transconjugant was isolated 
and termed P. aeruginosa PH4. Confirmation that the new host was P. aeruginosa was 
achieved by adding 20 fil 10 % N ,N ,N \N ’-Tetramethyl-p-phenylenediamine solution to 
cells smeared onto 3MM paper. The presence of a purple colouration confirmed the 
cells were oxidase-positive P. aeruginosa rather than the E. coli donor strain.
The frequency of transformation and tests regarding tetracycline sensitivity were 
performed as described previously (3.14.1.3.)
3.14.2.2. Tnl737K H  Mutagenesis of Pseudomonas aeruginosa PH4 
Mutagenesis of P. aeruginosa PH4 was performed using similar procedures as before 
with the exception that succinate minimal medium was always supplemented with 
1 mM methionine since the parent strain, P. aeruginosa K372, is a methionine 
auxotroph. Consequently, the selective media were:-
i) Succinate minimal agar + 1 mM Met
ii) Succinate minimal agar+ 1 mM Met + 500 |iM  myo-InsP6
iii) Luria agar + 500 p.M myo-InsPg
iv) Luria agar + Hg15
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Chapter 4
Inositol Phosphate-Mediated Iron Transport in 
Pseudomonas aeruginosa PAOl
4.1. Introduction
myo-Inositol hexakisphosphate {myo-InsP6) has been reported to have siderophore 
activity in P. aeruginosa (Smith et al., 1994). It is found in the natural environment 
of P. aeruginosa, particularly soil, and is thought to occur in many, if not all, plant 
and animal cells (Cosgrove 1980; Stephens et al., 1991). The siderophore activity of 
myo-InsP6 was strongly iron-regulated, being repressed after growth in iron-replete 
conditions and was inhibited by electron transport chain inhibitors such as carbonyl 
cyanide m-chlorophenylhydrazone (CCCP). In this chapter, a structure-iron transport 
relationship is built up using a number of lower inositol polyphosphates.
4.2. myo-Inositol Hexakisphosphate-Mediated Iron Transport in Pseudomonas 
aeruginosa PAOl
The ability of myo-InsPg to mediate iron transport into P. aeruginosa was determined 
under the conditions used throughout this study and was used as a standard against 
which all other compounds could be compared. The structure of myo-InsP6 is 
illustrated below.
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Figure 4.1. myo-Inositol Hexakisphosphate
The resulting myo-InsPg-mediated iron transport into P. aeruginosa PAOl is 
illustrated in figure 4.2 (p78); the initial rate of iron uptake was 1.63 pmol/min/109 
cells and after 30 minutes the total amount accumulated was 19.08±1.59 pmol/109 
cells (Mean±SEM, n=3).
4.3. Inositol Pentakisphosphate-Mediated Iron Transport in Pseudomonas 
aeruginosa PAOl
Iron transport assays were performed using myo-Ins(l,3,4,5,6)P5, DfL-myo- 
Ins(l,2,4,5,6)P5, my0-Ins(l,2,3,4,6)P5 and D/L-myo-Ins(l,2,3,4,5)P5, and their 


















Figure 4.3. myo-Inositol Pentakisphosphates (1, myo-Ins(l,3,4,5,6)P5; 2, D/L-myo- 
Ins(l,2,4,5,6)P5; 3, myo-Ins(l,2,3,4,6)P5; 4, D/L-myo-Ins(l,2,3,4,5)P5).
The use of myo-InsP5s allowed the determination of the effects of removing 
individual phosphate groups hence modifying several vicinal phosphate group
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arrangements. The resulting myo-InsP5-mediated iron transport profiles are 
illustrated in figure 4.4 (p79) and the data are summarised in table 4.1.
Inositol Polyphosphate




After 30 min 
(pmol/109 cells) 
(Mean±SEM, n=3)




m yo -InsP6 1.63 19.08±1.59
Table 4.1. myo-Inositol pentakisphosphate-mediated iron transport into 
P. aeruginosa PAOl. Uptake data from myo-InsPg is duplicated for 
comparison (* accumulated after 15 min).
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4.4. Inositol Tetrakisphosphate-Mediated Iron Transport in Pseudom onas  
aeruginosa  PAOl
A range of inositol tetrakisphosphates were used to develop further the structure-iron 
transport relationships. Using these compounds it was possible to examine the 
importance of several bis- and trisphosphate motifs and whether the use of either D- 
or L- enantiomers had any effect on the ability to mediate iron transport into P. 
aeruginosa. Using these compounds, it was also possible to determine the effect of 
adding large functional groups to the inositol ring and whether changing the 
orientation of the 2-position functional groups from the axial to the equatorial 
orientation had any effect. The compounds used are illustrated below.
Figure 4.5. Inositol tetrakisphosphates (1, D/L-myo-Ins(l,3,4,5)P4; 2, scyllo- 
Ins(l,3,4,5)P4; 3, D/L-myo-Ins(l,2,4,6)P4; 4, D/L-myc>-Ins( 1,2,4,5)P4; 5, D/L-3,6-di- 
0-benzoyl myo-Ins(l,2,4,5)P4; 6, ^cy//o-Ins(l,2,4,5)P4; 7, m yoIns(l,3,4,6)P4;
8, 2,5-di-O-methyl myo-Ins(l,3,4,6)P4)
The iron uptake profiles associated with this range of inositol tetrakisphosphates are 
illustrated in Figures 4.6 (p80) and 4.7 (p81) and the data are summarised in Table
4.2.
Inositol Polyphosphate Initial Rate of 53Fe Fe Accumulated After





D/L- myo-Ins(l,2,4,6)P4 3.05 9.76±4.53
D/L myo-Ins(l,2,4,5)P4 25.00 95.83±19.93
D/L di-O-bz myo-InsP4 2.00 12.40±5.10
D/L scy//o-Ins(l,2,4,5)P4 24.39 73.49±12.50
myo-InsP6 1.63 19.08±1.59
Table 4.2. Inositol tetrakisphosphate-mediated iron transport into P. aeruginosa 
PAOl. my0 -InsP6-mediated iron transport is duplicated for comparison.
In addition to the compounds in table 4.2, myo-Ins(l,3,4,6)P4 and 2,5 di-Omethyl 
myo-Ins(l,3,4,6)P4 were tested for their ability to mediate iron transport into P. 
aeruginosa. myo-Ins(l,3,4,6)P4, was still capable of chelating iron in this system 
although insufficient was available to produce an iron transport profile. In contrast, 
2,5 di-0-methyl myo-Ins(l,3,4,6)P4 was unable to chelate iron in this transport assay 
and precipitation was always observed.
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4.5. Inositol Trisphosphate-Mediated Iron T ransport in Pseudomonas 
aeruginosa PAOl.
The final group of inositol phosphates to be tested were the inositol trisphosphates 
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Figure 4.8. myo-Inositol Trisphosphates (1, myo-Ins(l,2,3)P3', 2, D/L-rayo- 
Ins(l,3,4)P3; 3, D/L-myo-Ins(l,4,5)P3; 4, D/L-myo-Ins(l,4,6)P3).
Inositol trisphosphate-mediated iron transport is indicated by figure 4.9. (p82) and 
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Table 4.3. myo-Inositol trisphosphate-mediated iron transport into P. aeruginosa 
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Figure 4.2. m;yoInsP6-mediated iron transport into P. aeruginosa 
PAOl grown in succinate medium. The uptake medium contained 
m;y0 -InsP6 (lOOpM), 55FeCl3 (200nM), glucose (60pM) and 1 ml 
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Figure 4.4. Inositol pentakisphosphate-mediated iron transport into 
P. aeruginosa PA O 1 grown in succinate medium. The uptake medium 
contained inositol pentakisphosphate (100 pM), 55FeCl3 (200 nM), 
glucose (60pM) and 1 ml of cells OD470 1.0. The dashed line represents 
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Figure 4.6. Inositol tetrakisphosphate-mediated iron transport into 
P. aeruginosa PAOl grown in succinate medium. The uptake 
media contained inositol tetrakisphosphate (lOOpM), 55FeCl3, 
(200nM), glucose (60jiM) and 1 ml of cells OD470 1.0. The dashed 


















^cj//o-Ins( 1,2,4,5)P,6 0 -
4 0 -
2 0 -
3,6 di-O-benzoyl m yo-Ins(l,2,4,5)P(
—i— i— i— i— |— i— i— i— i— |— i— i— i— i— |
i 20 25 300 5 10 15
T im e  (m in )
Figure 4.7. Inositol tetrakisphosphate-mediated iron transport into 
P. aeruginosaPAO l grown in succinate medium. The uptake 
media contained inositol tetrakisphosphate (100 pM), 55FeCl3 
(200 nM), glucose (60pM) and 1 ml of cells OD470 1.0. The dashed 
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Figure 4.9. Inositol trisphosphate-mediated iron transport into 
P. aeruginosa PA O 1 grown in succinate medium. The uptake 
media contained inositol trisphosphate (100 pM), 55FeCl3(200nM), 
glucose (60pM) and 1 ml of cells OD470 1.0. The dashed line 
represents myo-InsP6-mediated iron transport for comparison.
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4.6. Discussion
Inositol phosphate-mediated iron transport assays provided a basis for the 
determination of several structure-iron transport relationships, myo-InsP6 is a 
naturally occurring compound that is ubiquitous throughout nature and was used as 
standard against which the other compounds were compared. It is important to note 
that the majority of compounds tested are either natural analogues that are not 
thought to be found in the natural environment of P. aeruginosa at levels capable of 
mediating iron transport or are entirely synthetic entities. These compounds 
therefore serve to identify key structural motifs and not to mimic environmental 
conditions.
The Fe(m) chelating ability of wyo-InsP6 is well documented (with an affinity 
constant between 1025- 1030) (Poyner et al., 1993) and is thought to form the basis of 
the antioxidant abilities of this compound (Graf et a l, 1987). myo-InsPg adopts a 
chair conformation and has six phosphate groups arranged around its cyclohexane 
ring. The orientations of the phosphate groups depend on the surrounding 
environment. When present in solution as the protonated free acid, five of the 
phosphate groups, in positions 1-, 3-, 4-, 5- and 6-, are arranged equatorially whereas 
the 2- position phosphate group is in the axial position (5e/la). However, when 
present as either the crystalline form or as the dodecasodium salt, a conformational 
change occurs. This results in the formation of a chair conformation with five 
phosphate groups (1-, 3-, 4-, 5- and 6-) arranged axially and the remaining phosphate 
group (2-) in the equatorial position (5a/le) (Blank et al., 1975; Amone and Perutz, 
1974). 31P NMR studies suggest that the change in conformation of the ring occurs at
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pH 9.4 (Isbrandt and Oertel, 1980). The adaptation to the 5a/le orientation results in 
each axial ester oxygen becoming in steric opposition with at least one other axial 
oxygen. Such steric repulsion results in changes in bond angles, torsion angle and 
intramolecular distances. Varying degrees of stress are also introduced between 
vicinal phosphate groups. However, vicinal phosphate groups in the 4- and 5- 
positions are trans related hence the steric repulsion between these two groups is 
minimal. The cis arrangement of phosphate groups in the 1-and 2- positions 
introduces further stress into the molecule hence the 5a/le orientation is regarded as 
sterically unfavourable (Blank et al., 1975). Consequently, conversion to the 5e/la 
form in aqueous conditions is thought to afford a more sterically favourable 
orientation. Moreover, Costello et al., (1976) suggested that at high concentrations 
of InsP6, the conformation of the phytate anion may change to the boat orientation 
which is considerably more compact and would be favoured as the solvent becomes 
increasingly depleted.
Iron transport assays were performed using myo-InsP6 in dilute aqueous solution 
(100 |iM) hence promoting the 5e/la conformation. It is this structural arrangement 
of myo-InsP6 that led Hawkins et al. (1993) to propose that the 1,2,3 (equatorial, 
axial, equatorial) trisphosphate motif is important in iron chelation. This motif may, 
therefore, be an important factor in the ability of myo-InsP6 to chelate iron and 
present it to the bacterium.
Of the six isomers of myoinositol pentakisphosphate, only myo-Ins(l,3,4,5,6)P5 is 
found at intracellular concentrations similar to those of myo-InsPg (Stephens et al.,
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1991). rayo-Ins(l,3,4,5,6)P5 is the major InsP5 in bovine brain and platelets
(Phillippy and Bland, 1988), although in plant extracts such as soya bean, it was 
present only in low concentrations (Phillippy and Bland, 1988). Although its exact 
biological role is unclear, myo-Ins(l,3,4,5,6)P5 has been shown to be an intermediate 
in both the synthesis and degradation of myo-lnsP^ in mung beans (Biswas et al., 
1978). In a number of amphibians and in the majority of birds, myo-Ins(l,3,4,5,6)P5 
serves as a modulator of the oxygen affinity of haemoglobin and is thought to 
function in a manner similar to mammalian 2,3-diphosphoglycerate (Bartet, 1982). 
In addition, Vallejo et al., (1987) reported that myo-Ins(l,3,4,5,6)P5 had the ability to 
excite neurons in the brain stems of rats hence having the potential as a 
neutransmitter.
Because myo-Ins(l,3,4,5,6)P5 is commercially available and is easily extracted from 
avian blood, it has been tested in more biological assays than any other inositol 
pentakisphosphates. Consequently, the lack of availability of the other isomers has 
resulted in a relative lack of knowledge regarding these molecules.
When studying the nomenclature and stereochemistry of inositol pentakisphosphates, 
it must be remembered that a plane of symmetry exists down the 2/5 axis. 
Consequently, of the six isomers of myo-InsP5, two are meso- compounds, myo- 
Ins(l,3,4,5,6)P5 and myoIns(l,2,3,4,6)P5 whilst myo-Ins(l,2,4,5,6)P5 and myo- 
Ins(l,2,3,4,5)P5 are present as racaemic pairs as illustrated in figure 4.3. The 
enantiomeric pairs listed above exist in a 50:50 mixture hence the designations D/L 
or ± are used. D-myo-Ins(2,3,4,5,6)P5 is not represented because this is the same as
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L-my0-Ins(l,2,4,5,6)P5 and similarly, D-wyo-Ins(l,2,3,5,6)P5 is the same as L-rnyo- 
(1,2,3,4,5)P5.
Iron transport assays using inositol pentakisphosphates indicated that loss of the 2- 
position phosphate group resulted in enhanced iron transport compared with myo- 
InsP6. In contrast, loss of the 3-position phosphate represented by D/L myo- 
Ins(l,2,4,5,6)P5 had little effect on the ability of the compound to mediate iron 
transport despite a slight increase in the initial rate. Table 4.1. indicates that removal 
of either the 5- or 6- position phosphate groups had detrimental effects on inositol 
phosphate-mediated iron transport. The detrimental effect was most noticeable with 
D/L myo-Ins(l,2,3,4,5)P5 which lacks the 6-position phosphate group.
Interestingly, the two inositol pentakisphosphates retaining the vicinal 1,2,3 (axial, 
equatorial, axial) trisphosphate motif, thought to be important in iron binding 
(Hawkins et al., 1993), were less able to mediate iron transport than those lacking 
this motif. Also of interest is the activity surrounding the 5-position phosphate 
group. Studies examining the ability of myo-Ins(l,4,5)P3 to act at the myo- 
Ins(l,4,5)P3 receptor indicated that the 4,5 bisphosphate motif is important in 
receptor recognition (reviewed by Potter and Lampe 1995). In this study, it also 
appears that disruption of the 4,5-bisphosphate motif by removal of the 5-phosphate 
group results in reduced activity. Studies observing structure-activity relationships at 
the eukaryotic myo-Ins(l,4,5)P3 receptor indicate that changes in functional group at 
the 6-position are important (Polokoff et al., 1988). This study similarly indicates
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that in inositol phosphate-mediated iron transport, changes in functional group at the 
6-position results in notably altered activity .
Iron transport assays were also performed using various inositol tetrakisphosphates. 
Several forms of Ins(l,3,4,5)P4 were assayed for their abilities to mediate iron 
transport into P. aeruginosa PAOl. All forms of Ins(l,3,4,5)P4, which do contain 
the 4,5-bisphosphate motif, were good mediators of iron transport and were 
considerably greater better than myo-InsPg.
myo-Ins(l,3,4,5)P4 is a naturally occurring compound although it is not thought to 
exist in the natural environment of P. aeruginosa. It is a metabolite of myo- 
Ins(l,4,5)P3 produced as a result of 3-kinase activity. The exact role of myo- 
Ins(l,3,4,5)P4 in eukaryotic systems is unclear although it does appear to have 
modest calcium mobilising activity (Cullen et al., 1994). The role of 3-kinase is 
particularly important and was initially thought to provide a mechanism of 
terminating the response elicited by myo-Ins(l,4,5)P3 by virtue of myo-Ins(l,3,4,5)P4 
having little physiological effect. However, more recently, specific binding sites for 
this compound have been found located in the plasma membrane of human platelets 
suggesting a more distinct role in cellular signalling. This is in contrast to the myo- 
Ins(l,4,5)P3 receptors which are normally found associated with intracellular 
membranes (Cullen etal., 1994).
It was particularly interesting to note that both D- and L-myo-Ins(l,3,4,5)P4 produced 
near identical iron uptake profiles as indicated in figure 4.6. In mammalian studies
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of rayc>-Ins(l,4,5)P3 acting at the Ins(l,4,5)P3 receptor, strong stereospecificity was 
observed. L-myo-Ins(l,4,5)P3 was unable to mobilise calcium and binding of this 
enantiomer was approximately 2,000-fold weaker than that of the natural enantiomer, 
D- myo-Ins(l,4,5)P3 (Strupish et al., 1988). This stereospecificity was also observed 
with several myo-Ins(l,4,5)P3 analogues acting as substrates for 3-kinase and 5- 
phosphatase (Safrany et al., 1992). The apparent lack of specificity of D- and L- 
myo-Ins(l,3,4,5)P4 suggests that inositol phosphate mediated iron transport does not 
occur via specific inositol phosphate receptors.
Studies using jcy//o-Ins(l,3,4,5)P4, where the 2-position hydroxyl group is in the 
equatorial rather than the axial orientation, produced an iron uptake profile that was 
near identical to the myo- derivatives. Previous studies examining the activity of 
myo-Ins(l,3,4,5)P3 at the myo-Ins(l,4,5)P3 receptor suggest that changes of 
conformation at the 2-position were also well tolerated (Wilcox etal., 1993).
The synthetic compound D/L-myo-Ins(l,2,4,6)P4 was also tested. This compound 
was of particular interest because of the three vicinal equatorial phosphate groups in 
the 1-, 2- and 6-positions. In common with compounds possessing the 1,2,3 
(equatorial, axial, equatorial) motif, this compound was also a poor mediator of iron 
transport.
Several Ins(l,2,4,5)P4 derivatives were tested. myo-Ins( 1,2,4,5)P4 is a synthetic 
compound designed to determine the effects of substituting the 2-position hydroxyl 
group of myo-Ins( 1,4,5)P3 with another phosphate group. myo-Ins( 1,2,4,5)P4 had
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considerable calcium mobilising activity in eukaryotic systems (Mills et al., 1993b) 
and was found to function as a full agonist with only 3-fold less potency than D -myo- 
Ins(l,4,5)P3. In addition myo-Ins(l,2,4,5)P4 was resistant to both Ins(l,4,5)P3 3- 
kinase and Ins(l,4,5)P3 5-phosphatase (Hirata et al., 1994).
In this study, myo-Ins(l,2,4,5)P4 was a particularly effective mediator of iron uptake 
into P. aeruginosa. Interestingly, this compound retains the 4,5-bisphosphate motif 
which, in eukaryotic studies, is considered vital in calcium mobilisation (Berridge 
and Irvine, 1984). A preliminary study using D- and L-enantiomers of myo- 
Ins(l,2,4,5)P4 produced near identical results which was consistent with data from 
with D- and L-myo-Ins(l,3,4,5)P4 (data not shown).
Additional transport assays were performed using a sterically modified version of 
myo-Ins(l,2,4,5)P4, produced by addition of O-benzoyl groups at the 3- and 6- 
positions. 3,6 di-O-benzoyl myo-Ins(l,2,4,5)P4 has the same arrangement of 
phosphate groups although substitutes two hydroxyl groups for -O-benzoyl groups. 
This compound was assayed in order to determine whether addition of large 
functional groups afforded any variation in the ability to mediate iron transport into 
P. aeruginosa. The resulting iron transport associated with this compound was very 
much less than that observed with myo-Ins(l,2,4,5)P4, and was similar to that 
achieved using myo-InsP6. Of two possible explanations, one may be that 
substitution of hydroxyl groups in the 3- and 6- positions with less charged O- 
benzoyl groups, reduces the ability of this compound to complex iron and therefore 
deliver it back to the bacterium. Alternatively, addition of large, sterically hindering
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groups, may reduce the ability of the compound to come into close contact with the 
surface of the bacterium hence reducing the ability of the compound to yield iron to a 
putative transport system.
Iron transport assays were also performed using scy//o-Ins(l,2,4,5)P4 which differs 
from myo-Ins(l,2,4,5)P4 with respect to the orientation of the 2-position phosphate 
group. ,scy//0-Ins(l,2,4,5)P4-mediated iron transport was similar to that achieved 
using myo-Ins(l,2,4,5)P4 which is consistant with D- and L-myo- and scyllo- 
Ins(l,3,4,5)P4 where the change in orientation at the 2-position was of little 
consequence.
It was unfortunate that myo-Ins(l,3,4,6)P4 was not available in sufficient quantities to 
perform transport assays However, this compound was able to chelate iron as judged 
by the relatively low counts on the nitrocellulose filters. Interestingly, 2,5 di-O- 
methyl myo-Ins(l,3,4,6)P4 was unable to chelate iron in this assay which may be a 
result of the substitution of the charged hydroxyl groups with less charged -O-methyl 
groups. This suggests that two vicinal phosphate groups are not sufficient to chelate 
iron without the presence of at least one vicinal hydroxide group. The ability of 3,6- 
di-0-benzoyl-myo-Ins(l,2,4,5)P4 to chelate iron may be associated with the charge 
surrounding the carbonyl group of the -O-benzoyl configuration.
The final group of compounds tested were the inositol trisphosphates. Figure 4.9. 
illustrates that these compounds produced a diverse range of iron transport profiles 
ranging from myo-Ins(l,2,3)P3, which produced a final accumulated amount of iron
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of 11.61±1.39 pmol/109 cells, to myo-Ins(l,4,5)P3, which produced a final 
accumulated amount of iron of 106.37±6.57 pmol/109 cells. Interestingly, the 1,2,3 
(axial, equatorial, axial) trisphosphate motif of myo-Ins(l,2,3)P3 is considered 
important for iron binding (Hawkins et al., 1993) whereas the 4,5 bisphosphate motif 
of my0-Ins(l,4,5)P3 appears important in calcium release in eukaryotic studies.
myo-Ins(l,2,3)P3 provides the minimal structure required for assessing the effect of 
the 1,2,3 (equatorial, axial, equatorial) trisphosphate motif. myo-Ins(l,2,3)P3 is a 
naturally occurring inositol trisphosphate that has been located in numerous 
eukaryotic cells in the concentration range 1-10 p,M (Barker et al., 1995). It is 
thought that myo-Ins(l,2,3)P3 is produced as a result of "phytase"-mediated 
dephosphorylation of myo-InsP6 (Cosgrove, 1969) and is unusual in that the majority 
of naturally occurring inositol phosphates do not possess a 2-position phosphate 
group (Barker et al., 1995). A study by Hawkins et al., (1993) suggested that 
compounds possessing the 1,2,3 (equatorial, axial, equatorial) trisphosphate motif, 
which includes both my<9-Ins(l,2,3)P3 and myo-InsPg, are particularly efficient at 
chelating Fe(III). Coupled with the observations that the cellular turnovers of both 
myo-Ins(l,2,3)P3 and myo-InsP6 are extremely slow, these findings suggest that the 
physiological role of myo-Ins(l,2,3)P3 may be linked to intracellular antioxidant 
properties (Barker et al., 1995). Iron transport assays using this compound 
strengthened the observation that the presence of this motif results in poor iron 
transport which was almost half that achieved using myo-InsP6. Unlike myo-InsP6, 
this compound does not posses the vicinal 4,5 bisphosphate motif which appears 
important for the iron uptake mediating activity of these compounds.
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The eukaryotic second messenger myo-Ins(l,4,5)P3 was the best mediator of iron 
transport tested in this study. The first reports of the second messenger activity were 
in 1983 and 1984 (Streb et al., 1983; Berridge and Irvine, 1984) when it was realised 
that this molecule provided the missing link between receptor stimulation and 
mobilisation of calcium from intracellular stores. This discovery has provided 
understanding of many receptor-coupled aspects of cellular control (Potter, 1992). 
Interestingly, this compound retains the 4,5 bisphosphate motif considered essential 
for the ability of this compound to act at the eukaryotic myo-Ins(l,4,5)P3 receptor. It 
also highlights the relative importance of alterations at the 2-position when compared 
to rayo-Ins(l,2,4,5)P4 as noted previously. In comparison to myo-Ins(l,2,4,5)P4, it 
illustrates that a change of functional group at the 2-position has some effect on the 
ability to mediate iron transport into P. aeruginosa. These results mirror those of the 
eukaryotic calcium mobilisation studies by Mills et a l, (1993b). In common with 
myo-Ins(l,3,4,5)P4 and myo-Ins( 1,2,4,5)P4, a preliminary study illustrated no 
difference between the activity of the D- and L- enantiomers of myo-Ins(l,4,5)P3 
suggesting further, the lack of a specific receptor (data not shown).
Iron transport assays were also performed using myo-Ins(l,3,4)P3. This compound is 
a naturally occurring inositol phosphate produced by the sequential action of 
Ins(l,4,5)P3 3-kinase and Ins(l,4,5)P3 5-phosphatase. In mammalian cells, the signal 
generated by myo-Ins(l,4,5)P3 can be terminated by 5-phosphatase to yield D-myo- 
Ins(l,4)P2, and also by 3-kinase to produce D-myo-Ins(l,3,4,5)P4. In addition to the 
direct metabolism of Ins(l,4,5)P3, 5-phosphatase is also capable of removing the 5-
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phosphate group from Ins(l,3,4,5)P4 to yield Ins(l,3,4)P3 (Berridge and Irvine 1989; 
van Dijken et al., 1994). In soluble extracts of porcine skeletal muscle Ins(l,3,4)P3 
is subsequently dephosphorylated to D-myo-Ins(3,4)P2, D-myo-Ins(3)P and finally to 
free inositol (Foster et al., 1994). Alternatively, a 5/6 kinase has been demonstrated 
to act upon myo-Ins(l,3,4)P3 to produce ray<9-Ins(l,3,4,6)P4 and myo-Ins(l,3,4,5)P4 
(Hughes e ta l ., 1994) with a 6-kinase:5-kinase activity ratio of 4:1.
rayo-Ins(l,3,4)P3 was a relatively poor mediator of iron transport and gave a profile 
only slightly greater than that achieved using myo-InsP6. This observation again 
suggests that the 5-position phosphate group appears important in the ability to 
mediate iron transport with disruption of the 4,5-bisphosphate motif resulting in 
reduced iron transport.
The final inositol trisphosphate to be tested was myo-Ins(l,4,6)P3. myo-Ins(l,4,6)P3
is a synthetic compound, originally designed to determine structure-activity
relationships of wyo-Ins(l,4,5)P3 and the relative importance of the 4,5-bisphosphate
motif in mediating intracellular Ca2+ release (Mills et al., 1993a). In eukaryotic
systems, it was noted that the naturally occurring inositol tetrakisphosphate myo-
2+Ins(l,3,4,6)P4 possessed Ca mobilising activity despite the absence of the 4,5- 
bisphosphate motif (Polokoff et al., 1988 and Ivorra et al., 1991). The subsequent 
synthesis of myo-Ins( 1,4,6)P3 revealed that this compound had 11-fold less potent 
calcium mobilising activity than myo-Ins(l,4,5)P3 but was 5-fold more potent than 
the natural compound, myo-Ins(l,3,4,6)P4 (Mills et al., 1993a). These data led Mills
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et al., (1993a) to suggest that the 1,6-bisphosphate configuration mimics the normal 
4,5-bisphosphate motif in myo-Ins(l,4,5)P3.
A similar phenomenon was observed with my0-Ins(l,4,6)P3-mediated iron transport 
whereby the iron transport activity associated with this compound was greater than 
expected when considering the lack of the 4,5-bisphosphate motif. This gives further 
suggestion that the 1,6-bisphosphate motif may mimic the normal 4,5-bisphosphate 
motif in myo-Ins(l,4,5)P3.
In summary, this chapter has identified two key structural motifs involved in inositol 
phosphate-mediated iron transport into P. aeruginosa. The presence of the 1,2,3 
(equatorial, axial, equatorial) trisphosphate motif appears to be associated with a low 
iron uptake profile. This motif has been suggested to play a key role in high affinity 
iron chelation (Hawkins et a\., 1993) and chapter 5 will attempt to determine whether 
the low iron transport associated with this motif is a result of iron being withheld 
from a putative transport system. Also, the addition of large sterically hindering 
groups reduces iron transport which may represent a reduced interaction between the 
ferri-inositol phopshate complex and a putative carrier system. The other key group 
is the 4,5-bisphosphate motif. Studies using the lower inositol phosphates suggest 
that compounds retaining this arrangement are better mediators of iron transport. 
This is in common wth eukaryotic calcium mobilisation studies whereby the 
presence of the 4,5-bisphosphate group is considered essential (Berridge and Irvine, 
1984).
9 4
This chapter also illustrates that changes at the 2- and 3-positions have modest 
effects on iron transport. In comparison with myo-Ins(l,4,5)P3, addition of a 
phosphate group to the 3-position (mjo-Ins(l,3,4,5)P4) was more detrimental to iron 
transport than the addition of a phosphate group to the 2-position (myo- 
Ins(l,2,4,5)P4). These data mirror those of eukaryotic studies in that myo-
Ins(l,3,4,5)P4 had minimal calcium mobilising activity whereas myo-Ins(l,2,4,5)P4 
was considerably more potent. Using scyllo- and myo-derivatives of Ins(l,2,4,5)P4 
and Ins(l,3,4,5)P4, it was apparent that orientation of the 2-position functional 
groups was of minor importance. Also of importance were the observations that both 
the D- and L- forms of Ins(l,3,4,5)P4, Ins( 1,2,4,5)P4 and Ins(l,4,5)P3 mediated 
similar iron uptake suggesting the lack of a specific receptor.
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Chapter 5
The Ability of Inositol Phosphates to Interact With 
Ferric Iron Relative to the Ability to Mediate Iron 
Transport in Pseudomonas aeruginosa
5.1 Introduction
Chapter 4 illustrated the ability of several inositol polyphosphates to mediate iron 
transport into P. aeruginosa PAOl and it was possible to determine various 
structure-iron transport relationships. Whilst iron transport assays illustrated the 
ability of the individual inositol polyphosphates to chelate Fe(III), they give no 
information regarding the relative affinities of each of the compounds towards 
Fe(ID).
Consequently, a series of experiments was performed to gain an insight into the 
relative abilities of several inositol phosphates to complex Fe(III). A hydroxyl 
radical generation assay was used to assess the ability of these compounds to bind 
Fe(m) in a manner that inhibits iron-catalysed hydroxyl free radical generation. 
Secondly, experiments were performed to determine the uptake profile using a 
combination of inositol polyphosphates which appear to have different iron 
complexation abilities. Finally, iron transport assays were performed to assess 
whether myo-InsPg-mediated iron transport confers a competitive advantage in the
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environment. This assessed the ability of myo-InsP6 to mediate iron transport at 
different pH values and by measuring the ability of myo-InsP6 to compete with a 
non-utilisable P. aeruginosa pyoverdine.
5.2 Hydroxyl Radical Assay
Graf et al., (1987) described the hypoxanthine-xanthine oxidase-based hydroxyl 
assay to demonstrate the anti-oxidant properties of InsP6, which was later extended 
to include other inositol polyphosphates by Hawkins et al., (1993). The antioxidant 
ability results from a complex mechanism in which the chelating ability plays an 
important role.
Briefly, oxidation of hypoxanthine by xanthine oxidase produces a mixture of 
hydrogen peroxide, hydroxyl radical and the superoxide anion (Klein et al., 1981). 
Hydroxyl radicals are produced as a result of the reaction between the superoxide 
anion and hydrogen peroxide in an iron-catalysed Haber-Weiss type reaction as 
illustrated below.
O2'+ Fe3+ —» 0 2 + Fe2+
2 O2 + 2H+ —^ H2O2 + O2
H20 2 + Fe2+ -> Fe3+ + OH" + OH-
The interaction of hydroxyl radicals with dimethyl sulphoxide results in the 
production of methyl radicals which can react in three ways (Klein et al., 1981). 
Methyl radicals may abstract a hydrogen to produce methane, dimerise to ethane or 
react with molecular oxygen to give the methylperoxy radical (M e-0-0 ‘).
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Subsequent decomposition of Me-O-O’ can result in the production of formaldehyde 
which is followed by measurement of absorbance at 410 nm.
2Me-0-0* H2C =0 + MeOH + 0 2
Consequently, addition of iron-chelating compounds, that render the iron incapable 
of catalysing the Haber-Weiss reaction, results in reduced hydroxyl radical formation 
and a subsequent reduction in formaldehyde production (Graf et al., 1984).
In order to catalyse hydroxyl radical generation, iron must have one or more free co­
ordination sites or have co-ordination sites occupied by a readily dissociable ligand 
such as water. The majority of iron chelators, such as EDTA, bind iron in such a 
manner that retains an active iron co-ordination site. This results in the formation of 
a complex that will still support hydroxyl radical generation. However, myo-InsP6 
forms a water-excluding chelate that will not support hydroxyl radical generation 
(Graf et al., 1987). This effect is observed even at high iron:myo-InsP6 ratios and is 
thought to be due to myo-InsP6 shifting the redox potential of iron and moderating 
the oxidation of Fe(II). Fe(II) can be oxidised either by oxygen, which produces low 
levels of hydroxyl radicals, or by hydrogen peroxide, which produces high levels of 
damaging hydroxyl radicals, myo-InsPg accelerates oxygen-mediated oxidation 
whilst not affecting hydrogen peroxide-mediated oxidation. This results in the 
conversion of Fe(II) to the relatively inert Fe(III) via a low hydroxyl radical 
generating mechanism which is then chelated in a non-reactive form by myo-InsP6. 
It is these mechanisms which are proposed to give myo-lnsR^ antioxidant properties 
in vivo (Graf et al., 1987).
9 8
Using this method, it was possible to determine the relative abilities of several myo­
inositol phosphates to inhibit formaldehyde production resulting from iron-catalysed 
hydroxyl radical generation.
5.2.1. Hydroxyl Assay Results
The abilities of several inositol polyphosphates to inhibit Fe(m)-catalysed hydroxyl 
radical generation are summarised below.
Inositol Phosphate % of Control Colour Production 
(M ean±SEM, n=3)
m yo-InsP6 0
m yo-Ins(l, 4,6)P3 7±1
myo-Ins(l,2,3)P3 31±0.2
myo-Ins(l,2,4,5)P4 66±3
3,6 di-O-benzoic myo-Ins(l,2,4,5)P4 68±4
myo-Ins(l,3,4)P3 82±4
myo-Ins(l,4,5)P3 104±1
Table 5.1. Inhibition of hydroxyl radical-mediated formaldehyde production by myo­
inositol phosphates (100 pM). The values represent the amount of formaldehyde 
produced, as percentages of control incubations without added inositol phosphates.
5.3. Competition Between Efficient and Poor M ediators of Iron  T ransport
Data from section 5.2. identified variations in the ability of several inositol 
phosphates to interact with ferric iron in a manner that prevents iron-catalysed
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hydroxyl radical formation. Despite apparent differences in their abilities to interact 
with iron, these data do not indicate whether these differences are of significant 
magnitude to allow competition for iron between individual compounds. In order to 
address this question, iron transport assays were performed containing equimolar 
(100 pM) concentrations of two inositol phosphate compounds that produced 
markedly different iron-uptake profiles. The aim of these experiments was to 
determine whether the inositol phosphate with the greater ability to interact with iron 
was able to compete for iron and confer an iron-uptake profile normally associated 
with that compound alone.
5.3.1. Iron Transport Assay Using Equimolar Inositol (1,2,3) Trisphosphate and 
myo-Inositol (1,4,5) Trisphosphate
Iron transport assays were performed using a combination of equimolar (100 pM) 
myo-Ins(l,2,3)P3 and myo-Ins(l,4,5)P3. From previous data, it was observed that 
myo-Ins(l,2,3)P3 was able to interact with iron in a manner which inhibited hydroxyl 
radical formation yet was a poor mediator of iron transport. Conversely, myo- 
Ins(l,4,5)P3 appeared less able to interact with iron Fe(DI) yet was associated with 
particularly high iron transport. Figure 5.1. (pl04) indicates that in the presence of 
both of these chelators, iron transport is considerably lower than that achieved using 
myo-Ins(l,4,5)P3 alone although not quite as low as that achieved with myo- 
Ins(l,2,3)P3 alone.
100
5.3.2. Iron  T ransport Assay Using Equim olar m yo-Inositol H exakisphosphate 
and myo-Inositol (1,4,5) Trisphosphate.
This uptake assay was also based on competition of equimolar (100 pM) 
concentrations of myo-InsP6 and myo-Ins(l,4,5)P3. myo-InsP6 was used since this 
was the only compound in this study capable of complete inhibition of hydroxyl 
radical generation. Figure 5.2. (p i05) illustrates that in an uptake medium 
containing both of these inositol phosphates, the uptake pattern resembles that of 
myo-Insp6 rather than myo-Ins(l,4,5)P3. The ability of myo-InsPg to compete with 
myo-Ins(l,4,5)P3 was notably greater than myo-Ins(l,2,3)P3.
5.4 Assessing the Ability of myo-Inositol H exakisphosphate to Confer a 
Competitive Advantage in the Environm ent.
This study has provided an insight into structure-activity relationships of various 
inositol phosphates. However, with the exception of rayo-InsP6, all the other 
compounds tested are unlikely to be found in the natural environment of P. 
aeruginosa at levels capable of mediating iron uptake. Consequently, additional iron 
transport assays were performed to assess whether the siderophore activity of myo- 
InsPg gave P. aeruginosa a competitive advantage in the environment.
5.4.1. Competition of myo-InsP6 with Pseudomonas aeruginosa ST:06 
Pyoverdine
The ability of P. aeruginosa to use exogenous siderophores for iron acquisition is 
well documented (section 1.7) where it is thought it may confer a competitive 
advantage. In addition to the iron transporting compounds that are utilisible by P.
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aeruginosa PA01, this bacterium may also be surrounded by siderophores from 
other bacteria that cannot be used. One such example of this is the pyoverdine 
produced by P. aeruginosa ST:06 (Pvd:06) which will bind iron, but will not mediate 
iron transport into P. aeruginosa PAOl (Gensberg, 1994). Iron transport assays 
were performed in order to determine whether myo-InsP6 has sufficient iron binding 
ability to remove iron from Pvd:06 and mediate iron uptake.
Uptake experiments were performed using a mixture of Pvd:06 (200|iM) and myo- 
InsP6 (IOOjiM) and are illustrated by figure 5.3 (pl06). It was observed that Pvd:06 
alone, does not mediate iron transport into P. aeruginosa PAOl despite its ability to 
chelate ferric iron. The combination of Pvd:06 and myo-InsP6 results in an uptake 
profile similar to that of Pvd:06.
5.4.2. The Effect of pH on myo-Inositol Hexakisphosphate-Mediated Iron- 
Transport
All the previous iron transport studies were performed at pH 7.0 although P. 
aeruginosa is found in a range of environments of varying pH. This is particularly 
true for soil environments. Iron transport assays were performed to determine myo- 
InsP6-mediated iron transport at pH 6.0, 6.5, 7.5 and 8.0. The iron transport profiles 
are illustrated in figure 5.4 (pl07) and the data are summarised in table 5.2.
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Initial R ate of 
55Fe U ptake 
(pmol/min/109 cells)
5:>Fe Accumulated 
A fter 30 min 
(pmol/109 cells) 
(Mean±SEM, n=3)
myo-InsP6 a t pH  6.0 2.69 22.75±6.64
myo-InsP6 a t pH  6.5 1.61 23.87±6.75
myo-InsP6 a t pH 7.0 1.63 19.08±1.59
myo-InsP6 a t pH 7.5 0.94 10.17±1.64
myo-InsP6 a t pH 8.0 0.72 8.91±2.31
Table 5.2. myo-InsPg-mediated iron transport into P. aeruginosa PAOl at a range of 
different pH values. The data at pH 7.0 are duplicated for comparison.
5.4.3. The Effect of pH on the Competition of #7iyo-InsP6 with Pseudomonas 
aeruginosa ST:06 Pyoverdine
Data from section 5.4.2 indicate that myo-InsPg-mediated iron-transport was 
enhanced at low pH hence further experiments were performed to determine whether 
lowering the pH had any effect on the ability of myo-InsP6 to compete with Pvd:06 
for iron. To examine the effect of low pH, iron transport assays were performed at 
pH 6.0. The resulting iron transport profile is illustrated in figure 5.5. (p i08) where 
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F igure  5.1. Equimolar m yoIns( 1,2,3)P3 and m yo-Ins(l,4,5)P3-
mediated iron transport in P. aeruginosa PA O l grown in succinate 
medium. The uptake medium contained mj<9-Ins(l,2,3)P3 (IOOjiM),
m yo-Ins(l,4,5)P3 (IOOjiM), 55FeCl3 (200nM), glucose (60nM ), and 
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Figure 5.2. Equimolar myo-InsP6 and m yoIns(l,4 ,5)P3-mediated
iron transport in P. aeruginosa PA O l grown in succinate medium.
The uptake medium contained myo-InsP6 (lOOpM), m yo-Ins(l,4,5)P3
(100nM),55FeCl3 (200nM) and 1 ml of cells at OD470 1.0. The 
dashed line represents normal iron transport associated with myo-InsP6 
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F igure  5.3. The combination of rayo-InsP6 and 06:Pvd-m ediated
iron transport in P. aeruginosa PA O l grown in succinate medium. 
The uptake media contained ray0 -InsP6 (100pM), 0:6 Pvd (200pM),
55FeCl3 (200nM), glucose (60jiM) and 1 ml of cells OD470 1.0. The
dashed line is duplicated from Fig 4.2. for comparison and error bars 
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Figure 5.4. ra)>0 -InsP6-mediated iron transport in P. aeruginosa PA O l
grown in succinate medium. Four different uptake media were used 
at pH 6.0, 6.5, 7.5 and 8.0. The uptake media contained myo-InsP6







myo-InsP6 at pH 6.0
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Pvd-0:6  + myo-InsP6 at pH 6.0
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Figure 5.5. The combination of myo-InsP6 and 0:6-Pvd-mediated 
iron uptake in P. aeruginosa PA O 1 grown in succinate medium. 
The uptake medium, adjusted to pH 6.0, contained myo-InsP6
(lOOgM), 0:6 Pvd (200gM), 55FeCl3 (200nM), glucose (60gM) 
and 1 ml of cells OD470 1.0. The dashed line is duplicated from 
figure 5.4 for comparison.
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5.5. Discussion
In dilute aqueous solution, myo-InsP6 assumes the 5e/la  conformation (section 4.6.) 
which is thought to afford myo-InsP6 the ability to inhibit completely Fe(IH)
catalysed hydroxyl radical formation at 100 p.M. Spiers et al., (1996) also noted
complete inhibition of the reaction using myo-Ins(l,2,3)P3 suggesting that this effect
was due primarily to the 1,2,3 (equatorial, axial, equatorial) trisphosphate motif
forming the correct conformation for optimal iron chelation. In addition, Hawkins et 
a i,  (1993), when studying inositol pentakisphosphates, noted that only those 
compounds possessing the 1,2,3 (equatorial, axial, equatorial) trisphosphate motif 
were capable of inhibiting this reaction. Similarly, it was noted that of a range of 
inositol tetrakisphosphates tested, only Ins(l,2,3,5)P4 and Ins(l,2,3,4)P4 were able 
completely, or almost completely, to inhibit hydroxyl radical generation when 
present at 100 pM. In contrast, Ins(l,2)P2 was unable to inhibit hydroxyl radical 
generation (Spiers et al., 1996).
In this chapter, and in common with iron transport data, the inositol trisphosphates 
varied greatly in their ability to inhibit free radical generation. myo-Ins(l,2,3)P3 
caused considerable, although not complete, inhibition of hydroxyl radical 
generation. myo-Ins(l,4,6)P3 was an effective inhibitor of Fe(DI)-catalysed hydroxyl 
radical generation whereas myo-Ins(l,3,4)P3 was unable to cause substantial 
inhibition. myo-Ins(l,4,5)P3 caused a slight potentiation of hydroxyl radical 
generation although the possible biological consequences of enhanced hydroxyl 
radical generation are unknown.
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The inositol tetrakisphosphates myo-Ins(l,2,4,5)P4 and 3,6 di-O-benzoyl myo- 
Ins(l,2,4,5)P4 were tested for their ability to inhibit Fe(DI)-catalysed hydroxyl radical 
generation. Interestingly, there was little difference between the ability of these two 
compounds to inhibit the reaction despite being considerably different in their 
abilities to mediate iron transport. Studies by Spiers et a l, (1996) have shown that 
Ins(l,3,4,5)P4 and Ins(l,2,4,6)P4 produced 70% and 80%, respectively, of the 
formaldehyde produced by the control.
Using these observations, it is possible to propose a model to demonstrate the 
manner in which inositol phosphates interact with Fe(III). In order to catalyse 
hydroxyl radical formation, iron must have one or more free co-ordination sites or 
have co-ordination sites occupied by a readily dissociable ligand such as water. As 
noted previously, the ability of myo-Ins( 1,2,3)P3 and myo-Jns?^ to inhibit iron- 
catalysed hydroxyl radical formation is thought to be due to the 1,2,3 trisphosphate 
motif providing an optimal binding arrangement (Hawkins et al., 1993). A model 
proposing the mechanism of interaction of Fe(III) with the 1,2,3 trisphosphate motif 
is illustrated which assumes the inositol phosphate to be in the 5a/le conformation. 
Consequently, this model suggests that the important component is the axial, 
equatorial, axial 1,2,3 trisphosphate arrangement rather the previously proposed 
equatorial, axial, equatorial arrangement. In the absence of cations, this conformation 
is thought to be sterically unfavourable although Isbrandt and Oertel (1980) 
suggested that the alkali metals preferentially bind to, and stabilise the 5a/le 




Figure 5.6. A diagrammatic model of the proposed interaction between Fe(III)
and m^o-Ins(l,2,3)P3
The proposed model for interaction between Fe(H[) and the 1,2,3 trisphosphate motif 
is based on Fe(IH) possessing 6 co-ordination sites to form an octahedral complex 
(Figure 5.6). It can be seen that the six oxygen anions of the 1,2,3 trisphosphate 
motif of myo-Ins(l,2,3)P3 interact with the 6 co-ordination sites of Fe(III). This 
results in the formation of a stable complex with no co-ordination sites being 
available to interact with the hydrogen peroxide of the hydroxyl radical assay. In 
addition, the hydroxyl groups in positions 4-, 5- and 6- may take part in hydrogen 
bonding hence stabilising the conformation of the inositol phosphate ring. This 
makes iron release from this compound to a putative carrier system particularly 
difficult.
I l l
A model is also proposed to indicate the mechanism by which myo-Ins(l,4,5)P3 is 
capable of potentiating the hydroxyl radical assay. Again, this model assumes the 
5e /la  conformation of the compound and is illustrated below.
2“
Figure 5.7. A diagrammatic model of the proposed interaction between Fe(III)
and myo-Ins( 1,4,5)P3
This model proposes that the site of interaction with iron is between the 1- and 5- 
position phosphate groups rather than the previously suggested 4,5 bisphosphate 
motif. Whilst the equatorial 4,5 bisphosphate arrangement in the 5e/la  conformation 
may be important in eukaryotic receptor recognition, it appears that it is the axial 1- 
and 5- position phosphates that are important in this model. Interestingly, the oxygen 
anions of these two phosphate groups only occupy 4 co-ordination sites of Fe(III)
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leaving two free sites. One site is probably occupied through interaction with the 3- 
position hydroxyl group leaving one free co-ordination site that is probably 
associated with an easily dissociable ligand such as water. This site therefore 
appears suitable for interaction with hydrogen peroxide of the hydroxyl radical 
system. In addition, the hydrogen peroxide is capable of undergoing hydrogen 
bonding to oxygen atoms of the 1- and 5-position phosphate groups which may 
potentiate hydroxyl radical generation. Interestingly, this compound was the most 
efficient mediator of iron transport and may illustrate the ease with which this 
compound yields iron to a putative iron transport system.
This model also explains the slight inhibition of the hydoxyl assay observed with the 
tetrakisphosphates myo-Ins(l,2,4,5)P4 and myo-Ins(l,3,4,5)P4. With these 
compounds, addition of an extra phosphate group provides additional negatively 
charged oxygen anions which are capable of interacting with co-ordination sites of 
Fe(III). This may explain the lower iron uptake profiles associated with these 
compounds in comparison to myo-Ins(l,4,5)P3. Because the principle site of 
interaction is via the functional groups at the 1-, 3- and 5- positions, and the 2- 
position group is less involved, the model also explains why the scyllo derivatives of 
Ins(l,2,4,5)P4 and Ins(l,3,4,5)P4 mediate similar iron profiles to the myo derivatives.
The model also explains why myo-Ins(l,2,4,5)P4 and 3,6 di-O-benzoyl myo- 
Ins(l,2,4,5)P4 appear to have similar abilities to interact with iron. Whilst the 
substitution of the hydroxyl group for the large O-benzoyl group at the 6 position 
should be of little consequence, removing the 3-position hydroxyl group may be
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considered as detrimental. However, the charge associated with carbonyl group may 
interact with the co-ordination site of Fe(DI) in a similar manner to the oxygen of the 
hydroxyl group. Consequently, the low iron transport profile associated with 3,6 di- 
O-benzoyl my0-Ins(l,2,4,5)P4 is probably a result of the large O-benzoyl groups 
reducing the ability of the compound to interact with the bacterial surface rather than 
reflecting a difference in ability to interact with iron.
This may also explain why myo-Ins(l,3,4,6)P4 is capable of chelating iron within this 
system whereas 2,5 di-O-methyl myo-Ins(l,3,4,6)P4 is not. All inositol phosphate- 
iron interactions have depended upon the interaction of at least two phosphate groups 
and one other charged group such as a hydroxyl group or the carbonyl bond. With
2,5 di-O-methyl myo-Ins(l,3,4,6)P4 there is very little charge associated with the O- 
methyl arrangement which may result in the inability of this compound to chelate 
iron.
myo-Ins(l,3,4)P3 is also capable of slightly inhibiting the hydroxyl assay. In 
common with rayo-Ins(l,4,5)P3, this has two axial phosphates and one axial hydroxyl 
group with which to interact with the co-ordination sites of Fe(HI). However, myo- 
Ins(l,3,4)P3 also has the equatorial 2-position hydroxyl group which may also be 
capable of interacting with one of the co-ordination sites of Fe(IH) hence causing a 
slight inhibition of the reaction. The iron transport profile associated with this 
compound is lower than expected and the reason for this is unclear. However, it 
may be a result of this compound presenting iron to the bacterial surface in a manner 
not easily utilised by the bacterium. The remaining compounds, myo-Ins( 1,4,6)P3
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and myo-Ins(l,2,4,6)P4 remain the two anomalies of this study. my<?-Ins(l,4,6)P3 is 
particularly efficient at inhibiting iron-catalysed hydroxyl radical generation yet is an 
efficient mediator of iron transport. When examining the compound in either the 
5e/la  or 5a/le conformation, the model does not explain why this compound is 
particularly effective at inhibiting the reaction. Furthermore, a compound v/ith such 
an ability to interact with iron would not be expected to be an efficient mediator of 
iron transport. This situation is even more confusing with respect to myo- 
Ins(l,2,4,6)P4. Addition of the phosphate group to the 2-position appears to reduce 
the ability of this compound to interact with iron, yet the iron uptake profile 
associated with this compound is indicative of a compound with much greater ability 
to interact with iron.
The assumptions regarding the abilities of these compounds to bind iron and then 
subsequently mediate iron transport into P. aeruginosa PAOl were given further 
strength by a series of competition iron transport experiments. These experiments 
using equimolar concentrations of one inositol phosphate associated with high iron 
transport and a low ability to interact with iron, and another associated with low iron 
transport and a greater ability to interact with iron, resulted in an iron transport 
profile associated with the compound that had the greater ability to interact with iron. 
For example, an equimolar mixture of myo-lns( 1,2,3)P3 and myo-Ins(l,4,5)P3 
resulted in an uptake profile considerably lower than that associated with myo- 
Ins(l,4,5)P3 alone. However, in this example, uptake was not as low as that 
associated with myo-Ins(l,2,3)P3 alone. A mixture of myo-InsP6 and myo- 
Ins(l,4,5)P3 resulted in an iron uptake profile that was almost identical to that
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achieved using myo-InsPg alone. The greater ability of myo-InsPg to reduce the 
uptake profile associated with myo-Ins(l,4,5)P3 is perhaps an indication that this 
compound has a greater affinity towards iron than myo-Ins(l,2,3)P3.
These data indicate that measuring the ability of these compounds to inhibit iron- 
catalysed hydroxyl radical generation gives some indication towards binding affinity. 
However, there are some notable exceptions. It therefore appears that those 
compounds with the greater affinity towards iron are less able to mediate iron uptake 
into P. aeruginosa., perhaps as result of a reduced ability to yield iron to a putative 
carrier system.
The observation that myo-InsPg is able to compete successfully with myo- 
Ins(l,4,5)P3 to mediate iron transport prompted futher competition studies using a 
natural siderophore. The aim of these experiments was to assess the ability of myo- 
InsP6-mediated iron transport to confer a competitive advantage in the environment. 
Iron transport assays were initially performed using a combination of myo-InsPg and 
Pvd:06 (pyoverdine produced by P. aeruginosa S.T:06) in which myo-InsP6 was 
unable to compete with the naturally ocuuring pyoverdine. This again supports the 
hypothesis regarding competition for iron, as pyoverdine has an estimated affinity for 
iron at neutral pH of 1032 M*1 (Demange et a\., 1987), whereas for myo-InsP6, this 
has been estimated to be in the range of 1025- 1030 M '1 (Hawkins et al., 1993). 
However, these experiments did not take into account the fact that P. aeruginosa is 
found in various evironments which may not necessarily be at neutral pH. myo-InsPg 
is a highly charged molecule possessing six phosphate groups that are capable of
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existing in various states of ionistation depending on the pH of the environment 
hence a series of iron transport experiments were performed at varying pH. The p/£a 
values for each of the phosphate groups around myo-InsP6 are illustrated below and 
indicate the sequential transition of each phosphate group from the free acid to the 
mono-anion and ultimately to the di-anion.
O P
Figure 5.8. rayo-Inositol hexakisphosphate illustrating the numbering
of the inositol ring
Position of Phosphate 
Group of myo-InsP6
pKa (Dissociation to 
Mono-anion)








Table 5.3. p£a values for the six phosphate groups of myo-InsP6 for the dissociation 
from free acid to the mono-anion and subsequent dissociation from the mono- to bi­
anion (Costello e ta l ., 1976).
1 1 7
Table 5.2 illustrates that conversion of each of the phosphate groups from the free 
acid to the mono-anion occurs over a narrow pH range. All six phosphate groups 
exist as the mono-anion at a relatively low pH. However, differences become 
apparent when considering conversion from the mono-anion to the di-anion which 
occurs over a broad pH range. For example, the 1-position phosphate has a piifa of 
5.7 for dissociation to the di-anion whereas the 3-position phosphate group has a 
mono- to di-anion p£a  of 12.0. Iron transport assays were performed at pH 6.0, 6.5,
7.5 and 8.0. Table 5.2. shows that over this pH range, there is some variation of 
ionisation around the myo-InsPg molecule.
The results from transport assays performed at different pH values are illustrated in 
figure 5.4. There is very little difference between iron transport at pH 6.0 and pH
6.5. This is expected because at both these pH values only the 1-position phosphate 
group has started to undergo transition to the di-anion. However, increasing the pH 
from 6.5 to 7.0 appears to reduce iron transport which mirrors the increased 
dissociation of the 2-position phosphate group. A further increase in pH from 7.0 to
7.5 results in a further reduction of iron transport as the 5-position phosphate group 
undergoes dissociation. Between pH 7.5 and pH 8.0, there is little difference in iron 
transport which is probably a result of similar degrees of ionisation. Clearly, 
reducing the pH reduces the extent of ionisation of myo-InsP6 which consequently 
appears to increase iron transport.
The observation that myo-InsP6 transport was enhanced at pH 6.0 in comparison to 
pH 7.0, prompted competition experiments with Pvd:06 at the lower pH value. The
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dissociation constants for the acidic groups of Pvd:06 are not available although 
those of pyoverdine PaA have been published (Albrecht-Gary et al., 1994). Whilst 
there are differences in structure between these two pyoverdines, PaA can be used as 
a guide to predict the level of ionisation of Pvd:06. The p/£a values for each acidic 
group of pyoverdine PaA are illustrated below.
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Figure 5.9. The structure of Pyoverdine PaA illustrating the positions of the 











Table 5.4. p/fa values for each of the acidic groups around Pyoverdine PaA
(Albrecht-Gary et al., 1994).
Table 5.4 illustrates that at both pH 7.0 and pH 6.0, pyoverdine PaA possesses two 
dissociated acidic groups (K5 and K6) hence reducing the pH from 7.0 to 6.0 should 
make little difference to the iron chelating ability of the molecule. Iron transport 
assays at pH 6.0 illustrate that the less ionised version of myo-InsP6 was still unable 
to compete with Pvd:06 (figure 5.5).
These results give further support to the theory that reducing the affinity of the 
compound towards iron results in enhanced iron uptake. When considering myo- 
InsP6, reducing the pH of the medium reduces the charge associated with the 
compound resulting in a lower affinity towards Fe(III). In common with other 
compounds with a lower affinity towards Fe(III), e.g. rayo-Ins(l,4,5)P3, this results in 
an enhanced iron uptake. However, because the enhanced myo-InsPg-mediated 
uptake at pH 6.0 is based on a reduced affinity towards iron whilst the extent of
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ionisation of the pyoverdine molecule appears unchanged, it appears even less likely 
that myo-InsP6 is able to compete with Pvd:06.
In summary, this chapter has attempted to relate the ability of several inositol 
phosphates to mediate iron transport in relation with their ability to interact with 
iron. A model was proposed to explain the apparent inverse relationship between the 
ability to mediate iron transport and the ability to interact with ferric iron. In general, 
it appears that increasing the affinity of a compound towards iron results in a reduced 
ability to mediate iron transport into P. aeruginosa PAOl. The clearest examples of 
this phenomenon include myo-InsPg and myo-Ins(l,2,3)P3 where it appears that the 
presence of the 1,2,3 (axial, equatorial, axial) motif confers an enhanced ability to 
interact with iron and a low iron transport profile. In contrast the 1,5-bisphosphate 
motif appears capable of interacting with iron in such a manner that allows 
interaction with hydrogen peroxide in the hydroxyl radical assay. Compounds 
containing this motif, namely myo-Ins(l,4,5)P3, rayo-Ins(l,2,4,5)P4 and myo- 
Ins(l,3,4,5)P4, appear to have lower affinities towards iron yet are considerably better 
mediators of iron transport. Such differences may highlight the relative abilities of 
these compounds to yield iron to a putative carrier system. Finally, myo-InsP6- 
mediated iron transport does not confer a competitive advantage in an environment 
where non-utilisable pyoverdines are present.
Having determined several structure-iron transport relationships and related these to 
the ability of these compounds to interact with ferric iron, chapter 6 attempts to
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determine the mechanisms by which iron complexed with inositol phosphates is 
liberated to the bacterium.
1 2 2
Chapter 6
Iron Release From Inositol Phosphates
6.1. Introduction.
Previous chapters provided an insight into the relationships between the ability of 
several inositol phosphates to interact with iron and their abilities to mediate iron 
transport into P. aeruginosa PAOl. Whilst there are some exceptions, it appears that 
the greater the affinity of a particular compound towards Fe(III) the less able it is to 
mediate iron transport. The aim of this chapter is to determine the mechanisms by 
which iron is liberated from inositol phosphates and made available to the bacterium.
The mechanisms by which endogenous siderophores yield iron to the bacterium are 
still subject to debate. Research into enterobactin-mediated iron uptake in E. coli has 
suggested two mechanisms, one of which involves the action of a cytoplasmic 
esterase, which cleaves the siderophore inside the bacterium hence releasing the iron 
(O'Brien et al., 1970). However, the discovery that certain hydrolysis-resistant 
synthetic siderophores could still release iron led to a heightened interest in other 
mechanisms (Heidinger et al., 1983). Consequently, it was suggested that reductases 
may reduce Fe(EI) to Fe(II) with a subsequent release of iron from the siderophore 
(Fischer et al., 1990). In P. aeruginosa, reductase activity has been implicated in the 
release of iron from the ferripyochelin complex, the ferricitrate complex (Cox, 1980) 
and the ferripyoverdine complex (Halle and Meyer, 1992a). It was believed that this
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system utilised specific enzymes although it now appears that all of the above 
operate via a common non-specific pathway (Halle and Meyer, 1992b).
In this study, three mechanisms of iron release were studied. Firstly, a 
conformationally restricted inositol phosphate, characterised by its inablity to change 
ring conformation, was used. Secondly, attempts were made to determine whether 
phytases cleave phosphates from the inositol ring with a subsequent release of iron 
and finally, a series of experiments were performed to determine whether reductase 
activity was capable of mediating iron release from inositol phosphates.
6.2. Inositol Phosphate-M ediated Iron  T ransport Using a Cyclic Phosphate 
Analogue of scyllo-Inositol (1,4,5) Trisphosphate
OH
•P _ 0  HO
Figure 6.1. Cyclic Phosphate Analogue of scyllo-Inositol (1,4,5) Trisphosphate
(D/L)-deoxy-6-hydroxymethyl-5cy//o-inositol l:7-cyclic,2,4-trisphosphate is a 
structurally complex compound. It was designed to examine the activity surrounding 
the 4,5 bisphosphate motif and to determine the effect of preventing conformational
124
mobility of myo-Ins(l,4,5)P3 (Riley and Potter, 1995). This compound is essentially 
a jcy//o-Ins(l,4,5)P3 derivative that has been tethered via the 4-position phosphate 
group to the equivalent carbon of the 3-position using a methylene group. Unlike 
myo-Ins(l,4,5)P3, this compound is unable to change conformation from the 5e/la to 
the 5a/le conformation.
Eukaryotic calcium mobilisation studies indicated that despite both conformational 
restriction and charge reduction at the highly sensitive 4,5-bisphosphate motif, this 
compound was able to behave as a full agonist. However, this was at an EC50 around 
40-fold higher than myo-Ins(l,4,5)P3 (Riley and Potter, 1995).
Iron transport assays were performed using this compound to indicate whether 
conformational change plays a role in the ability of inositol phosphates to release 
iron to P. aeruginosa PAOl. The results are illustrated in figure 6.2 (p i31) which 
indicate that this compound retains some iron transport activity although less than 
that achieved using myo-Ins(l,4,5)3. The initial rate of iron-uptake was 22.22 
pmol/min/109 cells and the final amount of iron accumulated was 32.55±2.11 
pmol/109 cells after 30 minutes.
6.3. The Role of Phytases in Inositol Phosphate-Mediated Iron Transport
Many organsisms use myo-InsP6 (phytate) as a phosphate source via enzymatic 
cleavage of phosphate groups from the inositol ring. Such phosphate cleaving 
enzymes have been termed phytases and two classes of phytases are recognised. 3- 
phytase catalyses the removal of the D-3-phosphate from phytic acid and 6 phytase
125
attacks the D-6 phosphomonoester. (Loewus, 1990; Gibson and Ullah, 1990). Both 
enzymes are capable of causing successive dephosphorylation of inositol 
pentakisphosphates to free inositol. The 3-phytases are found typically in micro­
organisms and filamentous fungi and the 6-phytase is the dominant plant enzyme. 
Phytases have been identified in Pseudomonas spp (Irving and Cosgrove, 1971) 
which do not appear to require substrate induction. There has been a recent 
resurgence in phytase research particularly within agriculture. It has been found that 
dietary supplementation with phytase optimises phosphate digestion from animal 
feed hence allowing the use of less expensive, low-grade feed and reducing manure- 
derived phosphate output into the environment. Research has focused on the 
addition of Aspergillus niger phytase to the feeds of piglets, broiler chickens, carp 
and rainbow trout (Mitchell and Edwards, 1996; Kirchgessner and Windisch, 1995; 
Schafer et al., 1995; Rodehatscord and Pfeffer, 1995).
In humans, addition of Aspergillus niger phytase to the diet also increases phosphate 
and iron absorption and appears to work well at the low pH encountered in the 
human stomach (Sandberg et a l, 1996). However, whilst the presence of additional 
phytase may improve iron absorption, it may also remove the protective effect of 
phytate increasing the risk of developing colonic cancer (Iqbal et a l,  1994).
In order to determine whether Pseudomonas phytase may play a role in inositol 
phosphate-mediated iron transport, iron transport assays were performed using the 
phosphorothioate derivative of scyllo-Ins(l,2,4,5)P4, scyllo-Ins(l,2,4,5)PS4, The 
phosphate groups of scyllo-lns( 1,2,4,5)PS4 are linked to the carbon ring via sulphur
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atoms rather than the usual oxygen atom hence conferring phytase-resistant 
phosphorothioate groups. The rationale behind using this compound is that if it was 
able to chelate iron yet not mediate iron transport, then this may be a result of 
phytases being unable to cleave the phosphorothioate bond preventing iron release to 
the bacterium. The structure of scyllo-Ins(l,2,4,5)PS4 is illustrated below.
Unfortunately, it was not possible to achieve solubilisation of iron in this system as
was also observed suggesting precipitation of the phosphorothioate compounds. 
This was observed even in the absence of cells. Consequently, the potential role of 
phytase in inositol phosphate-mediated iron transport remains unresolved.
6.4. The Role of Reductases in Inositol Phosphate-M ediated Iron  T ransport
As noted in the introduction, whilst much is known about siderophores and receptor 
production in P. aeruginosa, comparatively little is known regarding the mechanism 
whereby iron is released from the siderophore itself. However, it has been noted that 
several species of bacteria produce reductase enzymes that are thought to reduce 
Fe(III) to Fe(II) which is only weakly bound to the siderophore. This change in
OH
HO
Figure 6 .3 .5cy//o-Ins(l,2,4,5)PS4
precipitation of the 55Fe always occurred. It was noted that a faint yellow colouration
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valency is thought to be responsible for the release of iron to the interior of the 
bacterium.
It was originally thought that the reductase enzyme reduced directly the 
ferrisiderophore complex. However, it appears that the reaction relies upon an 
NADH/FMN oxidoreductase system thought to involve a chemical reduction by 
FMNH2 (Halle and Meyer, 1992b). It is thought that the reaction is initiated by the 
enzyme-catalysed reduction of FMN to FMNH2 by NADH. Next is the FMNH2- 
mediated reduction of Fe(III) to Fe(II). The amount of Fe(II) produced can be 
quantified by its ability to form a coloured Fe(II)-Ferrozine complex which is 
followed spectrophotometrically. Evidence for this mechanism is provided by the 
observation that FMN is an essential component in the reaction. In addition, the 
reaction is inhibited by the presence of oxygen. It was thought that the inhibitory 
effect of oxygen was due to reoxygenation of Fe(II) to Fe(IH), thus competing with 
the Fe(II)-Ferrozine formation (Straka, 1979). However, in light of the FMNH2 
mechanism, it appears that oxygen inhibition is a result of oxidation of the FMNH2 
(Halle and Meyer, 1992b).
The reactions are summarised below.
FMN + 2 NADH -> FMNH2 + 2 NAD+
2 Fe3+ + FMNH2 -> 2 Fe2+ + FMN + 2H+
Fe + Ferrozine —> Fe(H)-Ferrozine (Abs 562 nm)
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This assay was used to measure the ability of P. aeruginosa PAOl reductase to 
reduce iron bound to myo-InsP6 and a variety of other inositol phosphates. Figure
6.4 (p i32) illustrates the NADH/FMN reduction of Fe(HI) bound to rayo-InsP6. The 
bacterial extract, mixed with ferri-myo-InsP6, was sparged with argon for 10 minutes 
and the reaction started by addition of NADH, FMN and Ferrozine. Anaerobic 
conditions were maintained by a constant flow of argon through the 
spectrophotometer cell. There was evidence of a slight lag phase, probably due to 
small amounts of residual oxygen in the system, followed by an increase in OD562 
over 30 min (figure 6.4). Also illustrated is the reduction of ferripyoverdine (0.2 
mM) which results in notably less Fe(II)-Ferrozine production than that achieved 
using ferri-myo-InsPg. The assay was also performed in aerobic conditions which 
inhibited the reaction although the slight increase in Fe(n)-Fen*ozine production after 
25 min may be due to eventual oxygen depletion. Similarly, replacement of bacterial 
extract with Buffer A (Section 3.11) resulted in almost complete inhibition of the 
reaction. Figure 6.4. also illustrates that reduction of ferri-myo-InsP6 is an FMN- 
dependent reaction.
Reductase assays were performed using a variety of inositol phosphates, and in all 
cases, reduction was dependent on the presence of bacterial extract i.e. there was no 
self reduction. Figure 6.5. (p i33) illustrates Fe(II)-Ferrozine formation following 
reduction of ferri-myo-Ins(l,3,4,5)P4, fem-myo-Ins(l,2,4,6)P4 ferri-myo- 
Ins(l,2,4,5)P4 and ferri-3,6 di-O-benzoyl myo-Ins(l,2,4,5)P4. It is interesting to note 
that there is very little difference between these compounds in their abilities to 
liberate iron following reductase activity. Also of interest are the data obtained using
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inositol trisphosphates (figure 6.6 - p i34). Assays using myo-Ins(l,3,4)P3, myo- 
Ins(l,4,5)P3 and myo-Ins(l,4,6)P3 indicated very little difference between them, all 
three liberated iron in the presence of reductase to a similar extent. However, myo- 
Ins(l,2,3)P3 resulted in notably less iron being liberated to the assay with the amount 
of Fe(II)-Ferrozine being almost the same as that achieved using myo-InsPg. Due to 
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Figure 6.2. Cyclic phosphate derivative o f ^cy//<9-Ins(l,4,5)P3-m ediated
iron transport in P. aeruginosa  P A O l grown in succinate medium. The 
uptake m edium  contained the cyclic phosphate derivative o f scyllo-  
Ins(l,4 ,5 )P 3 (lOOpM), 55FeCl3 (200nM ), glucose (60|iM ) and 1 ml of 
cells at OD470 1.0. The dashed line represents m yo-InsP6-m ediated iron 
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120 - i) Reduction o f ferri-myo-InsPg (n=3)
ii) Reduction of ferripyoverdine
iii) Reduction o f ferri-myo-InsP6 without FMN
iv) Reduction of ferri-myo-InsP6 in aerobic conditions
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Figure 6.4. Anaerobic reductase activity o f P. aeruginosa  lysate. 
Each 2 ml assay contained 1.6 mg protein, inositol phosphate or 
pyoverdine (0.2 mM), FeCl3 (0.2 mM), Ferrozine (0.8 mM ), N ADH






























iii) 3,6-di-O-benzoyl m yo-Ins(l,2,4,5)P4
iv) m yo-Ins(l,3,4,5)P4
v) Reduction of myo-InsP6 for comparison.
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Figure 6.5. Anaerobic reductase activity o f P. aeruginosa  lysate. Each 
2 ml assay contained 1.6 mg protein, inositol phosphate (0.2 mM ), FeCl3

























i) Reduction of ferri-m>'o-Ins(l,4,6)P3
ii) Reduction of ferri-m;y0-Ins(l,3,4)P3
iii) Reduction o f ferri-m>'o-Ins(l,4,5)P3
iv) Reduction o f ferri-m>o-Ins(l,2,3)P3
v) Reduction of ferri-myo-InsPg for comparison
T im e  (m in )
Figu re  6.6. Anaerobic reductase activity of P. aeruginosa  lysate. Each 
2 ml assay contained 1.6 mg protein, inositol phosphate (0.2 mM), FeCl3
(0.2 mM), Ferrozine (0.8 mM), NADH (0.15 mM) and FMN (0.05mM )
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6.5 Discussion
This chapter has made progress in developing an insight into the mechanisms by 
which inositol phosphates liberate iron to the bacterium. The use of a 
conformationally restricted analogue of jcy//o-Ins(l}4,5)P3 gave an indication that a 
change in ring conformation is not essential for inositol phosphate-mediated iron 
transport. The ability of this compound to chelate iron may be a result of there being 
sufficient mobility of the equatorially arranged 1- and 5-position phosphate groups 
with additional interaction from the 6-position hydroxyl group. Alternatively, 
interaction with iron may occur via a combination of the modified 4,5 motif and the 
equatorially arranged 6-position hydroxyl group. Similarly, conformational 
restriction was not a barrier to the ability of this compound to mediate calcium 
mobilisation in eukaryotic systems which may reflect some retention of activity 
surrounding the 4,5 motif (Riley and Potter, 1995).
It was unfortunate that it was not possible to assess the role of phytase activity. The 
fact that the cells used in iron transport assays were grown in phosphate-rich 
succinate medium should be of little consequence as Irving and Cosgrove (1971) 
noted that Pseudomonas phytase production did not require substrate induction. The 
appearance of precipitated iron sulphide and the subsequent 55Fe(DI) precipitation 
suggested that the phosphorothioate analogue of scyllo-Ins(l,2,4,5)P4 had 
decomposed. This was most likely due to disruption of the phosphorothioate bonds 
linking the phosphate groups to the inositol ring.
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The results obtained from the reductase assay were particularly interesting and gave 
further support to some key trends. It is interesting to note that reductase activity is 
capable of reducing Fe(III) bound to myo-InsP6 to Fe(II) resulting in the formation of 
the coloured Fe(II)-Ferrozine complex. In common with previous work regarding 
ferripyoverdine transport (Halle and Meyer, 1992a), the reductase activity 
demonstrated here was dependent upon strict anaerobiosis and the presence of 
bacterial extract i.e. there is no self reduction of the iron.
Reductase assays using a variety of inositol phosphates produced a somewhat 
confusing picture. However certain key trends are apparent. The observation that 
pyoverdine appeared to yield less Fe(H[) to the reductase system compared to myo- 
InsP6, is probably indicative of the greater affinity of pyoverdine towards Fe(III). It 
was interesting that both myo-Ins(l,2,4,5)P4 and 3,6-di-O-benzoyl myo-Ins(l,2,4,5)P4 
gave similar results. It is known from previous work that these compounds have 
similar abilities to interact with iron yet mediate considerably different iron uptake 
profiles in P. aeruginosa PAOl. These results again suggest that the abilities of 
these two compounds to interact with iron are similar, hence the differences in iron 
uptake profiles are probably a result of the differing degrees of steric hindrance 
associated with these compounds.
Whilst there is little to distinguish rayo-Ins(l,3,4)P3, myo-Ins( 1,4,5)P3 and myo- 
Ins(l,4,6)P3, there is a clear difference with myo-Ins(l,2,3)P3. The degree of Fe(II)- 
Ferrozine formation is considerably lower with this compound and may be reflection 
of the 1,2,3 trisphosphate motif binding Fe(III) in such a manner that impairs
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reduction to Fe(II). In this respect, rayo-Ins(l,2,3)P3 and rayo-InsP6 appear to share 
very similar properties, an observation noted throughout this study.
Finally there is also an interesting correlation between myo-InsP6 (IP6), myo- 
Ins(l,2,4,5)P4 (IP4) and rayo-Ins(l,4,5)P3 (IP3). Each of these compounds is 
associated with increasing iron transport (IP6<IP4<IP3), decreasing ability to inhibit 
iron-catalysed hydroxyl radical generation (IP6>IP4>IP3) and increasing ability to 
supply Fe(IH) to a reductase system (IP6<rP4<IP3).
Despite reductase activity being detected in many mirco-organsims, the enzyme has 
only been purified in a few examples including ferri-2,3-dihydroxybenzoic acid 
reductase in Bacillus subitilis (Gaines et al., 1981), and a ferrichrome reductase from 
E. coli (Fischer et al., 1990). Halle and Meyer (1992a) purified a ferripyoverdine 
reductase in P. aeruginosa that was a soluble of protein of molecular weight 27,000 
to 28,000 Da. Despite iron regulation of siderophore and outer membrane 
siderophore receptor production, reductase production was not subject to such 
control. Only some fungi have increased reductase activity in response to iron 
limitation, namely Neurospora crassa (Ernst, 1977) and Saccharomyces cerevisiae 
(Lesuisse and Labbe, 1989). Halle and Meyer (1992a) noted that the reductase is 
located cytoplasmically which implies that the ferrisiderophore complexes must 
become internalised prior to reduction. No enzyme activity was located in the 
periplasm. This study does not indicate whether the ferri-inositol phosphate 
complexes are internalised, a phenomenon that appears unlikely when considering 
the highly ionised nature of these compounds. However, a membrane bound fraction
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has been found in B. subtilis (Gaines et al., 1981) which is thought to account for 
25% of reductase activity and in E.coli, 33% of the ferrireductase activity was 
associated with the membrane fraction (Fischer et al., 1990).
Immunological studies examining the P. aeruginosa ferripyoverdine reductase 
suggest that it is highly conserved amongst Pseudomonas spp (Halle and Meyer 
1992a). Similarities were observered for 18 fluorescent strains as well as the non- 
fluorescent strain P. stutzeri which produces the siderophore desferriferrioxamine E 
in comparison to the pyoverdines of the other strains. These results suggest that the 
same reductase is produced regardless of the strain or the siderophore it uses. 
Extending this concept further, P. aeruginosa reductase has been found to catalyse 
the reduction of ferricrocin, ferrioxamine B, ferrichrome A and ferrioxamine E 
(Halle and Meyer, 1992b). All of these observations further suggest the lack of 
specificity of this enzyme and instead lead to the suggestion that it functions as a 
general NADH/FMN reductase.
The lack of iron regulation of this P. aeruginosa NADH/FMN reductase suggests 
that it may have additional roles in the bacterium other than the release of iron from 
ferripyoverdine. Bagg and Neilands (1987a) noted that the interior of the bacterium 
must be highly reducing to convert Fe(III) to Fe(II) since Fe(II) is responsible for the 
Fe-Fur co-repressor effect. In B. subtilis, the FMN-dependent ferrisiderophore 
reductase is one of the components of the multienzyme complex involved in the 
biosynthesis of aromatic compounds (Gaines et al., 1981; Hasan and Nester 1978). 
In addition, the ferrichrome reductase isolated from E. coli (Fischer et al., 1990)
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appears to be closely related to the ferric-iron reductase involved in ribonucleotide 
reduction and is recognised as a NAD(P)H:flavin oxidoreductase (Fontecave et al., 
1987). Finally, the flavin-containing NADH-nitrate reductase from squash cotyledon 
is capable of ferrisiderophore-reductase activity (Smarrelli and Castignetti, 1986) 
which futher demonstrates the lack of specificity of these enzyme systems.
All of these similarities suggest that the multi-step reduction involving a 
NADH/FMN reductase followed by FMN-mediated chemical reduction of the 
ferrisiderophore, may be a general mechanism occuring in all siderophore producing 
bacteria and fungi. Provided the inositol phosphate has access to the reductase 
system, it does appear that this system is capable of reducing inositol phosphate- 
bound Fe(III). This supports the hypothesis that bacterial reductase sytems are 
relatively non-specific.
Chapters 4,5 and 6 have demonstrated the ability of inositol phosphates to mediate 
iron transport and have identified several key trends. It has been possible to 
determine structure-iron transport relationships, how the ability to mediate iron 
transport is affected by their abilities to interact with iron and how this iron may be 
released to the bacterium. Chapter 7 will discuss the mechanisms whereby the 
bacterium is capable of using inositol phosphates as a means of iron acquisition.
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Chapter 7
Assessing the Mechanism of Inositol 
Phosphate-Mediated Iron Transport in 
Pseudomonas aeruginosa
7.1. Introduction
The aim of this chapter is to explore the bacterial mechanisms which may be 
involved in inositol phosphate-mediated iron transport in P. aeruginosa PAOl. It 
examines the possible involvement of active transport mechanisms by studying the 
effects of low temperature and the presence of metabolic inhibitors. A series of 
experiments was performed to determine the role of the outer membrane and its 
associated proteins. Iron transport assays were performed using several strains that 
were deficient in the expression of several individual outer membrane proteins and in 
spheroplasts of P. aeruginosa PAOl which lack the outer membrane. To 
characterise the effects of the outer membrane further, inositol phosphate binding 
assays were performed using P. aeruginosa outer membranes. Finally, attempts were 
made to isolate a transport-deficient mutant of P. aeruginosa unable to utilise myo- 
InsP6 as an exogenous siderophore.
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7.2 Assessing The Role of Active Transport Mechanisms.
The two parameters used to assess whether inositol phosphate-mediated iron 
transport in P. aeruginosa PAOl was dependent on active transport were low 
temperature and the presence of a metabolic inhibitor. The compounds myo-]nsP6, 
mjo-Ins(l,2,4,5)P4 and my0-Ins(l,4,5)P3 were chosen as they represent varying 
molecular weights. myo-InsP6, molecular weight 923 Da, is regarded as too large to 
traverse porins via simple diffusion (Hancock et al., 1979), whereas myo- 
Ins(l,4,5)P3, with a molecular weight of 552 Da, may be capable of traversing porins 
in the outer envelope.
7.2.1. The Effect of Temperature on myo-Inositol Hexakisphosphate-Mediated 
Iron Transport in Pseudomonas aeruginosa
The effect of low temperature was assessed by removing a sample from the iron- 
transport reaction mixture at t=0.5 min and placing on ice for the duration of the 
assay. After 30 min, the chilled mixture was filtered and washed in the same manner 
as all other iron-transport assays. The cell-associated activity remaining on the filter 
was determined using p-scintillation counting.
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Inositol Phosphate Accumulated 5:>Fe After 30 Accumulated 55Fe A fter 30




m yo-Ins(l,4,5)P3 26.88 106.37±6.57
Table 7.1. The effect of low temperature on the ability of myo-InsP6, myo- 
Ins(l,2,4,5)P4 and myo-Ins(l,4,5)P3 to mediate iron transport into 
P. aeruginosa PAOl after 30 min.
Table 7.1. illustrates that temperature has a notable effect on the ability of the above 
inositol phosphates to mediate iron-transport. In all three cases, inositol phosphate- 
mediated iron transport was reduced considerably when performed at 4°C indicating 
that some component of the pathway is temperature dependent.
7.2.2. The Effect of Carbonyl Cyanide m -Chlorophenylhydrazone on myo­
inositol Hexakisphosphate-M ediated Iron-T ransport in Pseudomonas 
aeruginosa
To establish whether active processes are required to facilitate inositol phosphate- 
mediated iron-uptake, transport assays were performed in the presence of carbonyl 
cyanide m-chlorophenylhydrazone (CCCP). CCCP uncouples oxidative reactions 
within the bacterial cell and consequently inhibits mechanisms requiring active 
energy. Assays were performed by addition of CCCP (1 mM) to the cell mixture
1 4 2
and incubated as usual prior to mixing with the chelate mixture at t=0 of the iron
transport assay.
Inositol Phosphate Accumulated 53Fe After 30 Accumulated 55Fe After 30
min with Addition of CCCP min (without CCCP)





Table 7.2. The effect of CCCP on the ability of myo-InsPg, myo-Ins(l,2,4,5)P4 and 
myo-Ins(l,4,5)P3 to mediate iron transport into P. aeruginosa PAOl after 30 min.
Table 7.2. illustrates that addition of CCCP to the uptake medium resulted in a 
marked reduction in inositol phosphate-mediated iron transport into P. aeruginosa 
PAOl. This is consistent with the low temperature data and suggests that at least 
some component of inositol phosphate-mediated iron transport is dependent upon 
active processes.
7.3. The Role of the O uter M em brane in myo-Inositol Hexakisphosphate- 
M ediated Iron  T ransport in Pseudomonas aeruginosa PA O l 
The role of the outer membrane in iron acquisition by P. aeruginosa PAOl is well 
documented. Specific receptors for pyoverdine, pyochelin and enterobactin have 
been identified in the outer membrane (sections 1.4.2; 1.4.3; 1.7). In addition, 
several OMPs of P. aeruginosa still have no function assigned to them and there is
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the possibility that one may be responsible for inositol phosphate-mediated iron 
uptake.
Iron transport assays were performed using strains of P. aeruginosa lacking either 
OprD, OprF or OprP. In addition, iron transport assays were performed in 
spheroplasts of P. aeruginosa which lack the outer membrane. Finally, a series of 
displacement binding assays were performed to determine the existence of specific 
binding sites.
7.3.1 myo-Inositol Hexakisphosphate-Mediated Iron-Transport in Strains of 
Pseudomonas aeruginosa Lacking Individual Outer Membrane Proteins.
myo-InsPg-mediated iron transport was assayed in P. aeruginosa H729, lacking 
OprD expression, P. aeruginosa H636, lacking OprF expression and P. aeruginosa 
H576 which lacks expression of OprP. The OMP compositions of these strains are 
illustrated in figure 7.1. (p i52). Figure 7.2. (p i53) illustrates that each of these 
strains is still capable of undergoing myo-InsP6-mediated iron transport indicating 
that none of these proteins are essential for myo-InsP6-mediated iron transport.
7.3.2. Inositol Phosphate-Mediated Iron Transport in Spheroplasts of 
Pseudomonas aeruginosa
Spheroplasts of P. aeruginosa were prepared by treatment of log-phase cells with 
lysozyme and EDTA as described in section 3.8. Spheroplasts, which are 
osmotically sensitive, lack most of the outer membrane and peptidoglycan of the cell
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wall and are useful in determining whether the outer layers of the cell wall play any 
role in inositol phosphate-mediated iron transport.
myo-InsP6, myo-Ins(l,2,4,5)P4, 3,6 di-Obenzoyl myo-Ins(l,2,4,5)P4 and myo- 
Ins(l,4,5)P3-mediated iron transport is illustrated by Fig 7.3. (p i54). It is important 
to note that the x-axis represents iron uptake from 105 cells as determined by viable 
counting of a cell suspension of OD470 1.0. In previous assays, iron uptake was 
expressed for 109 cells hence the actual amount of iron associated with each 
individual cell appears to be considerably greater when using spheroplasts.
It is interesting to note that all four compounds produced very similar iron transport 
profiles, with respect to both initial rate and accumulated values after 30 min. In 
spheroplasts, there appears to be a loss of all structure activity relationships. Even
3,6 di-O-benzoyl myoIns(l,2,4,5)P4, a compound associated with poor transport in 
normal cells, produced a transport profile similar to the other compounds.
Unfortunately, it was not possible to test the role of either low temperature or 
metabolic inhibitors as both of these caused lysis of the highly sensitive spheroplasts.
7.3.3. Competitive Binding Assays of Tritiated Inositol Phosphates to 
Pseudomonas aeruginosa Membranes.
Competitive binding assays were performed to assess whether myo-InsPg is capable 
of binding specifically to components of P. aeruginosa membranes in a manner 
indicative of the presence of specific receptors. For the data represented below,
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binding was performed using outer membranes purified by the Sarkosyl method. 
Preliminary experiments were performed using P. aeruginosa total membrane 
fractions and outer membranes prepared using sucrose gradient purification; all gave 
similar binding results. Sarkosyl-purified outer membranes were preferred because 
of their relative ease of production compared to the sucrose gradient method. In 
addition, Sarkosyl-purified outer membranes were regarded to be more relevant to 
bacterial transport across the outer membrane than simply using total membrane 
fraction.
7.3.3.1 Competitive Binding Assays of [3H]-InsP6 to Pseudomonas aeruginosa 
Membranes.
A previous study by Smith et al., (1994) using crude membrane fraction suggested 
the presence of specific myo-InsP6 binding sites using self displacement of [ H]- 
InsPg (Kd 143 nM) The aim of this study was to demonstrate binding to the outer 
membrane fraction and to determine whether displacement by a series of other 
compounds was possible. Competitive binding assays of [ H]-InsP6 to various P. 
aeruginosa membranes were performed as described in section 3.12. Assays 
measuring competition with [3H]-InsP6 binding by unlabelled myo-InsP6, myo- 
Ins(l,2,4,5)P4, 3,6 di-(9-benzoyl myo-Ins( 1,2,4,5)P4 and myo-Ins(l,4,5)P3 were 
performed. myo-Ins( 1,2,3)P3 was also included to determine whether the 1,2,3- 
trisphosphate arrangement played any role in binding. Specific binding was only 
recorded with myo-InsP6 (Kd 1200 nM) as illustrated in Fig. 7.4 (p i55), all other 
compounds failed to displace [ H]-InsPg over the concentration of unlabelled ligand
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used in this assay. Table 7.3 illustrates the % dpm specifically bound at 100 pM 
(10,000 nM) using the above unlabelled compounds.
Unlabelled Inositol Phosphate % [3H]-InsP6 Specifically Bound a t 100 
pM  unlabelled ligand 
(M ean±SEM  n=3)
myo- InsP6 29±4
myo-Ins(l,2,4,5)P4 98±1
3,6 di-O-benzoyl myo-Ins(l,2,4,5)P4 99±1
m yo-Ins(l,2,3)P3 115±7
myo-Ins(l,4,5)P3 80±7
Table 7.3. Competitive binding of 1 nM [3H]-InsPg with unlabelled myo-InsPg, 
myo-Ins(l,2,4,5)P4, 3,6 di-0-benzoyl myo-Ins(l,2,4,5)P4, myo-Ins(l,2,3)P3 and 
myo-Ins(l,4,5)P3 (lOOpM) to sarkosyl-prepared outer membranes of P. aeruginosa
PAOl grown in succinate medium.
7.3.3.2 Competitive Binding Assay of [3H]-InsP(l,4,5)3 to Pseudomonas 
aeruginosa O uter M em branes with Unlabelled myo-Ins(l,4,5)P3.
Throughout this study, rayo-Ins(l,4,5)P3 has appeared to be a particularly good 
mediator of iron transport in P. aeruginosa PAOl which raised the possibility of 
specific myo-Ins( 1,4,5)P3 binding to the bacterial cell surface. One preliminary 
binding assay was performed to determine the ability of rayo-Ins( 1,4,5)P3 to compete 
with the binding of [3H]-InsP(l,4,5)3. Because [3H]-InsP(l,4,5)3 was available in a 
very limited quantity, only one assay was performed. However, from the results 
obtained, there was no apparent specific binding. The results are illustrated in Table
7.4.
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Unlabelled myo-Ins(l,4,5)P3 (nM) % [3H]-Ins(l,4,5)P3 Bound 






Table 7.4. Competitive binding of 1 nM [3H]-Ins(l,4,5)P3 with unlabelled 
myo-Ins(l,4,5)P3 to sarkosyl-prepared outer membranes of P. aeruginosa 
PAOl grown in succinate medium.
7.4. Transposon Insertion Mutagenesis of Pseudomonas aeruginosa 
This chapter demonstrated the importance of active transport mechanisms and has 
identified the outer membrane as a key factor in myo-InsPg-mediated iron transport. 
However, the exact mechanism of action is unknown. In order to assign a 
mechanism of action of these compounds, attempts were made, using transposon 
mutagenesis, to obtain a mutant unable to use ferri-rayo-InsPg as a source of iron. 
Two strains of P. aeruginosa were used which were deficient in endogenous 
siderophore production but were still capable of undergoing myo-InsP6-mediated iron 
transport.
A derivative of P. aeruginosa IA1, PH3, was mutagenised using Tn501 in plasmid 
pMTlOOO. Secondly, a derivative of P. aeruginosa K372, PH4, was mutagenised 
using Tn/737KH contained in plasmid pMT6121. It was decided not to use the Tn5- 
based system contained in pUW964 as Tn5-based mutations have been found to be
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unstable in P. aeruginosa (Comelis et al., 1992 and our own observations with P. 
aeruginosa PHI, Smith et al., 1992). Both P. aeruginosa IA1 and P. aeruginosa 
K372 were capable of myc>-InsP6-mediated iron transport (Figure 7.5 - p i56) and the 
outer membrane protein compositions of these strains are illustrated in figure 7.1.
7.4.1. Tn50i Mutagenesis of Pseudomonas aeruginosa PH3
Tn507, a transposon encoding mercury resistance, was used in insertion mutagenesis
using pMTlOOO, a temperature-sensitive derivative of plasmid R68, (Tsuda et al.,
1984). Tn501 is bound by small inverted repeats and is capable of transposing into a
wide variety of hosts (Bennett et al., 1978). pMTlOOO was conjugated into P.
aeruginosa IA1 to produce P. aeruginosa PH3 as described previously (section
3.14.1.2).
At the restrictive temperature of 42°C, the frequency of mercury resistant cells was 
1.6xl0’4/viable cell. This is similar to the value obtained by Tsuda et al., (1984) 
when mutagenising P. aeruginosa PAOl with pMTlOOO (they reported 4.8x1 O'4). 
In addition to the Tn507-encoded mercury resistance associated with pMTlOOO, the 
plasmid also encodes tetracycline resistance that is not associated with Tn507. 
Consequently, 100 mercury resistant transformants were tested for tetracycline 
resistance and all were found sensitive. This confirmed that the vector was lost at the 
restrictive temperature and the mercury resistance was a result of transposition of 
Tn507 into the chromosome.
1 4 9
Transposition of P. aeruginosa was performed and 25,000 colonies were screened on 
succinate minimal agar, succinate minimal agar + 500 |iM InsP6, Luria agar + 500 (I 
M InsP6 and Luria agar + Hg15 as described in section 3.14.1.4.
Approximately 5% of transposed colonies were unable to grow on minimal media 
yet were able to grow on complex media, illustrating that the system was producing 
nutritional auxotrophs. However, despite these efforts, no strains unable to use myo- 
InsP6 as an iron source were isolated.
7.4.2. Tn7 737KH Mutagenesis of Pseudomonas aeruginosa PH4 
Tn7737KH on plasmid pMT6121 was conjugated into P. aeruginosa K372 to 
produce P. aeruginosa PH4. Tn7737KH is a combination of Tn7737Km (Ubben and 
Schmitt, 1987), which encodes kanamycin resistance, and a mercury-resistant 
element. The mercury-resistant element, a fragment from pHP45£2Hg, was
introduced because P. aeruginosa is intrinsically resistant to high concentrations of 
kanamycin (Tsuda et aL, 1995). Plasmid pMT6121 is a derivative of plasmid R68 
which is temperature sensitive and encodes tetracycline resistance.
Again, the frequency of transformation of P. aeruginosa 
PH4(pMT6121 ::Tn7 737KH) was calculated. At the restrictive temperature of 42°C, 
the frequency of mercury resistant cells was and found to be 1.5xl0'5/viable cell 
which is again similar to 8x1 O’5 reported by Tsuda et al., (1995). One hundred 
transposed cells grown at the restrictive temperature and encoding mercury resistance 
were screened for tetracycline sensitivity. All colonies tested were tetracycline
1 5 0
sensitive indicating loss of the vector and that mercury resistance was a result of 
Tn7737KH incorporation into the chromosome.
Transposon mutagenesis of P. aeruginosa PH4 was performed and 25,000 colonies 
screened on succinate minimal agar + 1 mM Met, succinate minimal agar + 1 mM 
Met + 500 |iM InsP6, Luria agar + 500 |iM  InsP6 and Luria agar + Hg15 as described 
in section 3.13.2.2. Growth on selective media indicated that 5-10% of cells were 
nutritional auxotrophs confirming that the mutagenesis system was working well. 
However, it was never possible to isolate a mutant unable to use myo-InsPg as a 
source of iron.
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1 2 3 4  5 6 7 8
Lane 1 Bio-Rad Molecular Weight Markers
Lane 2 P. aeruginosa PAOl (Succinate Minimal Medium)
Lane 3 P. aeruginosa K372 (Succinate Minimal Medium)
Lane 4 P. aeruginosa IA1 (Succinate Minimal Medium)
Lane 5 P. aeruginosa PAO l (Luria Broth + 400 |iM  EDDHA)
Lane 6 P. aeruginosa H729, OprD- (Luria Broth + 400 |iM  EDDHA)
Lane 7 P. aeruginosa H636, OprF- (Luria Broth + 400 pM  EDDHA)
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Figure 7.2. m;yoInsP6-mediated iron transport in strains of
P. aeruginosa  lacking individual outer m em brane proteins grown in LB 
+ ED D H A  (400 jiM ). The uptake m edia contained m yo-InsP6 (100 mM),
55FeC l3, glucose (60 pM) and 1 ml of cells OD470 1.0. The dashed line 
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Figure 7.3 Inositol phosphate-m ediated iron transport in P. aeruginosa  
P A O 1 spheroplasts grown in succinate medium. The uptake m edia 
contained inositol phosphate (100 fiM), 55FeC l3 (200 nM ) and 1 ml o f
spheroplasts OD470 1.0. (105 cells). N.B. The data represent n=3 and 
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Figure 7.4 Competitive binding of 1 nM  H -InsP6 with unlabelled
m yoInsP 6. Each binding mixture contained 0.5 mg sarkosyl-
prepared outer mem brane from succinate grown P. aeruginosa  
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Figure. 7.5. m^o-InsP6-mediated iron transport in P. aeruginosa  IA1 
and P. aeruginosa  K372 grown in succinate medium. The uptake 
m edia contained m yo-InsP6 (lOOmM), 55FeCl3 (200nM ) and 1.0. ml 




The chapter has achieved several goals in attempting to elucidate the mechanisms by 
which P. aeruginosa PAOl can utilise myo-InsP6 as a means of iron acquisition. 
However, it was not possible to isolate a transport mutant.
In particular, this chapter has highlighted the importance of the Gram-negative outer 
membrane. It was of interest that all the Opr-deficient mutants tested were able to 
undergo myo-InsPg-mediated iron uptake. Under normal conditions, OprD is thought 
to be responsible for the uptake of basic amino acids and has also been implicated in 
the uptake of imipenem (Yoshihara and Nakae 1989; Quinn et al., 1986; Trias et al., 
1989). Meyer (1992), noted that strains lacking OprD were deficient in 
desferriferrioxamine E-mediated iron transport hence suggesting a role for this porin 
in iron transport. However, it is apparent that this protein is not involved with myo- 
InsP6-mediated iron transport. The exact role of OprF is unclear, although it appears 
to be associated with general porin activity and cell structure (Woodruff et al., 1986; 
Gotoh et al., 1989; Woodruff and Hancock, 1988). OprF is of particular interest 
because of its previous association with exogenous siderophore-mediated iron 
transport into P. aeruginosa (Meyer, 1992). In comparison to the parent strain, P. 
aeruginosa PAOl, the OprF-deficient mutant was unable to use desferriferrioxamine 
E, desferriferrioxamine B, desferriferricrocin and desferriferrichrysin. However, in 
this study, myo-InsP6-mediated iron transport was unaffected in the OprF-deficient 
mutant. The association of OprP with phosphate transport in P. aeruginosa 
(Hancock et al., 1982; Worobec et al., 1988; Poole and Hancock, 1986) makes an 
OprP deficient strain particularly interesting with respect to inositol phosphate-
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mediated iron transport The rationale for its use was whether the phosphate moieties 
of rayo-InsPg would have affinity towards this particular OMP even though maximal 
expression occurs in phosphate deplete conditions which are not encountered in 
succinate minimal medium. However, there was little difference between this and 
the parent strain in their abilities to undergo myo-InsP6-mediated iron transport. In 
addition, the siderophore-deficient strains P. aeruginosa IA1 and K372 were both 
able to undergo myo-InsP6-mediated iron transport despite lacking components of the 
outer membrane associated with ferrisiderophore uptake as illustrated in figure 7.1.
The importance of the outer membrane was particularly apparent when performing 
iron transport assays in spheroplasts of P. aeruginosa PAOl. The iron uptake 
profiles associated with various inositol phosphates were greater than those achieved 
using normal cells. This indicates that relatively large amounts of iron become 
associated with these delicate cells. Also of interest was the total lack of structure- 
activity relationships normally associated with these compounds which may 
represent differences in the way individual inositol phosphates present iron to the 
altered bacterial cell surface.
The ability of myo-InsP6 to interact with the outer membrane was illustrated by 
competitive binding experiments using [3H]-InsP6. The data indicated competitive 
binding between [ H]-InsP6 and myoInsP6 which was in agreement with previous 
work (Smith et al., 1994). However, none of the other compounds tested were able 
to displace [3H]-InsP6 from the outer membranes suggesting that the binding was 
specific to myo-InsPg. In addition, considerable attempts were made to demonstrate
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specific [3H]-InsP6 binding to whole cells of P. aeruginosa although binding 
appeared too transient to be recorded (data not shown). Also, attempts were made to 
separate outer membrane fractions using column chromatography to determine 
whether particular membrane fractions were responsible for [3H]-InsP6 binding. 
However, difficulties achieving complete solubilisation of outer membranes without 
impairing column efficiency prevented these studies (data not shown). Because of 
the observations that myo-Ins(l,4,5)P3 was the most efficient mediator of iron 
transport in this study, a preliminary experiment was performed to determine 
whether this compound was capable of binding specifically to the outer membrane. 
However, no specific binding was observed.
Several studies have examined the ability of myo-InsPg to bind specifically to various 
eukaryotic sites. Nicoletti et a l, (1990) noted the presence of myo-InsP6 receptors at 
various sites within the brain including cerebral hemispheres, anterior pituitaries and 
cerebellar neurones. Interestingly, they noted that specifically bound [3H]-InsP6 was 
not displaced by myo-Ins(l,4,5)P3, a phenomenon also noted in this study. Hawkins 
et a l, (1990) noted myo-InsP6 binding sites on neuronal cell bodies which was 
distinct from previously characterised Ins(l,3,4,5)P4 and Ins(l,4,5)P3 binding. These 
data suggested a possible extracellular role as a neuronal excitant. In support of this 
role, Theibert et a l, (1991) suggested that the myo-InsP6 receptor also appeared to 
affect calcium accumulation and the locations of the receptors were consistent with a 
neuronal, synaptic role. Later work by Voglemaier et a l, (1992) and Theibert et a l, 
(1992) suggested that the myo-InsP6 receptor isolated from bovine cerebellar 
membranes is essentially identical to the clathrin assembly protein AP-2. AP-2
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promotes assembly of clathrin into coated vesicles at the plasma membrane and is 
proposed to be involved with receptor recycling. The proposed links between the 
myo-InsP6 receptor and AP-2 suggest that myo-InsP6 has roles both in signalling 
pathways and receptor-mediated endocytosis Voglemaier et al., (1992).
Of particular interest to this study was the observation that [3H]-InsP6 would bind 
specifically to cerebellar membranes (Poyner et al., 1993) possibly via 
phospholipids. One suggestion for this mechanism was that positively charged 
cations form a bridge between the negatively charged phospholipid and the 
negatively charged myo-InsP6. It is thought that the inositol phosphate may not have 
sufficiently high affinity for the metal ion to remove it from the phospholipid. With 
respect to myo-InsPg-mediated iron transport in P. aeruginosa, this is particularly 
important with respect to the possible bridging effect between the inositol phosphate, 
Fe(III) and the negatively charged phospholipids of the bacterial outer membrane. 
The effect of such bridging mechanisms on the outer membrane is unknown.
It is interesting to note that inositol phosphate-mediated iron transport depends upon 
active transport systems with both low temperature and CCCP having negative 
effects. In general, low temperature and CCCP reduced iron transport to 
approximately one third of that normally seen after 30 minutes. This is particularly 
interesting with respect to myo-Ins( 1,4,5)P3 as the relatively low molecular weight of 
this compound (552 Da) is within the size range of compounds capable of entering 
the bacterium via porin-mediated passive diffusion. In general, hydrophilic 
compounds up to 600 Da may permeate from the growth medium to the periplasm
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(Nikaido and Saier, 1992; Benz, 1994) although this is unlikely for highly charged 
inositol phosphates. Clearly, the enhanced iron transport normally associated with 
this compound is not a result of diffusion. It is also noteworthy that even in the 
presence of a metabolic inhibitor, the total amount of iron accumulated after 30 
minutes was never zero. This may be a result of binding to the bacterial cell surface 
or the activity of non-specific, low affinity iron transport mechanisms.
The dependence upon active transport suggests the involvement of either a TonB- 
type system, a periplasmic-binding-protein-dependent system, or both. Much of the 
work regarding TonB-mediated active transport has centred around E. coli vitamin 
B 12 transport. Vitamin B i2 interacts with the OMP BtuB and is transported across 
the outer membrane resulting in 1000-fold concentration in the periplasm relative to 
the growth medium. The next stage is interaction with the periplasmic binding 
protein BtuC. Mutations in btuC result in inhibition of vitamin B 12 transport across 
the cytoplasmic membrane although vitamin B j2 will still concentrate in the 
periplasm (Reynolds e ta l ., 1980; Bradbeer, 1993). Consequently, active transport of 
this nutrient across the outer membrane is independent of periplasmic binding 
proteins. Vitamin B 12 transport across the outer membrane is also blocked by CCCP 
suggesting that the energy source must be the cytoplasmic membrane (Postle, 1993). 
The ability of TonB to act as an energy transducer and the necessity for the 
cytoplasmic membrane electrochemical potential were confirmed by Jaskula et al., 
(1994). It was shown that cleavage of TonB to separate the periplasmic domain from 
the cytoplasmic domain inhibited TonB function. Furthermore, they located specific 
sites within the cytoplasmic membrane domain that when removed, inhibited energy
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transduction between the cytoplasmic and outer membranes. Clearly, vitamin B 12 
transport relies on active transport mechanisms whereby energy is supplied from the 
cytoplasmic membrane to the outer membrane via the action of TonB. It is therefore 
possible that myo-InsP6-mediated iron transport is dependent upon such a system.
Alternatively, inhibition of myo-InsPg-mediated iron transport by CCCP may be the 
result of inhibiting a periplasmic-binding-protein-dependent system. These systems 
have been identified in the iron uptake systems of several species of bacteria 
including E. coli (Stephens et al., 1995), Serratia marcescens (Angerer et al., 1992), 
Haemophilus influenzae (Adhikari et al., 1995) and Neisseria gonorrhoeae (Adhikari 
et al., 1996). The roles of the FepABCDG proteins in enterobactin-mediated iron 
transport in E. coli are well documented as indicated in the introduction (section 
1.6.2; Stephens et al., 1995). In this system, the periplasmic binding protein, FepB, 
recognises the ferrienterobactin complex. For H. influenzae and N. gonorrhoeae, the 
periplasmic binding protein recognises free ferric iron released from the outer 
membrane receptors. However, for S. marcescens, the mechanism by which iron 
traverses the outer membrane is unknown although SfuA, the periplasmic binding 
protein of S. marcescens, will accept iron solubilised with oxaloacetate, sodium PP{ 
and citrate. There is distinct homology between the sfuABC, hitABC and fbpABC  
loci of S. marcescens, H. influenzae and N. gonorrhoeae, respectively. Briefly, each 
system comprises a ferric binding protein (SfuA/HitA/FbpA), a hydrophobic 
cytoplasmic permease (SfuB/HitB/FbpB) and a nucleotide binding protein 
(SfuC/HitC/FbpC). The nucleotide binding protein facilitates hydrolysis of a
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nucleotide phosphate, e.g. ATP which provides energy for this uptake system. This 
system is termed an ABC (ATP Binding Cassette) transporter-exporter system.
The observation that myo-InsP6 was not able to induce any detectable change in 
OMP composition of P. aeruginosa PAOl (Smith et aL, 1994) suggests that this 
system is unlikely to depend upon TonB-dependent receptor systems. Similarly, 
iron-uptake assays using strains deficient in individual OMPs and siderophore 
production, and the lack of success using transposon mutagensis systems all support 
this theory It is therefore possible that this system relies upon a periplasmic- 
binding-protein-dependent system analogous to the sfu system of S. marcescens. 
Whilst the hit and fbp  systems of H. influenzae and N. gonorrhoeae bind free ferric 
iron released into the periplasm following receptor recognition of ferri-glycoprotein 
complexes, the sfu system of S. marcescens appears most analogous to myo-InsPg- 
mediated iron transport in light of the lack of an associated outer membrane protein.
When the sfuABC locus was inserted into E. coli, expression of sfuABC  was 
dependent upon Fur activity (Angerer et al., 1992). Parallels can be drawn with myo- 
InsP6-mediated iron transport in P. aeruginosa which is iron-regulated (Smith et al., 
1994) and may also involve the Fur protein. Using E. coli sfuABC  transformants 
lacking some of the usual components of siderophore-mediated iron transport, it was 
noted that not all siderophores could be transported across the cytoplasmic 
membrane by the Sfu system. These included ferrichrome, coprogen and 
dihydroxybenzoate. In addition, studies were performed to examine citrate
mediated-iron transport in sfuABC transformants of E. coli mutated in thefecBCD E
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genes. Under moderate iron limitation, citrate would carry iron across the outer 
membrane and the Sfu system would mediate iron transport across the cytoplasmic 
membrane in sufficient quantities to permit growth. However, in conditions of 
severe iron deficiency, citrate transport required the presence of the FecA receptor 
and an intact TonB system. This may be because under conditions of moderate iron 
depletion, the iron diffusion rate is sufficiently high to fulfill the iron requirement 
whereas when iron levels are particularly low, active energy, as supplied by TonB, is 
required to facilitate transport across the outer membrane. The probable reason for 
the inability of ferrichrome, coprogen and dihydroxybenzoate to serve as iron donors 
to the Sfu system may be because their iron affinities are too high. Citrate however, 
probably binds iron with sufficient affinity that a transport system has evolved for 
this carrier and yet sufficiently weak to donate it to the Sfu system. Using E. coli 
sfuABC  transformants it was noted that citrate-mediated iron transport via the Sfu 
system was considerably more efficient than via the Fee system, further illustrating 
the success with which citrate functions as an iron transporter (Angerer et al., 1992). 
Using a series of strains of S. marcescens, Angerer et a l, (1992) demonstrated the 
existence of ferrienterobactin, ferriaerobactin, ferrichrome, ferrioxamine B, 
ferricitrate and hemin transport proteins although enterobactin was the only 
siderophore synthesised by the strains tested. Interestingly, despite the ability of 
citrate to act as a mediator of iron transport in S. marcescens, Angerer et a l, (1992) 
were unable to induce the expression of a citrate receptor in the outer membrane. 
Consequently, the exact mechanism of transport of the ferricitrate complex across 
outer membrane remains unclear. This is analogous with myc>-InsP6-mediated iron 
transport in P. aeruginosa in which it was not possible to induce a specific outer
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membrane receptor. If such a system does exist in P. aeruginosa, myo-InsP6, like 
citrate, may be a suitable donor of ferric iron to a periplasmic binding protein.
The final aspect of this study was the attempt to create a mutant strain that was 
unable to undergo myo-InsP6-mediated iron transport. Despite the screening of 
approximately 50,000 mutants, none were unable to use iron complexed with myo- 
InsP6. The estimation that a bacterial chromosome comprises approximately 10,000 
genes indicates that the scale of the screening procedure was sufficient. However, 
other workers have experienced problems when trying to isolate iron transport- 
deficient mutants of P. aeruginosa. Iron transport studies involving the endogenous 
siderophore pyoverdine noted that a mutant deficient in production of the 90 kDa 
ferripyoverdine receptor, FpvA, still exhibited residual pyoverdine-mediated iron 
transport (Poole et al., 1991). Poole et al (1991) suggested the presence of a second 
uptake system for ferripyoverdine which was not affected by high iron 
concentrations. Additionally, growth of the mutant in the presence of pyoverdine did 
not enhance this residual pyoverdine-dependent iron uptake indicating that if such a 
second system did exist, then it was not pyoverdine inducible. A similar 
phenomenon was observed with enterobactin-mediated iron uptake in P. aeruginosa 
(Poole et al., 1990). Whilst a mutant was obtained that lacked the enterobactin- 
inducible 80 kDa PfeA outer membrane protein, it was still able to undergo 
enterobactin-mediated iron transport, albeit at a considerably reduced rate. 
Interestingly, this iron uptake was independent of whether the mutant had been 
grown in the presence of enterobactin or whether the growth medium contained high 
or low levels of iron. Even when the parent strain was cultured without enterobactin
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and in the presence of high levels of iron, it was still capable of a limited amount of 
enterobactin-mediated iron uptake. This suggested the presence of two uptake 
mechanisms which would therefore require at least two mutations to eliminate them. 
It therefore appears that a single mutation in either the pyoverdine or enterobactin- 
mediated iron transport systems is insufficient to eliminate iron transport via that 
route. As suggested by Poole et a l  (1990), "the potential for multiple uptake 
pathways for the same iron-siderophore complexes undoubtedly reflects the need to 
acquire this essential and not readily obtainable nutrient." The lack of success in 
obtaining a mutant unable to undergo myo-InsP6-mediated iron transport may 
therefore be a result of more than one transport system being in operation.
Another possibility for the lack of success may be that the mutation required to 
prevent this uptake mechanism may be lethal to the bacterium, for instance by 
deletion of a key receptor, enzyme or structural component. There are several 
possibilities. One such possibility is that the only way to prevent myo-InsP6-mediated 
transport is via the deletion of a global iron transport regulator such as the fu r  gene. 
Isolation of a fu r -null mutant has not been possible, probably a result of lethality 
(Prince et al., 1993; Ochsner et al., 1995). Previous work in this chapter illustrated 
the importance of active processes in myo-InsP6 mediated transport. If myo-InsP6- 
mediated transport is via a periplasmic-binding-protein-dependent active transport 
system, then again, deletion of of such a system may be lethal. The work regarding 
reductase activity may provide an additional suggestion. It was noted that reductase 
activity was capable of removing Fe(HI) from a variety of inositol phosphate 
compounds by reduction to Fe(II) and may play a key role in myo-InsP6-mediated
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iron transport. It is interesting to note that the ferrichrome reductase isolated from E. 
coli (Fischer et al., 1990) appears to be closely related to the ferric-iron reductase 
involved in ribonucleotide reduction and is recognised as a NAD(P)H:flavin 
oxidoreductase (Fontecave et al., 1987). It is therefore possible that P. aeruginosa 
reductase performs similar functions suggesting it may be an important homeostatic 
regulator rather than purely a siderophore-specific enzyme. Consequently, deletion 
of genes associated with this enzyme may also be lethal. Finally, the observation by 
Poyner et al., (1993) that myo-InsP6 binds specifically with membrane phospholipids 
may provide a further suggestion. It is possible that the inositol phosphate-bacterium 
interaction is via a cationic bridging mechanism and may be a key event in this 
transport mechanism. This may also be a reflection of the apparent inability of myo- 
InsP6 to induce changes in the outer membrane protein composition of P. aeruginosa 
PAOl as indicated by Smith et al., (1994). If such a system is in operation, then a 
mutation in outer membrane phospholipid synthesis would be severely detrimental to 
the survival of the bacterium.
In summary, whilst this chapter was unable to identify an exact mechanism of action 
of myo-InsP6-mediated iron transport, several key elements gave been identified. 
Briefly, a large component of this phenomenon is dependent upon active transport, 
and whilst the outer membrane plays a key role in this mechanism of transport, the 
involvement of a specific outer membrane protein cannot be demonstrated. The 
inability to isolate a mutant unable to use myo-lnsP^ as a source of iron may reflect 
the involvement of a key structural component, binding protein or enzyme system. A
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model is proposed which indicates a periplasmic-protein-dependent system although 
the mechanism of transport across the outer membrane is unclear.
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Figure 7.6. Model for inositol phosphate-mediated iron transport in P. aeruginosa. 
This diagrammatic representation illustrates rayo-Ins(l,2,3)P3 presenting iron to the 
surface of the bacterium with a periplasmic-binding-protein-dependent system 




Following the first report of my0 -InsP6-mediated iron transport in P. aeruginosa 
PAOl by Smith et a l, (1994), this study has characterised the phenomenon further. 
Using a range of inositol phosphate compounds, it has been possible to determine 
several structure-iron transport activities and relate these differences to their relative 
abilities to interact with iron. This study also made some assessment of how these 
compounds yield iron to the bacterium and finally assesses the mechanisms by which 
the bacterium is able to accumulate iron using these compounds.
To determine the key structural elements responsible for myo-InsP6-mediated iron 
transport, a series of iron transport assays was performed using a range of lower 
inositol phosphates. It was evident that these compounds produced a diverse range of 
iron uptake profiles and certain key trends became apparent. Most notable were the 
activities surrounding the 1,2,3 trisphosphate motif and the 1,5 bisphosphate motif. 
Briefly, those compounds possessing the 1,2,3 trisphosphate motif are poor mediators 
of iron transport whereas the 1,5-bisphosphate motif appears to be conducive to 
mediating iron transport in P. aeruginosa. To develop these observations further, the 
hydroxyl radical assay was used to determine the ability of these compounds to 
interact with Fe(III). The 1,2,3 trisphosphate motif appears particularly effective at
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interacting with Fe(III) in such a manner that inhibits hydroxyl free radical 
generation. Such an interaction may, therefore, prevent the compound from 
liberating iron to a putative carrier system resulting in a low iron transport profile. In 
contrast, the 1,5-bisphosphate motif does not appear to be particularly effective in 
inhibiting Fe(III)-catalysed hydroxyl free radical formation. Consequently, the 
enhanced iron transport associated with this motif may reflect the ease with which 
iron is liberated to a putative carrier system. Competition iron transport studies 
indicated that the apparent differences in the affinities for iron are sufficient to 
permit competition for the metal. The inability of myo-InsP6 to compete with a non- 
utilisable pyoverdine for available iron, indicated that inositol phosphate-mediated 
iron transport may not necessarily confer a competitive advantage.
It was also noted that the presence of large functional groups appears to reduce 
inositol phosphate-mediated iron transport. These groups made little difference to 
the ability of 3,6 di-O-benzoyl myo-Ins(l,2,4,5)P4 to interact with Fe(IH) despite 
conferring a low iron uptake profile. This suggests that the large sterically hindering 
groups reduce the ability of the compound to interact with the putative iron transport 
system.
In attempting to assess the mechanisms by which iron is released from the ferri- 
inositol phosphate complex, two key observations were made. Firstly, the use of a 
conformationally restricted compound indicated that the ability of inositol phosphates 
to undergo a change of ring conformation was not an essential component of myo- 
InsP6-mediated iron transport. Secondly, the P. aeruginosa reductase system is
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capable of reducing inositol phosphate-bound Fe(III) to Fe(II) with a subsequent 
release from the ferri-inositol phosphate complex. Whilst Halle and Meyer (1992a) 
noted that P. aeruginosa ferri-siderophore reductase activity was limited to the 
cytoplasm, this study does not indicate whether the ferri-inositol phosphate 
complexes are actually internalised.
Attempts to determine the mechanism by which inositol phosphates mediate iron 
transport into P. aeruginosa noted the importance of the outer membrane and the 
dependence upon active transport systems. Clearly, the outer membrane plays a key 
role as its removal led to considerably enhanced inositol phosphate-mediated iron 
transport and a loss of all structure-iron transport relationships. It was also possible 
to demonstrate specific binding to some component of the outer membrane although 
it was not possible to demonstrate the involvement of a specific outer membrane 
protein. The use of a metabolic inhibitor demonstrated that at least some component 
of inositol phosphate-mediated iron transport was dependent upon active systems. 
Finally, despite considerable attempts, it was not possible to isolate a mutant unable 
to use myo-InsP6 as a source of iron.
In light of the evidence above, myo-InsPg-mediated iron transport in P. aeruginosa 
may occur via a periplasmic-binding-protein-dependent system analogous to the Sfu 
system of S. marcescens. In support of this theory are the observations that both 
citrate-mediated iron transport in S. marcescens and rayo-InsPe-mediated iron 
transport in P. aeruginosa PAOl are unlikely to depend upon a TonB-dependent OM 
receptor although they are both active processes. However, whilst the outer
17 1
membrane plays a key role in inositol phosphate-mediated iron transport in P. 
aeruginosa PAOl, the exact mechanism is unclear. It was demonstrated that myo- 
InsP6 was capable of binding specifically to some component of the P. aeruginosa 
outer membrane, perhaps phospholipids. This mechanism may form the basis of the 
inositol phosphate-bacterial outer membrane interaction. It is unlikely that inositol 
phosphates would traverse the hydrophobic outer membrane due to their highly 
charged structures hence they may simply present iron to a putative carrier system at 
the bacterial surface. The apparent inverse relationship between the ability to 
mediate iron transport and the ability to interact with iron, may reflect the ease with 
which these compounds yield iron to such a carrier system. Such interactions would 
explain why the presence of large sterically hindering groups impair the inositol 
phosphate:bacterium interaction and why D- and L-enantiomers of several 
compounds mediated similar uptake profiles. The free ferric iron released to the 
periplasm may then interact with a periplasmic binding protein analogous to SfuA of 
S. marcescens. Consequently, removal of the outer membrane removes the first site 
of interaction exposing various components of the cytoplasmic membrane transport 
systems. It may be that these components have particularly high affinities for iron 
and there is a subsequent loss of structure-activity relationships as all inositol 
phosphates yield iron readily to these systems.
It can be seen that myo-InsP6-mediated iron transport provides an alternative 
mechanism for iron acquisition. Whilst the exact mechanism of action is unclear and 
may not necessarily confer a competitive advantage in the environment, it does
1 7 2
provide an alternative strategy for iron acquisition that reduces the metabolic 
demands created by siderophore biosynthesis.
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